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Abstract 
 
Adverse drug events (ADE) cause many deaths annually in addition to affecting the 
quality of life of many others. The descriptive mixed methods approach, specifically 
exploratory case study and experimental design that guided this research utilized the 
survey and focus group methods to evaluate perceptions about robotic technology (RT) to 
reduce the rate of ADEs in U.S. nursing homes (NH). There is a lack of scholarly 
research into whether a conceptual approach rooted in RT can be implemented to assist 
with drug administrations in NHs. The purpose of this study was twofold. The first 
purpose was to evaluate the causes of ADEs specifically related to tablets, capsules, and 
pills. The second purpose was to evaluate the perceptions of nurses and administrators 
relative to the use of RT to assist in reducing ADEs. In the quantitative part, the sample 
means from 102 surveys from nurses and administrators were evaluated with the t test 
and the paired t test; while in the qualitative part, survey results, reported errors, and 
focus group data was assessed collectively. The research results did not indicate any new 
causes of ADEs and showed that the participants had a favorable perception of RT. Based 
on the results of this research, RT may be tailored in such a way that it can significantly 
reduce ADE occurrences for citizens in U.S. NHs. 
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Chapter 1: Introduction of the Study 
According to Brandt and Zarowitz (2015), additional research is necessary to 
increase understanding of the complex problem of adverse drug events (ADEs) in nursing 
homes (NHs), especially since many health care systems overall are not optimally 
designed to prevent ADEs. In this regard, each NH participating in this research was 
evaluated regarding how solid drugs, specifically tablets, capsules, and pills, were 
administered in order to determine the causes of ADEs found in these NHs. Researchers 
in the current literature, examined in Chapter 2, identified the need for a new approach to 
substantially reduce ADEs due to the impact and longevity of this known problem 
throughout the medical community. In February 2012, Handler (2012) estimated that 
93,000 NH residents in the U.S. will perish annually as a result of ADEs (p. 1). If 50% of 
these deaths can be prevented, 46,500 lives will be saved.  
In this research, I investigated the utility of a noninvasive form of robotic 
technology (RT) for tackling the profound problem of ADEs in U.S. NHs. According to 
Van den Bemt, Jetske, Robertz, Kormelink, and Pels (2011), research related to the use of 
robotics-based innovations to reduce human-initiated ADEs in NHs does not exist.  
It was appropriate then to evaluate the role that robotics-based innovations could 
serve in preventing thousands of deaths from the consequences of ADEs to determine if it 
could possibly become a viable option. Such a system may be able to overcome many of 
the reasons nurses fail to administer drugs consistently, adequately, and appropriately to 
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all NH residents. A robotic system tailored to assist with drug administrations may be 
able to curtail the overwhelming number of ADEs that occur annually in NHs.  
A decrease in ADEs may lead to a decrease in death rates related to ADEs, thus 
extending human life and improving the quality of care given to thousands of NH 
residents. Also, the unfortunate hardships endured by many families of loved ones 
suffering from the difficulties of an ADE may be greatly diminished. A robotic system 
capable of assisting with drug administrations may be able to provide a medium that can 
offset errors in calculations, shortcomings in expert knowledge, and shortages of 
personnel qualified to administer drugs. 
Chapter 1 includes a short review of current literature that describes what ADEs 
are and the negative impact they have on society. Despite advances in various 
technologies associated with reducing ADEs, scholarly literature on using RT to reduce 
ADEs in NHs is scarce. For that reason, I investigated how nurses and administrators felt 
about using RT for that possibility in addition to analyzing how ADEs occurred from 
several perspectives to answer three qualitative research questions and two quantitative 
research questions. Chapter 1 also contains a description of the parameters within which I 
conducted this research and why this research was important to society.  
Background 
Medication Errors in Nursing Homes 
For several reasons, the number of Americans reaching the age of 65 or older is 
rising (Administration of Aging, 2014, p. 1). In 2013, this segment of the population 
represented 14.1% of the U.S. population and by 2040 the Administration of Aging 
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(2014) estimated that this number will grow to 21.7% (p. 1). As this segment of the 
population grows NHs will increase in their importance to society due to the need for 
specialized care (Harris-Kojetin, Sengupta, Park-Lee, & Valverde, 2013). 
Many Americans will require the assistance of nurses with specialized skills that 
span all levels of care, including the administration of prescribed drugs, in order to 
sustain life. Although NHs are staffed with trained individuals, medication errors in these 
facilities are common and occur on a regular basis (Wittich, Burkle, & Lanier, 2014). In 
fact, Harris-Kojetin et al. (2013) claimed that NH residents are the most at-risk group that 
will suffer from medication errors.  
Bates and Slight (2014) asserted that when these medication errors escalate to 
harm a patient or cause a patient to die, an ADE has occurred. Thus, Bates and Slight 
defined an ADE as an incident that causes unintended harm or death to a patient as a 
result of medications that were given. These events can occur at the preparation or 
administration stage of the medication-use process (Van den Bemt et al., 2011); the 
prescription or delivery stage of the medication-use process (Kiekkas, Karga, 
Lemonidou, Aretha, & Karanikolas, 2011); or the procuring, dispensing, or monitoring 
stage of the medication-use process (Bates & Slight, 2014). While the range is wide-
spread across the medication-use process, Bates and Slight stated that many of these 
events are preventable mistakes regardless of the stage in which they occur.  
Many researchers, whose work is summarized and analyzed in Chapter 2, have 
concluded that the causes of ADEs are numerous and occur during distribution, 
transcription, and administration, but more often during prescription and administration 
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according to Bates and Slight (2014). Researchers who aimed to improve upon 
distribution, transcription, and administrations have used information technology (IT) as 
a contributory tool to combat ADEs. Despite the widespread usage of IT in the medical 
industry (Sekhar, Tariq, Kim, Pridgeon, & Hannaford, 2013), the robotic sector of IT is 
not widely used in the NH industry (Borenstein, 2011). 
In contrast to the lack of usage in NHs, Borenstein (2011) affirmed that robotic 
systems have been successful in dispensing medications in hospital pharmacies. Similar 
robotic systems have also been successful in delivering bulk medications to hospital 
wards, performing intricate surgical procedures, and providing precise telemedicine 
capabilities in intensive care units (Borenstein, 2011; Summerfield, Seagull, Vaidya, & 
Xiao, 2011).  
Evaluation of ADEs in Nursing Homes 
 The medical industry has recognized that ADEs are common (Wittich et al., 2014) 
and cause a substantial financial burden in the U.S. (Harris-Kojetin et al., 2013). Nursing 
homes have also recognized the financial impact of ADEs (U.S. Department of Health 
and Human Services, 2014b) where, according to Harris-Kojetin et al. (2013), the 
financial burden placed on NHs is amplified by the fact that the elderly are at a greater 
risk of encountering an ADE. Barnett et al. (2011) claimed that this risk is magnified by 
the reality that many NH residents suffer from compound medical problems, which 
contributes to their limited physical capacity and inability to communicate symptoms. 
Collectively, these contributions could very easily increase their risk factor of ADEs, 
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especially since many NH residents are taking many drugs simultaneously (Campanelli, 
2012).  
In 2013, Aljadhey et al. (2013) found ADE incident rates at 8.5 per 100 
admissions in an academic hospital in Riyadh, Saudi Arabia. Another study conducted by 
Weiss and Elixhauser (2013) reported ADE incident rates at approximately 75 per 10,000 
for people aged 65 or older who had been discharged from U.S. hospitals across 32 states 
(p. 1). Also in the U.S., Sawarkar, Keohane, Maviglia, Gandhi, and Poon (2012) 
estimated that life-threatening ADEs occurred at a rate of 1.33 per 100 administrations in 
a single hospital (p. 5). Handler (2012) estimated that on average 2 million ADEs occur 
annually for all NHs in the U.S. and as a result of these errors an estimated 93,000 or 
4.7% of NH residents die from related complications (p. 1). Aljadhey et al. reported in 
2013 that death rates exceeded 105,000 people per year (p. 648).  
With an increasing population people 65 years old or older (Administration of 
Aging, 2014, p. 1), these numbers will increase proportionately. Many more will perish, 
and an unknown number will suffer from the unfortunate incidents of ADEs. This is why 
there is world-wide concern over current percentages of ADE incident rates throughout 
the health care industry (Aljadhey et al., 2013). 
 These statistics indicate that previous and current methods, processes, and 
systems have not been able to overcome the significant problem of ADEs in NHs. While 
improvements have been made, the literature indicates that these improvements are based 
on extensions of existing methods, processes, and systems. Despite these improvements, 
the number of elderly persons affected is still overwhelming (Handler, 2012), indicating 
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the need for a new approach. Based on this indication, I examined the perceptions of NH 
professionals on the idea of using RT, one potential approach, to reduce ADEs at the 
administration stage. 
Potential Use of Robotic Technology 
 In a few recent studies, several researchers examined the causes of ADEs in 
hospitals, pharmacies, and NHs. These researchers showed that a significant part of these 
errors can be directly linked to human error. Perhaps human error is one reason IT has 
become so instrumental in the medical industry (Kiekkas et al., 2011; Westbrook, Rob, 
Woods, & Parry, 2011). However, current drug administration systems may still lack the 
capacity to decrease ADEs to where occurrences can begin trending down. To improve 
upon this possibility, various disciplines of IT should be expanded in all stages of the 
medication-use process, particularly at the most vulnerable stages of prescribing and 
administrating (Bates & Slight, 2014). As one of many IT disciplines, RT should be 
considered in the quest to further reduce ADE numbers (Huston, 2013). 
While many systems have been implemented to combat ADEs, the problem 
persists at an alarming rate (Handler, 2012). Perhaps RT should be considered to improve 
upon this alarming rate because of the astonishing successes of RT in other areas of the 
healthcare industry. Some of these successes may not have been possible otherwise 
(Herman, 2012). For example, Philip (2004) found that dispensing errors in hospitals 
within that study’s sample population dropped by 67.1% when pharmacists used robotic 
dispensing systems (p. 282). Just 5 years later, Kirschling, Rough, and Ludwig (2009) 
found that the same kind of system was able to improve the delivery and dispensing of 
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medications from 67.7% to 95.6% in a different set of hospitals (p. 1754). In 2013, 
Francois et al. (2013) conducted a study in the University Hospitals in Geneva, 
Switzerland and found that pharmacists who used robotic dispensing systems were able 
to reduce manual error rates by 66% (p. 88).  
With the rate of ADEs still unacceptably high (Aljadhey et al., 2013), it may be 
possible to emulate the fundamental use of stationary dispensing systems in hospitals in a 
different environment—mobile robotic systems in NHs—to assist nurses at the drug 
administration stage rather than at the dispensing stage. To this end, a different type of 
drug-assisting system may be necessary for long-term residents (in NHs) who typically 
have a consistent drug regimen for a long period of time as opposed to a typical short-
term patient (in hospitals) whose drug regimen is brief, but could change frequently for 
various reasons (Bates & Slight, 2014). Despite many ground-breaking contributions 
resulting from RT, this technology has not been extensively explored as a potential 
alternative to reduce the numerous cases of ADEs in NHs (Wild, 2011). As a result, 
information related to robotic-based innovations to reduce human-initiated ADEs in NHs 
is scarce (Van den Bemt et al., 2011). 
From a broader perspective, RT has transformed many aspects of the 21st century. 
In everything from assisting man in outer space to deep water exploration, from 
manufacturing automobiles to soldering the small components within cell phones, from 
surgical assisting medical equipment to unmanned vehicles, from hospital pharmacies to 
drug manufacturing, RT has played an integral role in advancing society from different 
perspectives (Dahl & Boulos, 2013). Dahl and Boulos (2013) asserted that the need to 
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innovate will ultimately drive more researchers to consider RT to solve many existing 
problems in addition to utilizing it to bring newer and better products and services to 
society. Perhaps this determination and necessity to innovate will result in a system 
capable of keeping ADE numbers low on a large and wide scale throughout the NH 
community.  
Problem Statement 
A substantial amount of current scholarly research indicates that ADEs occur 
regularly in NHs (Wittich et al., 2014; Sawarkar et al., 2012; Bates & Slight, 2014; 
Kruer, Jarrell, & Latif, 2014; Samaranayake et al., 2014). The literature associates this to 
several causes, but the human element may be the primary factor that contributes the 
most (Kiekkas et al., 2011; Westbrook et al., 2011). While NHs have implemented many 
initiatives to combat this problem, it persists, adversely affecting the quality of life for 
many residents. There is an abundance of scholarly research related to ADEs, but there is 
a lack of credible research into how effectively medications might be administered using 
innovative approaches that have been used very little or not at all. Specifically, there is a 
lack of scholarly research into the use of RT for administering drugs in nursing homes. 
As a result, there is an insufficient understanding about whether innovations in RT can 
improve upon human-initiated ADEs of solid medications in nursing homes (Van den 
Bemt et al., 2011; Wild, 2011). 
Purpose of the Study 
The purpose of this mixed methods research was twofold: (a) To evaluate the 
causes of ADEs, specifically related to tablets, capsules, and pills, in a NH environment. 
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(b) To evaluate RT in the same environment, assessing whether nurses and administrators 
think it could be useful in reducing ADEs. In this regard, perceptions regarding the 
potential for RT to reduce ADEs (a continuous numerical variable measuring the average 
response to research questions in a Likert-scale survey) was the dependent (response) 
variable. There were two independent variables in this study: The demonstration of a 
robotic model (a categorical variable reflecting whether the participant was or was not 
shown a demonstration of the model) is the first; and which survey (before and after a 
demonstration of the model) is the second.  
Nature of the Study 
In this mixed methods research, I examined the causes of ADEs related to solid 
medications, specifically tablets, capsules, and pills, administered to residents in NHs. I 
evaluated the results from the qualitative aspect of my research to provide a basis upon 
which to assess alternative methods of reducing the number of ADE occurrences that take 
place in these NHs. Despite the numerous approaches identified in current literature, 
sufficient scholarly research involving RT, one possible solution to solve this societal 
issue, is not available. Other alternatives may include education for doctors and nurses, 
procedure modification and enforcement, communication improvement, staff additions, 
and enhancement of existing techniques. Although all of these alternatives have been 
used in NHs, ADEs still occur on a regular basis.  
An experimental design was the basis for the quantitative portion of my research 
where I investigated if showing a model of RT to nurses and administrators increased 
their acceptance of this technology to assist with solid drug administrations in NHs. 
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Lauer (2004) indicated that at a minimum experimental research must contain at least two 
randomly selected groups (control group and treatment group) so that the independent 
variable (reflecting the treatment) can be manipulated between the groups to determine if 
it influences the dependent variable. To carry out an experimental design, Lauer stated 
that the treatment is always applied to the treatment group whereas the treatment can be 
applied to a lesser degree or not at all to the control group.  
In the quantitative portion of my research, I built a model of RT and used it for 
the purpose of demonstrating how this technology might be used in a NH environment to 
assist with solid drug administrations. To effectively assess how nurses and 
administrators felt about RT designed for this purpose, I selected two separate groups of 
participants (the control group did not see a demonstration of the model and the treatment 
group saw a demonstration of the model).  
Prior to demonstrating the model to the treatment group, I asked both groups to 
take anonymously the RT survey found in Figure B1. Once completed, I demonstrated 
the model to the treatment group, via a group presentation, and asked those nurses and 
administrators to take anonymously the same survey again. Using the responses from the 
survey (before and after demonstrating the model), I was able to obtain data specific to 
the treatment group, the control group, and all participants in general. I then compared 
the perceptions of the two groups.  
The qualitative portion of my research was guided by exploratory case study. 
According to Crowe et al. (2011), case study designs are appropriate when the researcher 
intends to investigate phenomena within their natural environment that they have little to 
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no control over. Crowe et al. added that it is also common for researchers to use case 
study designs when researchers seek to apply new ideas to existing phenomena when 
preliminary research is limited. As a result, how and why questions are formed because 
the borders between the phenomenon and the natural environment are not plainly 
apparent, such as the borders between RT and ADEs in NHs. Perhaps this is why Crowe 
et al. stated that case study research is a comprehensive research strategy that utilizes 
multiple methods to triangulate various sources of data, which can include both 
quantitative and qualitative data, to investigate real-life phenomena. Thus, case study 
designs can effectively led to new theory when new ideas are applied to existing 
phenomena. These characteristics of case study design are applicable to my research.  
In the qualitative portion of my research, I integrated data from the Adverse Drug 
Event (ADE) survey (Appendix A), focus group discussions, and NH error reports in 
order to gain insight into the causes of ADEs. The focus groups was conducted after the 
treatment group has seen the model demonstration, and after both surveys have been 
completed. I gained some insight into the causes of ADEs in NHs from the personal 
perspective of nurses and administrators working in NHs. Thus, the ADE survey contains 
26 questions related to experience, training, and guidelines & procedures, which are the 
three main areas associated with ADEs according to current literature. 
I entered the data from the ADE surveys and from the focus group discussions 
into the NVivo analysis software, where I compared and contrasted the results with 
reported reasons that contribute to ADEs. By combining actual and perceived causes of 
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ADEs, my research led me to understanding the phenomenon more clearly, which will 
contribute to the success of any new measures to reduce the high rate of ADEs.  
Research Questions and Hypotheses 
To conduct this research, I evaluated nurse and administrator perceptions on why 
ADEs occurred in NHs. This evaluation extended further to assess the administration of 
solid drugs to residents to evaluate if there were procedural components that may also 
lead to ADEs. The causes of ADEs (related to solid drugs only) obtained from various 
data sources was identified to determine what and how errors occurred between residents 
and nurses.  
Also, critical to this research was an evaluation related to nurse and administrator 
perceptions regarding the use of RT to assist in drug administrations. An evaluation from 
this perspective was necessary to determine if ADEs could possibly be reduced with 
some type of robotic system capable of dispensing medicines. Specifically, this research 
study was guided by the following five research questions (RQs); the first three pertain to 
the qualitative portion of the study and the last two pertain to the quantitative portion:  
1. How are drugs administered in the participating nursing home? 
2. How do ADE errors in the form of pills, tablets, or capsules occur in nursing 
homes? 
3. What knowledge do managers have of existing practices to reduce ADEs? 
4. Do nursing home professionals have a favorable perception about the potential 
for RT to reduce ADEs?  
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5. Do nursing home professionals have a more favorable perception about RT to 
reduce ADEs after viewing a demonstration of that technology? 
RQs 1 through 3 were informed through the analysis of focus groups, document 
analysis, and the responses that I obtained from the ADE survey (Appendix A). RQs 4 
and 5 were informed by a quantitative analysis (hypotheses and hypothesis tests) of the 
RT surveys (Figure B1). In Chapter 3, I will elaborate on the mathematical expression of 
the hypotheses and the data collection and analysis required to evaluate them. 
Responses to the RT survey (Figure B1) were used to inform a response variable. 
In the survey, the response is based on a Likert scale ranking value of +1 to +5, with +3 
indicating a neutral response (neither favorable or unfavorable). Thus, the higher the 
response, the more favorable the respondent’s perception of RT became. Since it was 
unknown how NH professionals may be influenced by viewing or not viewing a robotic 
model, several hypotheses were used to address RQs 4 and 5.  
Van den Bemt et al. (2011) noted that the use of robotic-based innovations to 
reduce ADEs in NHs is scarce. Regarding RQ4, it was possible that the participants 
overall may not view RT for reducing ADEs as a viable option in NHs. This means that 
nurses and administrators may have some difficulty in accepting or understanding an 
innovation that does not currently exist, regardless of whether they see a demonstration of 
the technology, via a model, or not. 
Thus, the research hypothesis for RQ4 is that the mean response (nurse and 
administrator perceptions of RT) from all participants prior to the treatment group 
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viewing the model is greater than the neutral response. This would indicate whether or 
not the participants feel RT may change the rate of ADEs in NHs.  
Regarding RQ5, it was possible that an actual demonstration of a model of RT 
would influence nurses and administrators to have a more favorable view of RT for the 
purpose of reducing ADEs in NHs. This determination could only be accomplished if the 
model is viewed by one group (treatment group) and not by another (control group). 
Hence, I assessed the data to understand nurse and administrator perception of RT from a 
broader perspective. Thus, for RQ5 I evaluated five hypotheses. 
The first research hypothesis for RQ5 was that the mean response for the 
treatment group after the demonstration is greater than the mean response for the control 
group (on its second survey, administered after the demonstration). This would indicate a 
favorable impact on those who viewed the demonstration compared to those who did not.  
The second research hypothesis for RQ5 was that the mean response from 
participants from the treatment group after viewing the demonstration is greater than a 
neutral response. This would indicate that the treatment group felt RT (as demonstrated 
by the model) may decrease the rate of ADEs in NHs.  
The third research hypothesis for RQ5 was that the average paired difference in 
responses from the treatment group before and after viewing the demonstration is greater 
than zero. This would indicate that these participants felt more strongly about the benefits 
of RT after viewing the demonstration.  
The fourth research hypothesis for RQ5 was that the average paired difference 
from the control group, from two surveys (one before and one after the treatment group 
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views the demonstration), is greater than zero. In the third research hypothesis, I 
attempted to determine if there was a difference in response for the treatment group after 
viewing the demonstration. This was, of course, the second time the treatment group took 
the survey. Thus, it was important to understand if that difference was solely the result of 
seeing the demonstration; or, if it was related to taking the same survey a second time. As 
a result, there was a need to evaluate the control group who took the survey a second 
time, but without seeing the demonstration. So, in this fourth hypothesis, I attempted to 
determine if there was a difference in the response for the control group between the first 
survey and the second.  
Recall that for the treatment group and the third research hypothesis, if there was 
a difference, then one of two things happened. Either the treatment group watching the 
demonstration made a difference or taking the survey a second time made a difference. 
To eliminate the second reason, I performed the same hypothesis test for the control 
group during a second round of the survey after the treatment group viewed the 
demonstration. The control group showed no difference in response during the second 
survey, which provided evidence that taking the survey a second time did not influence 
the results.  
The fifth research hypothesis for RQ5 was that the average paired difference from 
the treatment group is greater than the average paired difference from the control group. 
In this research hypothesis, I compared how much the treatment group response changed 
before and after viewing the model, to how much the control group response changed 
from taking the RT survey (Figure B1) the first time to the second time. This research 
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hypothesis would indicate that the treatment group had a more favorable view of RT as a 
result of seeing the demonstration than the control group which did not view the 
demonstration. 
Conceptual Framework 
A conceptual approach rooted in the successes of RT in other industries and in 
other aspects of the medical industry is presented in this research as one possible 
alternative to accomplish a reduction in ADEs. Many researchers have investigated the 
drug administration issue extensively, but according to Aljadhey et al. (2013) no one has 
published a comprehensive solution to reduce ADEs of all types throughout the medical 
industry. This calls for continued, more in-depth investigation into the causes, which 
potentially calls for new and innovative approaches to solving this long-standing 
problem. Over the last decade, RT has advanced a great deal and has brought benefits to 
society that otherwise may not have been possible (Sekhar et al., 2013). Perhaps this 
technology can be configured in such a way that it could also make a substantial positive 
impact for this particular social issue as well.  
My research was guided by five RQs that were designed to investigate the 
acceptance of RT to reduce ADEs. With these questions, I gained insight into the causes 
of drug administration errors from three perspectives: actual causes of ADEs, why nurses 
and administrators believe ADEs occur, and the effect of internal policies and procedures 
on ADEs. The rationale for my research stemmed from the call for further research into 
ADEs and the lack of consideration of RT as a solution. Consider Bates and Slight’s 
(2014) conclusion that stated many of the most serious cases of ADEs are preventable 
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while Van den Bemt et al. (2011) concluded that ADEs are due to many types of 
medication errors. Kiekkas et al. (2011) concluded the same as Van den Bemt et al., but 
added that these types of medication errors should undergo continued investigation.  
Continued investigation suggests that the causes of ADEs are vast and that not 
enough is known to produce a system capable of reducing many of the preventable ADEs 
that Bates and Slight (2014) described. Perhaps the missing piece of this investigation is 
the personal perspective of the nurse, the administrator, and the medication-use policies 
and procedures in place in NH facilities. These perspectives collectively were not 
investigated in the literature that I reviewed in Chapter 2. It is possible then that these 
perspectives could play a vital role in discovering new information relative to the causes, 
which could contribute to significant progress on reducing ADE numbers, especially 
since these perspectives are present in all NHs where ADEs occur.  
Definitions 
ADE: an incident that causes any type of harm or death to a patient as a result of 
medications that were administered to the patient (Bates & Slight, 2014, p. 1027). 
Early/late administration: administration of the transcribed medication 60 
minutes or more before the prescribed time (early) or administration of the prescribed 
medication 60 minutes or more after the transcribed time (late) (Barker, Flynn, Pepper, 
Bates, & Mikeal, 2002, p. 1897). 
Improper dosage: administration of a drug quantity, either in strength, weakness, 
or number, that was different from the prescribed order (Barker et al., 2002, p. 1897). 
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Improper technique: an incorrect administration of a prescribed medication as a 
result of exclusion, inclusion, or incorrect execution of any portion of the administration 
procedure indicated in the chart or as indicated by the manufacturer of the medication 
(Barker et al., 2002, p. 1897). 
IT: acronym referring to information technology.  
Medication errors: the error of execution, which is an event where there is failure 
to complete a planned medication action as it was originally intended; error of planning, 
which constitutes an error resulting from the use of a wrong plan to achieve an aim 
(Institute of Medicine, 2004, p. 30). 
Model: executable specifications of a particular system that imitates a real-world 
system or hypothetical system (Murphy & Wakefield, 2013, p. 39). 
No administration: an absolute failure to administer a prescribed medication 
according to the transcribed order in the chart (Barker et al., 2002, p. 1897). 
NH (nursing home): acronym associated with a privately operated establishment 
where maintenance and personal or nursing care are provided for persons (as the aged or 
the chronically ill) who are unable to care for themselves properly (Webster’s Ninth New 
Collegiate Dictionary, 1983, p. 812). 
r (perception): the response (dependent) variable, individual nurse and 
administrator perception of the potential for RT to reduce ADEs (as measured using a 
survey). 
R (sample mean): the mean response of a sample (nurse and administrator), 
measuring average perception of the potential for RT to reduce ADEs. 
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RT (robotic technology): a noninvasive subset of robots that are programmed to 
navigate independently based on human instruction with the ability to assist in drug 
administrations based on pre-assignment of specific drug cabinets for specific residents 
(Borenstein, 2011, p. 87). 
RQ (research question): refers to one of five research questions that the research 
addresses. 
Simulation: an act that uses a model to understand behaviors, characteristics, or 
outcomes of a proposed extension to an existing system, imitation of an existing system, 
or to a new concept (Sokolowski & Banks, 2009, p. 155). 
Wrong medication: the negligent act of administering a medication that was not 
ordered or transcribed for a particular resident (Barker et al., 2002, p. 1897). 
Assumptions 
I assumed that the administration of drugs in the participating NHs was managed 
by a non-robotic system. In conjunction with the assumption of non-usage of a robotic 
system, I assumed that nurses would have no insight into how RT could work for the 
purpose of assisting with the drug administration task and would be willing evaluate the 
use of RT to potentially aid in the reduction of ADEs. In lieu of an actual robotic system, 
I built a model to demonstrate how the technology would work. I assumed that the model 
was an accurate and appropriate replica of a similar real-world system where medications 
are interconnected with some type of barcode technology. Thus, a simulation using this 
model would sufficiently gauge its intended purpose, which was to assess nurse and 
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administrator perceptions about RT for the purpose of assisting with drug 
administrations.  
Scope and Delimitations 
The research population was composed of three NHs within a 60-mile radius of 
the Memphis Metropolitan area that were categorized as NHs or skilled nursing facilities. 
According to the U.S. Census Bureau (2012), there are 15 other metropolitan areas across 
the U.S. of comparable size, approximately 1 million to 1.6 million citizens. The 
Memphis Metropolitan area was chosen because it is the closest and largest metropolitan 
area where I live that has a large number of NHs of various sizes and qualities to 
randomly choose from. This location also made collecting the data very convenient. 
Based on the literature I reviewed in Chapter 2, there have been no studies related to 
ADEs in NHs conducted in this geographical area. 
The participating NHs were chosen based on a 5-point quality scale designed by 
the Centers for Medicare and Medicaid Services (CMMS) to rate overall care in NHs. 
NHs rated as 1, the lowest ranking, encountered many care issues while NHs rated as 5, 
the highest ranking, encountered very few care issues (CMMS, 2015). The research 
population was composed of three NHs where the associated quality ratings were 1, 1, 
and 2. The CMMS (2013) counted 2,848 out of 15,661 NHs in the U.S. that had a quality 
rating of 3 or below (p.1). Based on this statistic, the results from this research can be 
generalized to approximately 18% of all NHs in the U.S.  
To more appropriately represent the population of NHs in the U.S. one small (less 
than 90 beds), one medium (between 90 and 180 beds), and one large (180 beds or more) 
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NH was recruited for this research. The classification of size was based solely on the 
number of beds to create the range of small, medium, and large. The small NH had 88 
beds, the medium NH had 119 beds, and the large NH had 211 beds.  
To conduct this research, I asked a specific group of nurses and administrators at 
each participating NH to participate in a survey. From this group of participants, I 
established two groups where I asked one group (treatment group) to view the robotic 
simulation (via a presentation) and the other group (control group) to refrain from 
viewing the simulation. To reduce the possibly of obtaining biased results from the two 
groups, I did not mention the model to the control group. NH residents were not a part of 
the study sample, because the simulation did not interface directly with residents. I asked 
only administrators and nurse supervisors from the same sample used for the survey to 
participate in a focus group discussion due to their availability and indirect care of 
residents. 
 Specific to delimitations, I used simulation to demonstrate limited functionality of 
a robotic system via a model. The model simulated assisting with the administration of 
solid drugs, specifically tablets, capsules, and pills, omitting all other categories of drugs. 
It was necessary to limit the categories of drugs because of the sheer number of drugs NH 
residents take and the delimitations in the simulation as opposed to a fully functional 
robotic system. An actual robotic application on a NH ward involving drug 
administration activities between nurse and resident did not take place.  
 This research was also delimited by three NHs. The inclusion of other NHs would 
have added a substantial amount of time and cost to collect the data. Therefore, the 
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sample size was relatively small, but represented NHs based on a quality care rating of 3 
(average) or less on a 5-point scale as determined by the CMMS (2015). Similarly, this 
research was confined to 10 solid drugs only, a delimitation that was considered in order 
to adequately demonstrate the model to nurses and administrators in a short period of 
time. It was also confined to solid drugs only to simplify the complexity of the simulation 
to make it practical and realistic. 
Limitations 
My research was limited by two factors. First, the data acquired from the focus 
group and the survey may not represent accurate accounts of ADE experiences by each 
nurse and administrator taking part in this research. Second, it was necessary to use a 
simulated system in place of a real robotic system. As a consequence, it was not possible 
to fully explain the technology in a staged demonstration as compared to a real robotic 
system being used by nurses on the NH ward.  
Significance of the Study 
It is inevitable that human-initiated mistakes will occur at the drug administration 
stage in NHs. As indicated in the literature, the medical industry and the scholarly 
research community have realized that this problem is quite severe. This realization has 
spurred numerous research studies related to ADEs, which have produced measures that 
have reduced ADE numbers along with adding to the body of knowledge related to this 
phenomenon. Even with current successes, the problem of ADEs in NHs still persists at 
an alarming rate (Handler, 2012). Therefore, continued scholarly research to lessen the 
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effects that ADEs have on society, especially on the elderly who rely on others for their 
care in NHs, is necessary.  
 Existing strategies may not have the capacity to reduce ADEs on a bigger scale, 
which supports the need for more scholarly investigation of existing measures and new 
innovations, such as a noninvasive form of RT. RT has proven instrumental in various 
aspects of the medical industry, but Van den Bemt et al. (2011) reported that the use of 
robotics to reduce ADEs in NHs virtually does not exist.  
It was possible that the simple model presented in this research would not 
convince nurses and administrators that robotics-based innovations would reduce ADEs 
at the administration stage by a great margin. Still, this concept may spur other 
researchers to expand upon it to where great margins may eventually be accomplished to 
garner positive social change on a bigger scale. As a result, more lives will be saved 
within a growing elderly population that will depend on NH care in the future.  
An actual robotic drug administration assisting system would be successful if it 
were noninvasive and improved administration accuracy of prescribed medications well 
beyond current success rates expressed in the literature. If an additional 30%, 40%, or 
50% of the 93,000 NH residents Handler (2012) estimated will die from ADEs could be 
isolated from them, the ending years of life for these seniors would at least be protected 
from this particular social issue. 
Summary 
The literature briefly mentioned in Chapter 1, and analyzed in greater detail in 
Chapter 2, clearly indicated that there is a significant problem with ADEs in U.S. nursing 
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homes. According to the Administration on Aging (2014), the number of Americans 65 
years old or older is growing rapidly. As this trend continues, more and more Americans 
will be compelled to rely on NHs for extended care, but if ADEs are still prevalent, 
extended care for many will suffer due to ADEs. It is critical then for this social issue to 
undergo continued research to find plausible solutions that will consistently reduce the 
number of ADEs to where it is not a significant problem. 
 There are multiple ways the problem of ADEs could be addressed. Current 
literature indicated that researchers and businesses have found RT to be instrumental in 
many ways. The medical industry, in particular NHs, is finding new ways to incorporate 
RT in caring for a growing elderly population. Soler et al. (2015) noted that social robots 
are currently being used in NHs as an alternative therapeutic treatment for diseases such 
Dementia and Alzheimer’s. Heylen, Van Dijk, and Nijholt (2012) conducted a study to 
evaluate the drawbacks of such robots to determine their validity for uses associated with 
the elderly. Borenstein (2011) noted that it is realistic to consider robotic systems in NHs 
because these systems can eliminate inconsistent behaviors that lead to ADEs.  
Before any possible solutions can be explored with regards to significantly 
reducing ADEs in NHs, additional research must be done to determine the causes. 
Consequently, I carried out a comprehensive investigation into the causes of ADEs in my 
research. To support this investigation, I used a mixed methods approach to gain a 
holistic understanding of these causes so that both a quantitative and qualitative 
perspective can be considered. I collected the data from historical records (ADE errors 
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reported by the NH to the National Institute of Health), simulation, survey, and focus 
group.  
In Chapter 2, I intend to document a thorough examination of existing studies 
related to ADEs in NHs. In this examination, I will explore existing methods, processes, 
and systems currently being used, as identified in the literature. In Chapter 3, I will justify 
the use of the mixed methods research method to describe how it was instrumental in 
exploring this phenomenon and include a thorough description of the data collection 
design previously mentioned. In Chapter 4, I will detail the results of the pilot study, and 
explain how the model was verified and validated for use in this research. I will also 
present a comprehensive description of the data and disclose thorough answers for each 
RQ. In Chapter 5, I will share my interpretation of the data, limitations that may have 
affected this research, recommendations for future research, and the implications for 
positive social change.  
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Chapter 2: Literature Review 
In this chapter, I will examine existing literature on medication errors that may 
lead to unintended ADEs in NHs. Within this examination, I will also discuss some of the 
existing methods, processes, and systems that are currently in use for drug administration, 
with particular emphasis on mobile robotic drug-assisting systems. My examination will 
conclude with a summary on the possibility of utilizing RT in such a way as to reduce the 
rate of ADEs at the administration stage.  
It was unclear from the literature just how many NH residents are affected by 
ADEs. It is clear, though, that the numbers are staggering, and with the elderly segment 
of the population poised to grow, so will the incident rate of ADEs. In fact, Parker-Pope 
(2011) reported that medication errors resulting in ADEs have risen more than 58% in the 
last few years, increasing from 1.2 million reported ADEs in 2004 to 1.9 million in 2008 
(p. 1). Even more startling is that these figures relate only to hospitals. When hospitals 
and NHs are considered together, the number of people affected by ADEs yearly could be 
well over 2 million. Just in medium-sized NHs (50 to 105 beds) in the U.S., Handler 
(2012) claimed that at least 2 million ADEs will occur annually (p. 1).  
Moore, Cohen, and Furberg (2007) highlighted the issue of ADEs from a 
compelling perspective. Based on information-related to voluntary reports of ADEs 
gathered by the US Food and Drug Administration, Moore et al. showed that between 
1998 and 2005 adverse medication reactions grew from 34,996 to 89,842 while fatal 
ADEs grew from 5,519 to 15,107 (p. 1752). If non-reported cases were known and 
included in these figures, it is reasonable to suggest that the figures would be much 
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higher than what is currently documented. Even with the known cases, this upward trend 
clearly suggests that this issue is quite prevalent and will continue to increase, unless our 
knowledge related to ADEs is extended far enough to reverse this trend.  
The literature indicated that researchers agree that a vast number of ADEs are 
preventable, yet they still occur (Bates, 2014; Tsao, Lo, Babich, Shah, & Bansback, 2014; 
Kruer et al., 2014). This could have indicated then that existing methods, processes, and 
systems are not adequate to further reduce the high numbers of preventable ADEs 
(Handler, 2012). According to Handler (2012), NHs should trend towards the use of an 
intelligent and reliable medication monitoring system to detect and manage ADEs from a 
broad perspective. Therefore, expansion of existing methods, processes, and systems 
alone may not be sufficient, unless expansion incorporates a high degree of intelligence 
and reliability. To this end, some form of a computerized system, such as RT, should be 
considered as a new approach to solve this problem. 
Literature Search Strategy and Analysis 
The literature that I reviewed throughout this chapter was gathered from a variety 
of electronic databases and sources. The electronic databases included ProQuest EBSCO, 
Academic Search Complete, ScienceDirect, PubMed, and GoogleScholar. The electronic 
sources included government websites such as the National Institute of Health, the 
Administration of Aging, and the U. S. Department of Health and Human Services. The 
peer-reviewed literature acquired directly from the electronic databases and sources were 
found using keywords such as medication errors in NHs, medication errors, adverse drug 
event in NHs, robotics in NHs, and reducing medication errors. These key search phrases 
  
 
28 
were identified by reading both peer-reviewed and non-peer-reviewed literature. The 
reference lists were successfully mined for additional sources. 
Since this research was based on the claim that ADEs are a significant social issue 
that is common in today’s society, an exhaustive and widespread view of current 
literature was necessary to describe that this is indeed a fact. For this reason, the selection 
of literature was broad to describe the definition, causes, effects, and prevention of ADEs 
in NHs. The literature also contained sources that described technologies that have been 
used and several that have not been used to highlight the possibility that RT might be 
instrumental in significant reduction of ADEs in NHs. The selection criteria resulted in 
over 85 sources, where approximately 60 qualitative and quantitative sources were 
chosen due to their relevance, thoroughness, and credibility to assess recent knowledge 
related to ADEs. 
Definition of an ADE 
Bates and Slight (2014) defined an ADE as an incident that causes unintended 
harm or death to a patient as a result of medications that were administered to the patient. 
An ADE can occur when a patient is given a wrong dosage that leads to an unwanted 
situation, like the loss of functions, confusion on the part of the patient, or rashes; or it 
can occur when medications cause allergic reactions (Brandt & Zarowitz, 2015; Wittich 
et al., 2013). An ADE can also occur as the result of administering the wrong medication 
to a patient or from administering the right medication in the wrong manner to a patient 
(Bates & Slight, 2014). Thus, ADEs are the result of medication errors that cause 
accidental harm, injury, or death.  
  
 
29 
According to the Institute of Medicine (2004), these medication errors can be of 
two types: 
1. Error of execution, which is an event where there is failure to complete a 
planned medication action as it was originally intended.  
2. Error of planning, which constitutes an error resulting from the use of a wrong 
plan to achieve an aim. (p. 30) 
Causes of ADEs 
A recent study conducted by the Agency for Healthcare Research and Quality 
(2001), also referred to as AHRQ, advocated that medical experts should embrace the 
fact that the causes of ADEs are divergent and varying. This means that no single cause 
can be identified as the root of such occurrences. In a typical health care facility setting, 
several factors can cause ADEs. However, AHRQ pointed to the fact that medication 
errors that result in injury or death are common across major hospitals. The reason why 
medication errors could comfortably be assigned by the research study as the major cause 
of ADEs is due to the fact that the medication-use process itself has several stages, which 
could have a number of different errors and mistakes.  
Perhaps it is for this reason that AHRQ (2001) pointed out that various studies 
recognized that errors are likely to occur at all stages of the medication-use process, 
which includes ordering, transcription, dispensing, administering, and monitoring. If each 
stage is prone to a portion of errors and mistakes, then reasonably it can be expected that 
medication errors would account for the greater percentage of all forms of ADEs. 
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Subsequently, there are some researchers who actually hold the opinion that ADEs and 
medication errors are inseparable.  
Regardless, medication errors resulting in patient injury or death are significant 
among hospitalized patients across all stages of the medication-use process (Bates & 
Slight, 2014). In NHs, medication errors are usually experienced at the prescription and 
administration stages (Kiekkas et al., 2011). The frequency of such errors usually 
depends on the specifics and intensity of the error-detection systems in use. 
Kiekkas et al. (2011) found that the methods of detecting errors vary at different 
stages of the medication-use process. Conversely, Campbell, Karnon, Czoski-Murray, 
and Jones (2007) claimed that error-detection systems that are utilized for every stage, 
except direct observation of administration, suggest that the rate of prescription errors per 
patient on a daily basis is 1.3% for omissions and 0.53% for commissions (p. 26). In 
another study, Van den Bemt et al. (2011) employed the use of direct observation relative 
to drug administration and observed that there was a medication administration error rate 
of about 21.2% or 428 errors out of 2,025 observed (p. 489). 
A medication error may result either from an act of omission or from an act of 
commission, which could lead to unfortunate harm to the patient and inaccurate 
administration of the medication (Aljadhey et al., 2013). For instance, there could be a 
prescription of the wrong dosage or the administration of the wrong dosage for medicines 
prescribed for a patient. Medication errors can also be due to the patient’s failure to take 
his or her medication or the caregiver’s failure to give the patient his or her medication. 
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Aljadhey et al. (2013) categorized these examples as diagnostic, treatment, and 
preventive types of medication errors.  
The available data on the issue of incorrect drug administration in NHs indicates 
that care transition between home care provision and institutional care provision 
represents a high level of risk (Brandt & Zarowitz, 2015). This may be because the 
regimens for medication are frequently altered during this kind of care transition. Thus, 
further research about the ways in which interactions can be improved between these 
stages of the medication-use process is called for. As such, all the concerned parties must 
acknowledge this problem and strive to properly evaluate the various approaches that can 
be employed in tackling these issues. 
Effects of ADEs 
The effects associated with ADEs were described by AHRQ (2001) and Wittich et 
al. (2014) as being divergent and varying. This is because the effects of ADEs take on 
many different forms in various health care settings. 
ADEs would bring about cost disincentives to the NHs due to the varying 
consequences that ADEs carry. For example, in many events of ADEs, there are injuries 
and loss of lives to patients. Once this happens, compensation should be paid to deserving 
patients and their families. It is these legal costs and compensation disincentives that 
often leave NHs and hospitals susceptible and liable to huge financial losses. According 
to the U.S. Department of Health and Human Services (2014a), also referred to as 
USDHHS, ADEs alone accounted for as much as $5 billion in expense annually in U.S. 
hospitals and NHs (p. 9). Indeed, this shows that there are heavy financial effects that 
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ADEs carry. Therefore, one of the best ways for healthcare facilities to trim unnecessary 
expenditures (and therefore increase their bottom line) is to ensure that there is a drastic 
reduction in the actual cases of ADEs.  
In conjunction with susceptibility and liability, AHRQ (2001) brought to light that 
in a given year, ADEs could be responsible for as many as 770,000 injuries and deaths 
taking place across various hospitals (p. 1) while in NHs Handler (2012) estimated that 
approximately 93,000 deaths occur annually (p. 17). Injuries resulting from the 
inappropriate use of medications create a variety of adverse drug reactions, most of which 
are not fatal (Bates & Slight, 2014), but still detrimental for the patient. In such 
situations, patients will suffer unexpectedly from the reactions they go through.  
Research indicates that adverse reactions are not always easily observed. Brandt 
and Zarowitz (2015) noted that nurses are in the best position to detect drug reactions, 
symptoms, and injuries that take place on the surface. Early detection is a critical factor 
to reduce ADEs as it gives medical experts much room to rapidly treat them. However, 
some reactions and injuries take place internally, where visibility virtually does not exist, 
unless the aide of medical equipment is used. It is these internal reactions and injuries 
that actually pose the greatest threat of the death (Samaras, Chevalley, Samaras, & Gold, 
2010). What is even worse in some cases is that medical experts have not been able to 
identify injuries early enough, because many adverse drug reactions take place gradually 
and over a long period of time.  
In fact, Samaras et al. (2010) claimed that some reactions resulting from 
medication errors are asymptomatic, until such a time that they become deadly. All in all, 
  
 
33 
the indication that seems present at this point is that medical experts have a very huge 
obligation in ensuring that they switch to the best means of reducing the effect, which is a 
preventive means. Otherwise, omission to manage these effects typically leads to dire 
consequences from multiple perspectives.  
Further review of the literature revealed that morbidity and mortality resulting 
from ADEs is costly (Harris-Kojetin et al., 2013). Parker-Pope (2011) estimated that 
about 1.9 million preventable ADEs happened in the U.S. in 2008 (p. 1) in addition to an 
estimated 1.9 million hospitals stays that occurred annually as a result of ADEs 
(USDHHS, 2014a). Therefore, the cost of morbidity and mortality resulting from 
preventable ADEs is astronomically high, even though many studies have identified 
various causes of ADEs. Perhaps this high cost can be attributed to different processes 
applied to the medication-use process (Bates & Slight, 2014) and the various policies set 
by governing bodies at the state and local level (O’Shaughnessy, 2013). Combined, these 
policies and medication activities typically create a complex environment that contributes 
to the risk of morbidity and mortality resulting from ADEs. 
Health care administrators and managers face severe financial consequences when 
ADEs occur (Wittich et al., 2014). For example, when news of injuries, deaths, and 
financial losses are repeatedly reported about in their facilities, they cannot expect the 
same level of patronage as before. Thanks to computers and the Internet, access to news 
and information is easier today than in years past. As a result, patients, residents, and 
other patrons of health care facilities have the ability to quickly spread news of ADEs 
that have taken place in a particular facility. 
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Furthermore, the spread of such negative reports may become worse when 
patients or victims are not given the best of customer relations in explaining the 
circumstances surrounding an ADE event. Subsequently, attendance to the facility may 
dwindle, and administrators and managers may suffer intense pressure. There could be 
constant monitoring by external health care supervisors (Kruer et al., 2014), and upon a 
number of warnings related to repeated cases, the health care facility could potentially 
face closure. When the problem reaches this stage, it could be said that the very worst has 
happened. Therefore, it is important to take every needed action to ensure that cases of 
ADEs do not become habitual or repeatable. To that end, the next section of the literature 
review looks at ways of preventing ADEs. 
Prevention of ADEs 
The reviewed literature overwhelmingly contended that most ADE events caused 
by errors in the medication-use process are preventable (Barnett et al., 2014; Bates & 
Slight, 2014). Medication errors as a result of human mistakes account for the greater 
portion of those causes (Westbrook et al., 2011). In much the same way, AHRQ (2001) 
revealed that minimizing medication errors would subsequently be a major step in 
preventing and eradicating ADEs. AHRQ is therefore of the opinion that instead of 
looking at the prevention of ADEs as a holistic intervention, more attention should be 
given to the prevention or eradication of various forms of medication errors in health care 
facilities overall. This approach would be especially effective in NHs, where Campanelli 
(2012) found that a majority of residents are taking several drugs daily.  
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In contrast, Aljadhey et al. (2013) asserted that limiting the prevention effort to 
minimizing medication errors would achieve only partial results. The fear is that ADEs 
may not be prevented in the long run if attention is paid only to medication errors. 
Similarly, according to the study conducted by AHRQ (2001) there are those who 
contend that medication errors and ADEs are inseparable while others reject the opinion 
that ADEs and medication errors are synonymous.  
My research was based on the premise of AHRQ (2001), which held the view that 
prevention of medication errors should be the main focus in trying to achieve prevention 
of ADEs. AHRQ suggested that the best way to reduce cases of medication errors is to 
institute a systematized technology that incorporates the principles of modern 
computerized systems. Therefore, the major aim of my research was to investigate the 
use of RT to possibly reduce ADEs. 
Many of the studies funded by AHRQ (2001) showed that computerized systems 
can be instrumental in efforts to reduce medication errors and ADEs. Computerized 
systems have the capacity to detect ADEs, which makes vital information available to 
administrators and managers from which they can create effective interventions and 
mitigation strategies to minimize these ADE events. These results are promising since 
previous studies have indicated that 28% to 95% of all ADEs are preventable. If 
computerized systems are used to prevent medication errors, the number of preventable 
ADEs may be greatly reduced.  
Computerized interventions may potentially reduce the rate of medication errors 
in NHs. These computerized interventions include the use of automated dispensing 
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devices, pharmacy dispensing robotics, bar coding connected with computerized records 
for medication administration, automated point-of-use distribution systems, and 
computerized physician order entry systems (Van den Bemt et al., 2011). Externally, 
other tools, such as third party monitoring, used in tracking medications that patients 
have actually taken have also proven to be especially beneficial.  
Sawarkar et al. (2012) believed that more emphasis should be given to prevention 
strategies to combat ADEs rather than focusing on incidence rates, especially since many 
administration errors go undetected. This approach requires comprehensive medication 
management where up-to-date records of medication regimens—including prescription 
and non-prescription drugs, patient-specific drug and food allergy information, and 
medications taken and not taken, along with dietary supplements—are readily available 
throughout the health care facility. This can be efficiently carried out through the use of 
RT coupled with other computerized systems.  
The quality of patient care can improve when healthcare workers are coordinated 
with ready access to patient medication information (Brandt & Zarowitz, 2015), 
especially if the patient suffers from chronic conditions, sees numerous providers, or 
takes multiple medications. Perhaps the rate of medication errors can be reduced due to 
well-informed and engaged health care workers. These improvements can range from 
routine actions like double-checking patients’ prescriptions to the more complex actions 
like forging an active partnership with providers in the management of health care.  
In order to reduce ADEs in NHs and achieve a culture of safety, it is important for 
the management tier of health care organizations to devote an adequate amount of time 
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and attention to safety issues. Additionally, they should also ensure that resources are 
available for safety teams and improvement of quality in NHs (Cunningham et al., 2011). 
As such, management would have to authorize investment into technological resources 
that have a proven record of efficacy, which may not currently be implemented on a large 
scale in NHs. These technological resources include, but are not limited to, electronic 
health recording systems and computerized provider systems for entering orders.  
Current Systems Used to Combat ADEs 
Traditional Ambulatory Reporting Systems 
 For some time, a number of health care facilities have depended on the efficacy of 
traditional ambulatory error-reporting systems in combating ADEs. The traditional 
ambulatory error-reporting system, which is referred to in some quarters as a medication 
ambulatory error-reporting system, has its own strengths and advantages, such as being 
easily accessible and cost effective (Zafar, Hickner, Pace, & Tierney, 2008). Despite 
these few advantages, some researchers have claimed that a medication ambulatory error-
reporting system is not viable in controlling or preventing most modern cases of ADEs. 
For example, Gandhi et al. (2003) noted that medication error-reporting, specific to 
outpatient practices, has declined in recent years due to hectic processes, limited access to 
comprehensive patient medication regimens, concerns of liability, and constant fear of 
potential bankruptcy proceedings.  
What is more scaring is that the factors listed in Weiss and Elixhauser (2013) 
research are multidimensional, which means that the use of traditional ambulatory error-
reporting systems renders itself ineffective in combating ADEs through several scopes 
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and means. By design, a traditional ambulatory error-reporting system seeks to identify 
errors and report them as soon as possible. However, because this is mostly done through 
a manual process, a large percentage of ADEs go unreported.  
Mayer, Dowsett, Brahmavar, Hornbuckle, and Brookfield (2010) indicated that 
while in 2008 the FDA received reports of 527,000 possible ADEs from drug 
manufacturers and 33,000 directly from healthcare facilities (p. 15), the FDA still 
believed that this was only a small fraction of all ADEs that actually occurred in 2008. 
This implies then that for various reasons healthcare facilities are not reporting all cases 
of ADEs to the FDA. Even more disturbing is the number of actual and potential ADEs 
that go unreported by nurses to the facility itself. It is difficult to find ways of reducing 
the number of ADEs when so many are unreported and the causes are widespread. 
Electronic Prescribing 
 At first glance, electronic prescriptions appear to be a noble alternative to 
eliminate the possibility of ADEs at the prescription stage. According to Wittich et al. 
(2014), any chance of misreading handwritten prescriptions from doctors is eliminated. 
Prescribed medications can be cross-referenced with the medical history of the patient to 
virtually eliminate any chance of a drug allergy or an adverse reaction caused by another 
drug. Because prescription information along with prescription history is stored 
electronically, multiple entities, such as hospitals, NHs, and pharmacies, can all have 
access to the same information, provided they have adequate computer systems.  
 When clinical decision support software is coupled with electronic prescriptions, 
the chance to reduce error rates of ADEs is heightened (Kruer, Jarrell, & Latif, 2014). 
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Kruer et al. (2014) claimed that this software can provide nurses with extensive 
information that can aid in the care of a patients drug regimen in addition to extensive 
advice on any drug a patient might be taking. If nurses need to understand the 
consequences of new drugs, a combination of drugs, or substitute drugs, they can inquire 
within the clinical decision support application to potentially avoid an ADE. Huston 
(2013) found that these systems can also be a plus for nurses to overcome issues such as 
poor competency in drug calculations, and to make them more efficient and effective at 
the drug administration stage.  
Specialized Systems 
 Beyond traditional means of trying to prevent ADEs, namely non-computerized 
processes and procedures, several specialized systems were identified in the literature for 
this same purpose. The existence of these specialized systems indicates that the problem 
of ADEs is widespread and very difficult to solve (Wittich et al., 2014). However, it 
might be possible to expand upon these specialized systems in some capacity to produce 
a new system that may render a greater degree of success in reducing ADE error rates. 
Bates and Slight (2014) recognized the potential for this possibility by supporting the 
idea that information technology should be used in a greater capacity for prescribing, 
administering, and dispensing. Perhaps information technology should be considered for 
all stages of the medication-use process, especially since ADE error rates are still high 
(Handler, 2012).  
 According to Sawarkar et al. (2012), many ADEs manifest into injuries because 
these events are typically not detected or not reported. This implies then that nurses fail 
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from multiple perspectives to effectively manage these events before they become critical 
to the patient. In response to this failure, (Wittich et al., 2014) suggested that an 
alternative strategy was necessary to offset these misses, which appear quite prevalent 
with traditional means of managing drug administration in NHs. Referred to as a trigger 
tool, their alternative strategy sought to increase the efficiency of detecting ADEs by 
adding a manual systematic examination of charts, where the aim was to identify from 
recorded writing in charts anything that may indicate that an ADE has occurred or might 
occur.  
 In another study conducted by Van den Bemt et al. (2011), the use of an 
automated medication dispensing system was deployed to determine what effect it might 
have on reducing ADE error rates. As a type of robotic system, this system focused 
primarily on dispensing the right medication for the right patient. This indicates that the 
other stages of the medication-use process are still vulnerable to ADEs, especially since 
many studies have found a high number of errors to also occur during other stages of the 
process. However, this kind of system has the potential to greatly reduce ADE incident 
rates at the dispensing stage. Pedersen, Schneider, and Scheckelhoff (2012) described the 
usage of three distinct types of automated dispensing systems that were instrumental in 
reducing error rates at the dispensing stage: automated dispensing cabinets, stationary 
robotic systems using bar-code technology, and carousels.  
 The technique associated with these systems depict a stationary system confined 
within the hospital pharmacy where error reduction was emphasized at the dispensing 
stage. The pharmacists and pharmacy assistants using these systems were not 
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administering medications directly to patients. Rather, they worked in a limited area and 
were only concerned with filling orders that flowed into the pharmacy, via the computer 
system, that would eventually be delivered to a particular ward in the hospital. The 
robotic-based approach proposed in my research extends this technique where the 
dispensing system is transformed into a mobile, self-guided, patient-specific system that 
can assist nurses in administering medications as needed in various locations in a NH. 
Therefore, a system to enhance protection against ADEs at the administration stage rather 
than the dispensing stage is closer to the actual point of giving the medication to the 
patient, which may decrease ADE error rates in NHs.   
Some attention has been given to the potential of RT to reduce ADE error rates at 
the administration stage in hospitals. In 2011, Summerfield et al. (2011) evaluated the 
effectiveness of a robotic medication courier system to deliver drugs from the hospital 
pharmacy to the intensive care unit. In 2013, Chen, Shen, Gurna, and Wu (2013) 
evaluated the usage of a robotic arm located in a hospital pharmacy to accurately fill 
patient prescriptions related to cancer treatments. In 2014, Samaranayake et al. (2014) 
implemented a bar-code assisted medication administration system in a teaching hospital 
in Hong Kong to reduce ADE error rates. Collectively, these self-guiding systems had a 
direct impact on ADE numbers in hospitals, but the fact that ADE numbers are still high 
in NHs (Handler, 2012) may inspire additional research to tailor these systems for the 
purpose of assisting with drug administrations in NHs.  
 While these systems have shown various degrees of reducing ADEs (mainly at the 
dispensing stage in the medication-use process), the implementation of these systems was 
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confined to hospitals. It is unknown what effect they may have in NHs. Perhaps some 
level of success with these systems can be achieved in NHs too, but arguably, they will 
have similar effects as were noted in the various hospitals. Aljadhey et al. (2013) 
recognized that the ideal technological system would be quite complex. Because no one 
system can definitively reduce ADE error rates from all perspectives, a collaborative 
combination of systems may be the answer to achieve ADE reduction from multiple 
perspectives rather than from an isolated single perspective (Wittich et al., 2014).     
Robotic Technology 
The available literature suggested that robotic systems cannot perform many of 
the tasks that require the cognitive and intellectual skills necessary to care for NH 
residents. However, RT may be instrumental in NHs for the performance of repetitive, 
non-cognitive, and non-intellectual tasks. In order to take advantage of its consistency, 
RT should be considered as an alternative approach to assist nurses in administering 
drugs. Herman (2012) acknowledged that significant opportunities exist for assistive 
robotic technologies designed to interface directly with NH residents to help them with 
various activities. These opportunities could also include a different category of assistive 
RT that could directly aid the health care worker who takes care of the NH resident. My 
research investigated the utility of a robotic system that would assist nurses in drug 
administrations to reduce ADEs, which is one avenue to improve upon the quality of life 
for NH residents. 
Further, the available literature on medication errors indicated that there is a high 
level of risk inherent in the period of transition between primary home care for patients 
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and their placement in NHs. Bates and Slight (2014) found that medication regimes are 
prone to be altered during this transition. Thus, there is a need for further research into 
methods of improving communication systems between these two periods of time. In 
order to do this effectively, there must be proper acknowledgement of the issues involved 
and a thorough evaluation of alternative approaches that can be employed, including the 
use of RT. 
A major strategy that can be used for reduction of errors during the transition 
period between primary/home care and NH care is the reconciliation of the medication 
orders between both points. This is especially relevant to outpatient situations, but also 
between different points within the NH. Kruer et al. (2014) mentioned that computerized 
prescribing is of great importance in outpatient settings, although this strategy might not 
yield visible safety benefits if additional decision support is not provided. This 
reconciliation may also involve carrying out a comparison of current medications being 
taken by the patient against medications being provided onsite so as to avoid any 
omission or transcription errors, drug-to-drug interactions, disease-to-drug interactions, 
and the possibility of duplicate therapy. The use computer technologies, including RT, 
can greatly enhance this process, and can help in determining the origin of such 
discrepancies (Bates & Slight, 2014). 
There are some important gaps and methodological issues about medication errors 
in the existing literature that I reviewed. One such gap is the perceived emphasis on safe 
usage of medicines, which should be adjusted to focus not only on incidence rates, but 
also on strategies that can be employed for error prevention. The use of RT should 
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incorporate clinical decision support and reconciliation of prescribed medications, based 
on the fact that Wild (2011) found that these components have been instrumental in 
reducing ADEs.  
Since medication administration is the last and most susceptible stage of the 
medication-use process, employing a combination of technologies at this stage would 
most likely be of great significance (Sawarkar et al., 2012). These technologies could 
include the use of electronic records for medication administration and machine-readable 
identification and matching. These technologies can be linked robotically and 
electronically in order to improve documentation of the medicines that have already been 
taken. 
The importance of computerized administration management and decision support 
related to ADEs in NHs cannot be overstressed. However, this area has received 
inadequate attention, as there seems to be only a small amount of research about the 
efficacy of computerized administration and decision support in NHs (Van den Bemt et 
al., 2011). The implementation of computerized methods of administration within this 
setting can also be quite challenging because NHs typically have limited resources.  
Gap in the Literature 
 Extensive research has been conducted to investigate the issue of ADEs from 
various perspectives. As a result of this research, many of the existing measures, systems, 
and approaches involve some form of information technology to reduce ADE 
occurrences. Despite the successful approaches mentioned earlier in this chapter, ADEs 
are still prevalent in U.S. nursing homes (Handler, 2012). This means that there is a need 
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to look into other possibilities, such as expanded applications of existing information 
technologies (Samaranayake et al., 2014), which may be able to trend ADE error rates 
down.  
 Borenstein (2011) noted that serious attention should be given to the practicality 
of robotic systems based on recent successes of these types of systems in hospital 
pharmacies. However, scholarly research related to the viability of robotic systems in 
NHs to assist with the drug administration task is scarce (Van den Bemt et al., 2011). 
This assertion appears true, because from the extensive literature search review I 
conducted, there were no studies that directly investigated the usage of RT in NHs to 
assist with drug administrations. Very little attention has been given to this particular 
possibility (Huston, 2013), which clearly indicates that it is a gap in the literature. Since 
ADEs negatively affect the quality of life of so many elderly citizens relying on NH care, 
it is worthy to explore this possibility to the fullest extent.  
Justification for Research Approach 
The premise of the mixed methods research lies in the utilization of both 
quantitative and qualitative methods in a single study. The characteristics of both 
methods are employed by the researcher to accomplish the intended goal of the research. 
Farquhar, Ewing, and Booth (2011) classified mixed methods research as a pragmatic 
approach to acquiring knowledge, where the knowledge claim is based on hypothesis 
outcomes and subjective conclusions related to actions, situations, and consequences. 
This approach guides the researcher to ask both closed and open ended questions to 
obtain data that may reveal more than one possibility. Thus, data collected from the 
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mixed methods approach is subjected to statistical and textual analysis to understand the 
phenomenon from different worldviews and assumptions.  
O’Byrne (2007) acknowledged that mixed methods requires the researcher to use 
qualitative techniques for one aspect of a study and quantitative techniques for another 
aspect of the same study. Otherwise, significant results would not be possible if equal 
investigation from both perspectives is not conducted. Therefore, both inductive and 
deductive reasoning is performed. Grinnell and Unrau (2011) added that a mixed 
methods study can begin with either the qualitative portion or the quantitative portion (p. 
352). Regardless of which portion the researcher begins with, the ultimate goal is to gain 
new knowledge about the phenomenon being studied by leveraging the respective 
benefits of each method.  
In a general sense, quantitative data analysis tools are rooted in the physical 
sciences, because quantitative data analysis tools are designed to take objectivity and 
reliability into account since emphasis is placed on objects that do not involve people 
(Mangan, Lalwani, & Gardner, 2004). Quantitative research involves a standardized and 
structured method of data collection. In contrast, qualitative data analysis tools are based 
on analyzing content that comes in a non-numerical manner. By adopting a qualitative 
approach, the researcher gains the opportunity to develop multiple themes, some of which 
may be different from any anticipated expectations at the beginning of the study.  
Quantitative research on the other hand, seeks to quantify the data by applying 
widely accepted statistical analysis (Craig et al., 2008). It also involves the quantification 
of the relationships between variables and can be used for proving a theory or 
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substantiating a hypothesis. Although results obtained through quantitative methods of 
research may provide less detail about human behavior than qualitative methods, human 
attitudes and motivation can be more effectively gauged through samples that represent 
potential trends in the population.  
Both quantitative and qualitative research techniques are valuable and are used to 
complement one another. However, for my research, a mixed methods technique was 
more suitable than either approach alone, due to the severity of ADEs that occur during 
the drug administration stage. Therefore, much attention should be given to exploring this 
stage from a quantitative and qualitative perspective. Any decision to employ a single 
approach would reveal a great deal, but a single approach may leave important 
information undiscovered.  
Data Collection Methods 
 When researchers embark on any research study, the question of which data 
collection method should be used or would be the most appropriate usually surfaces. 
According to Farquhar et al. (2011), researchers should choose methods that have the 
greatest chance of providing diverse information about the problem being studied. 
However, this approach may be difficult for new researchers due to their limited 
knowledge of either qualitative or quantitative approaches. Among social researchers, 
Farquhar et al. contended that mixed methods research is growing in popularity, meaning 
social researchers would have to be familiar with both approaches. It is critical then for 
the data collection method to coincide with the nature of the study and that the researcher 
is up to par on the chosen approach.  
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 A combination of positivism and interpretivism obtained from a mixed methods 
approach is gaining interest among health and social researchers who study complex 
problems (Farquhar et al., 2011). These researchers are free to choose methods that 
complement each other to enhance the depth of understanding related to the problem 
being studied. It is important, though, that researchers choose an appropriate set of 
methods based on predetermined notions of what techniques will acquire the greatest 
results. Determining the cause of ADEs in NHs is an emerging event, because the causes 
randomly occur based on various situations (Wittich et al., 2014). Therefore, to gain a 
greater understanding of ADEs in NHs beyond what is present in current literature, it 
may be necessary to use a combination of methods to view the issue from a positivism 
and interpretivism perspective simultaneously.  
To gain insight into whether NH personnel will embrace robotic systems to assist 
with drug administrations, the researcher must assess their perspective as to whether this 
approach would meet their needs. Since robotic systems are not currently being used in 
NHs for this purpose, a survey will provide a medium to acquire some feedback to 
evaluate this approach.  
 Given that the process of administering drugs is a social interaction that takes 
place in various locales within the NH facility, the mixed methods design is ideal to begin 
discovery of the acceptance of robotic systems in this environment. A major advantage of 
the mixed methods design is that it calls for a combination of data collection methods. 
These in turn give the researcher an opportunity to gain a greater comprehension of the 
phenomenon, simply by exploring related data broadly. A deeper interpretation of ADEs 
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can be achieved if reported causes are combined with a specific list of related questions 
synthesized with verbal assessments of the when, why, and how.  
Furthermore, data collected from secondary methods can enhance the validity of 
data collected from primary methods, if the datum from any secondary method correlates. 
For example, the data collected from a focus group can either support or refute data 
collected from a survey within the same study. Thus, correlation can be determined in 
regards to validity of the data collected from the two methods. An advantage of using a 
focus group is that enhanced conversation can occur in a single setting with individuals 
who are close to the issue. A standard set of questions can be elaborated upon directly 
with the participants or expanded upon based on responses from the participants. With 
these advantages, the researcher has a great opportunity to collect a rich set of data by 
asking appropriate questions relative to the conversation that can support the data from 
another method.  
 If only a single method is used as the primary data collection tool to evaluate 
ADEs, the data may be insufficient to determine the full realm of ADE causes. Survey 
participants can very easily fabricate their answers, which would not reveal the true 
nature and causes of ADEs. Participants of focus groups can very easily exaggerate ADE 
instances they witnessed, actually caused, or simply heard about. Verbal feedback in this 
setting can be untrue, partially true, or influenced by peer pressure, which also weakens 
the context of the data. Flawed discovery of the nature and cause of any phenomenon is 
not the aim of scholarly research. These possible scenarios highlight the need for 
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researchers to be aware of their choices and the consequences that they may bring to their 
research.  
Verification and Validation of Models 
In general, Sargent (2013) noted that models are commonly used to design new 
systems, extend existing systems, and research new approaches to existing problems. 
Sokolowski and Banks (2009) added that a model can be used to substitute a real system 
to gain new understanding of some particular aspect of it. Sargent further noted that every 
model should be predicated on a specific purpose. Consequently, each implementation of 
a specific purpose is to study a real-world or proposed system (Law & Kelton, 2000), 
which is the fundamental utility of a model.  
According to Feinstein and Cannon (2001), a main problem with a model is that 
the degree of effectiveness depends on the model’s intended purpose. Stated another way, 
the validity or acceptable range of accuracy, as predetermined by the model designer, is 
based on its intended purpose (Sargent, 2013). In some cases it is critical for the model to 
function exactly as intended without errors, issues, or concerns. In other cases it is 
acceptable if the model is not exact, meaning it is acceptable if the model functions close 
to the real system. Perhaps this is why researchers must take into consideration the 
constructs of fidelity, verification, and validity to justify the acceptable range of accuracy 
in either case.  
Model Fidelity 
The fidelity of a model is concerned with the perception of the learner on how 
real the simulation seems when it is compared to the real-world system (Feinstein & 
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Cannon, 2001). Ignoring this consideration may lead to creating a model that is 
insufficient to carry out the intended purpose. Therefore, the designer should place 
emphasis on the equipment associated with the model to create a high degree of similarity 
to the real-world system relative to the environment. Sargent (2013) cautioned though 
that it is costly to obtain absolute fidelity of a model, meaning some of the equipment 
used to develop the model may be different from the real thing. Sokolowski and Banks 
(2009) described this difference as an approximation of the real thing.  
Because approximation is a possibility in the construct of models, it is critical for 
the designer to test the model until the acceptable range of accuracy Feinstein and 
Cannon (2001) described is accomplished. Otherwise, the model is invalid and not 
sufficient for the intended purpose. However, Sargent (2013) noted that even for models 
that are deemed valid, the designer should be cognizant that the model still may not 
handle all situations in the environment in which it will be demonstrated.  
Model Verification 
 Feinstein and Cannon (2001) asserted that verification and validation go hand in 
hand. Verification is ensuring that the implementation of the model is correct (Sargent, 
2013); it is a process by which the designer applies various approaches to determine if the 
model produces the desired results (Feinstein & Cannon). Validation, on the other hand, 
is the process of determining that the model satisfies its intended goal within the 
established domain of accuracy (Feinstein & Cannon; Sargent).  
 According to the definitions of verification, designers cannot render a model 
correct if it contains serious errors. Depending on the type of model, mathematical or 
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symbolic, different approaches to verification may take place. For instance, a 
mathematical model may be verified through debugging software while a symbolic 
model may be verified by accomplishing all the conditions of a well-crafted plan that 
incorporates all possible outcomes of the intended purpose (Sokolowski & Banks, 2009).  
Both mathematical and symbolic models can also be validated through 
comparison testing, where the results from multiple variations of the same model are 
compared for consistency (Sokolowski & Banks, 2009). Regardless of the type of model, 
whenever possible the verification process should involve subject matter experts who can 
objectively evaluate the fitness of the model by comparing it to a real system (Feinstein 
& Cannon, 2001). The general outcome from this approach reduces risk, builds 
confidence, and reinforces justification that the model will be able to meet the intended 
purpose.  
Model Validation 
 In tandem with verification is the process of validation. Sokolowski and Banks 
(2009) defined validation as a cyclical process of testing to ensure that the model meets 
its intended purpose as determined by the model designer. As part of the cyclical process 
of testing, the designer is tasked to assess the degree of accuracy of the model’s 
representation of the real system by the results that it produces as compared to 
expectations set during the design stage of the model. This means that a model may 
produce results that may be close to being accurate or vary slightly among multiple tests 
and still be deemed valid by the designer.  
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However, Sargent (2012) cautioned that if a model fails to meet any of its 
predefined experimental conditions, it cannot adequately represent the pertinent aspects 
of the real-world system. Thus, the results from testing the model will be invalid. Even 
with this possibility, Sokolowski and Banks (2009) noted that the degree of accuracy 
depends on the intended purpose of the model and how it is tested. Ultimately, the degree 
of accuracy is the level of confidence that the designer has in the model based on the 
results it produces as compared to the expected results (Sargent, 2013). 
Advantages and Disadvantages of Modeling and Simulations 
 Sokolowski and Banks (2009) presented a general list of advantages and 
disadvantages that are common in modeling and simulation. Perhaps the biggest 
advantage of simulation is the ability for the designer to confirm feasibility ahead of 
investing time, money, and resources into building a real system (Murphy & Wakefield, 
2013). It is far easier to adjust and test a model for various conditions repeatedly than it is 
to design, redesign, and retest the real thing repeatedly. By using simulation to confirm 
feasibility, model designers have the ability to introduce various behaviors, if desired, to 
see how the model will react.  
Since models typically imitate real systems, investigating the effect of various 
behaviors and addressing any problems that result from them are important in 
ascertaining that the model is valid (Sokolowski & Banks, 2009). This investigation 
could also reveal unforeseen constraints, which could expose a weakness in the model, 
causing the developer to revise the model’s functionality to enhance its validity. In this 
regard, Sargent (2013) acknowledged that modeling and simulation provide a means to 
  
 
54 
develop in-depth understanding and research of a hypothetical or proposed application. 
Therefore, the model must be fit to accomplish the goal of understanding and research.  
 Sokolowski and Banks (2009) noted that the results of a simulation do not have to 
be conclusive to render the simulation successful. In general, what-if questions may arise 
with respect to the outcome of the simulation, but for simulations where inferences are 
avoided, what-if questions are expected. In either case, adjustments to the model may 
become necessary, which extends the time of when the model could become real. 
Sokolowski and Banks declared that this is acceptable because stakeholders should be 
confident in the simulation results before investing money and resources to develop the 
model into a real system. On the other hand, sometimes a real system is not the goal. 
Instead, the real system already exists, but the goal of the simulation is training, which is 
typically better and more cost effective versus training on the real system.  
Simulations Using Models 
Sokolowski and Banks (2009) explained that a model, which imitates a particular 
real-world system, is the instrument used by simulation. Thus, simulation is an act that 
uses a model to understand behaviors, characteristics, or outcomes of a proposed 
extension to an existing system, imitation of an existing system, or to a new concept. 
Murphy and Wakefield (2013) stated that models used within simulations are executable 
specifications of a particular design. Therefore, as the specifications change, so does the 
model which gives the designer the opportunity to refine the model so that it eventually 
functions as desired to accomplish its intended purpose.  
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Sokolowski and Banks (2009) noted that simulation is no longer primarily used 
only by military branches for training activities. Simulation is also used in many other 
areas, such as business, politics, transportation services, social sciences, and health 
sciences (Sargent, 2013; Sokolowski & Banks, 2009). Stakeholders in these industries are 
concerned about the viability of the targeted approach, but before investing time, money, 
and resources into the approach, they are looking for some assurance that the approach 
has a high probability of success as determined through simulation. For example, Old 
Dominion University and the Virginia Model, Analysis, and Simulation Center combined 
their efforts to establish a research program for the purpose of developing models to 
represent innovative solutions for a variety of problems that persist in the medical 
industry (Sokolowski & Banks, 2009). The outcomes of their simulations ultimately 
determine go-forward decisions to invest time, money, and resources to transform models 
into real-world systems.  
In simulation, the model is typically put through repeated trials to determine its 
fitness with respect to its intended goal. Stated another way, it is necessary to execute the 
model many times to verify and validate that it produces a consistent result over time 
relative to the environment that it is designed for. However, in some cases a model is 
merely a one-time show or demonstration of its intended purpose. Sokolowski and Banks 
(2009) called this facet of simulation experience, where the model is designed for the 
purpose of new development or for the enhancement of motor skills, decision-making 
skills, or operational skills. Therefore, the usage of a model to demonstrate experience 
can be investigated through simulation.  
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Simulation, which executes a model, can be used when the real system is 
unavailable. In other words, this could be because the real system does not exist or 
because engaging the real system could be hazardous to human life (Sokolowski & 
Banks, 2009). This latitude provides model designers with the opportunity to investigate, 
by way of simulation, the feasibility of ground-breaking innovations beyond what 
currently exists. Murphy and Wakefield (2013) asserted that simulation used in this 
manner is a significant contributor to ground-breaking innovations that eventually 
become real-world systems.  
Summary and Conclusion 
The literature that I reviewed in Chapter 2 presented overwhelming evidence that 
ADEs are a significant problem in NHs and hospitals. While there is no single definition 
for an ADE, Bates and Slight (2014) presented a simple explanation of what constitutes 
an ADE; an ADE is any type of injury or death to a patient as a result of medication they 
were given. However, the types of injuries that result are quite vast, which may be a 
contributing factor into why this problem is persistent and difficult to solve. AHRQ 
(2001) and Wittich et al. (2014) described it as divergent and varying.  
ADE errors can occur in all stages of the medication-use process (Bates & Slight, 
2014), where human involvement is required to order, transcribe, dispense, and 
administer medications. These mistakes degrade the quality of life for unfortunate 
recipients. Some patients even die from them. Health care facilities are negatively 
affected by the huge financial costs associated with the effects of ADEs. In this regard, 
professionals from the medical industry and the scholarly research community realize the 
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severity of this problem and are actively carrying out research to decrease the high 
number of ADEs reported in the literature.  
Even with recent advancements, such as traditional ambulatory reporting systems, 
computerized error-reporting systems, electronic prescribing, and various types of 
specialized systems, AHRQ (2001) suggested that researchers should investigate the 
extended use of technology as a viable alternative to reduce ADE numbers further. This 
implies that current forms of technology should be evaluated in new ways to produce 
innovation that might have a positive impact on this problem. For instance, RT has 
brought many benefits to society, particularly in the medical industry, but with regards to 
ADEs, the utilization of RT has been very limited in the NH setting (Van den Bemt et al., 
2011). 
Even with an investigation into RT as a possible solution, a broader view of the 
causes of ADEs must be understood, especially since ADE numbers are extraordinary 
(Handler, 2012). None of the literature that I reviewed in Chapter 2 approached 
exploration of the problem from multiple perspectives simultaneously. Perhaps this 
limitation limited progress. Regardless, it is crucial to understand the natural causes of 
the issue firsthand along with the personal perspective of management and the employee 
in the same arena at the same time.  
Farquhar et al. (2011) supported the idea of using multiple methods, because the 
researcher typically acquires a more comprehensive view of the problem, which increases 
the depth of understanding. Relative to my research, it was necessary because ADEs are a 
long standing problem that can have devastating effects on patients, their family, and 
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often times the NH. In this case, a mixed methods approach is called for. With this type 
of approach, naturally occurring cases, along with the personal perspective of those 
directly involved with the drug administration task in NHs, can be analyzed both 
qualitatively and quantitatively. In Chapter 3, I describe my research design in detail and 
how the gap in the literature (the scarce usage of RT to reduce ADEs in NHs) was 
addressed.   
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Chapter 3: Methodology 
The first purpose of this mixed methods research was to assess the causes of 
human-initiated ADEs of solid drugs, namely tablets, capsules, and pills in the NH 
environment. The second purpose was to assess the perceptions of nurses and 
administrators in regards to the usefulness of RT to aid in reducing the frequency of 
ADEs within NHs.  
To carry out the second purpose, I built and utilized a physical model to 
demonstrate RT to a limited group of nurses and administrators within Memphis-area 
NHs. Primary data collected via the focus group method, the survey method, and 
historical records (past ADE errors reported to the National Institute of Health) was used 
to address the RQs. This chapter contains a detailed description of the research design 
and methodology that I chose to explore ADEs and the robotic simulation that was 
demonstrated to nurses and administrators. Further details in regards to how the chosen 
research design and methodology was instrumental to explore this issue are forthcoming 
in this discussion. In this narrative, I also provided a rationale for the chosen data 
collection design, selection logic of the participants, justification for the sample size, 
instrumentation, and how the design helped me answer the RQs and test six hypotheses. 
In addition, the data analysis plan was expressed along with possible threats to validity 
and issues of trustworthiness. 
The plans expressed for this research were reviewed and conditional approval was 
granted by the Institutional Review Board (IRB) on November 9, 2015. Approval to 
proceed in conducting this research was contingent upon providing the IRB with a signed 
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letter of cooperation from each of three community research partners. The Walden IRB 
approval number associated with this research is 11-09-15-0123805. 
This research was conducted in two randomly selected NHs in the Memphis 
Metropolitan area and one randomly selected NH slightly outside of the Memphis 
Metropolitan area. Among the three NHs, collectively more than 368 residents were 
being cared for during this research. In comparison to the Memphis Metropolitan area, 
there were 15 other metropolitan areas across the U.S. of comparable population size of 
approximately 1 million to 1.6 million citizens. The Memphis Metropolitan area was 
chosen because it is where the researcher lived, which made collecting the data easy and 
convenient to acquire.  
The three NHs selected for this research had three distinct characteristics: size and 
quality. First, one NH was small (less than 90 beds), one NH was medium (90 to 180 
beds), and one NH was large (more than 180 beds). Second, selection was based on 
availability to participate in this research. Third, selection was based on a medium quality 
rating of 3 (out of 5) or less to eliminate any bias in the results due to the quality rating of 
the NH. According to this scale established by the CMMS (2015), a rating of 1 was the 
lowest ranking, meaning these NHs were plagued with a high number of care issues. A 
rating of 5 was the highest ranking, meaning these NHs did not have a high number of 
care issues.  
Research Design 
This research was guided by the mixed methods approach, where both 
quantitative and qualitative methodologies were used in the analysis of the data. The 
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basis for the qualitative portion was exploratory case study and the basis for the 
quantitative portion was an experimental design. This approach allowed me to utilize a 
variety of instruments, including surveys and focus groups, analyzed both qualitatively 
and quantitatively.  
The mixed methods approach permitted me to examine ADEs from two 
viewpoints. First, according to Sawarkar et al. (2012), nurses are primarily responsible 
for administering drugs in the NH setting. Therefore, there is a direct relationship 
between ADEs and the administration activities nurses perform. For this reason, it was 
necessary to understand what circumstances caused nurses to make mistakes during 
administration activities that led to ADEs.  
Second, the issue of ADEs is so critical (Parker-Pope, 2011) that for ethical, 
employment, and legal reasons nurses may refrain from reporting or admitting to drug 
errors that they may have caused. While this is a serious consideration to ponder, 
additional consideration was taken to understand how and why errors at this stage of the 
medication-use process occurred. From this research, I gained insight from varying 
angles how to possibly minimize drug administration mistakes so that any new approach, 
such as RT, can be designed in a manner that would help reduce ADEs. Based on 
previous studies in this area of research (as noted in Chapter 2), RT has not been used to 
assist with drug administration in NHs (Borenstein, 2011). This deficiency makes the 
mixed methods methodology ideal to begin discovering the possibilities of this approach.  
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Design Composition 
The study design entailed five parts. In the first part, I planned to investigate 
historical ADE data collected and reported by each participating NH over a consecutive 
3-month period of time within the last six months prior to my research. A current 
timeframe provided me with the opportunity to evaluate recent occurrences of ADEs. 
Within this investigation, I focused specifically on solid drugs, because the model was 
designed and constructed only for drugs that come in solid form. Regardless, this 
limitation still allowed effective triangulation with the data that I collected from the 
survey and the focus group. To protect the privacy of the historical data, I asked the NH 
only for the name of the drug, the time of day associated with the ADE, and the reason 
for the ADE. 
In the second part, I used two separate 5-point Likert scale surveys. I used the 
ADE survey (Appendix A) for a qualitative assessment of how nurses and administrators 
believe ADEs may occur related to the areas of experience, training, and guidelines & 
procedures. The results from the ADE survey helped to answer RQs 1, 2, and 3. I used 
the RT survey (Figure B1) for a quantitative evaluation of how nurses and administrators 
feel about RT for the purpose of assisting with solid drug administrations to reduce 
ADEs. The results from the second survey helped to answer RQs 4 and 5.  
Prior to administering either survey, I explained the nature and purpose of both 
surveys to all participants. I did not explain that I would assign them to a control group or 
to a treatment group. I also did not make the participants of the control group aware that 
the treatment group would see a demonstration of RT. As far as the control group knew, 
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they would simply be taking a survey, twice, regarding RT’s feasibility in a NH 
environment. The treatment group was told, separately, that they would see a 
demonstration of RT. 
For the control group, I explained the reason for taking the survey a second time 
as follows. It was necessary for me to obtain a second round of responses to determine if 
distractions or interruptions may have caused a variance in their initial responses, 
especially since everyone (participants) would not be available at the same time. I 
explained that I was seeking their honest and objective perceptions of the use of RT to 
assist in drug administrations in NHs. To make this determination, I only needed to re-
survey some of the participants instead of all participants.  
After answering a few questions that arose, I asked all participants to immediately 
and anonymously take both surveys. By administering both surveys at the same time, I 
limited disruption to their work schedule in addition to saving time to collect and 
organize this segment of the data. After one week, I asked the control group participants 
to take the RT survey (Figure B1) for a second time. The time delay between the first 
time the control group took the survey and the second time was intentional. By waiting a 
week, the participants may be less likely to remember all of the answers they provided on 
the first occasion, and this was the case. Thus, taking the survey again and after a period 
of time allowed me to determine if their responses changed simply because they took the 
survey a second time.  
The 1 week delay took place in advance of but just prior to demonstrating the 
model to the treatment group and in advance of the treatment group taking the RT survey 
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(Figure B1) a second time (after they view the model). I anticipated that this timing 
would minimize any influences and biases that the treatment group may impose on the 
control group relative to them viewing the model and taking the survey on the second 
occasion.  
 In the third part, I introduced the model to the treatment group to gain their 
individual perspectives on using RT, after they saw a demonstration of how the 
technology would work, to assist in drug administrations. By demonstrating the model to 
the treatment group and not to the control group, I had the opportunity to determine if a 
physical demonstration of the model would influence their answers to the RT survey as 
compared to the control group. 
Both groups were comprised only of administrators, registered nurses, licensed 
practical nurses, certified nurse assistants, and one nurse practitioner. Direct interaction 
between the model and the participants did not occur, because I built the model for 
demonstration purposes only. For this reason, I did not use the model on the NH floor to 
interact with actual residents. I merely demonstrated the model in a conference room that 
was designated by the lead administrator at each participating NH. 
In the fourth part, which began immediately after demonstrating the model, I 
asked the treatment group to take anonymously the RT survey (Figure B1) a second time. 
This timing allowed me to acquire data that expressed how the treatment group thought 
about RT before seeing the model and how the treatment group thought about RT after 
viewing the model. To prevent interfering with their work activities, I granted each 
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participant from the treatment group five days from the day of the demonstration to 
complete the RT survey for the second time. 
After the survey period concluded, I began the fifth part where I gathered the 
thoughts and opinions of administrators (including nurse supervisors) via a focus group 
discussion guided by the focus group questions listed in Appendix D. Since 
administrators do not typically administer medications, the focus group approach was 
ideal to capture their perspective on ADEs. In addition, the focus group provided me with 
a means to obtain some insight into current processes and procedures deployed within 
each NH.  
By assessing the issue of ADEs with three data collection methods, I was able to 
integrate the data from each method to thoroughly answer the RQs and gain a greater 
understanding of ADEs at the administration stage. I executed all five parts in each 
participating NH separately and in succession. 
Research Rationale 
The design framework for my research was comprised of a group presentation (a 
demonstration of a model of robotics technology), two surveys, and a focus group 
discussion. The scholarly literature covering these methods was described in Chapter 2. 
This design served two purposes. First, combining the data collected from these methods 
provided the means to associate quantitative and qualitative data to assess the issue of 
ADEs comprehensively. By acquiring multiple perspectives on the same issue, a 
profound level of understanding would most likely emerge during the research (Farquhar 
et al., 2011). Since the issue of ADEs in NHs is a serious problem that is costly from 
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multiple viewpoints (USDHHS, 2014a), it was necessary to understand as much about the 
issue as possible in this research, so that any potential solution can achieve minimizing 
ADEs on all points.  
Second, understanding from multiple viewpoints was critical to my research. 
Currently, many individuals suffer from ADEs and others die, despite valiant efforts by 
past researchers to find better solutions. With the population of the elderly gradually 
increasing (Administration of Aging, 2014), so will the number of seniors who rely on 
NHs for their care. Similarly, the number of individuals suffering or dying from ADEs 
will increase too, unless a universal solution can be found to keep ADE numbers low. 
Because a universal solution has not been found, a broader view of different segments of 
data at the same time may be the key to finding a universal solution. Only a small number 
of studies examined in the literature that I reviewed took this approach, where different 
segments of data was collected and analyzed with a mixed methods design.  
According to Grinnell and Unrau (2011), it is common to use a combination of 
methods in research studies (p. 335). Several researchers in the reviewed literature used 
this approach and found that it substantially improved the outcome of their studies. In the 
case of my research, a combination of methods is warranted, because insight from both 
nurses and administrators is necessary to understand the root causes of ADEs to a greater 
extent than what is currently known.  
Multiple researchers from the reviewed literature showed how various 
technological applications reduced the occurrences of ADEs (Van den Bemt et al., 2011). 
As the literature review in Chapter 2 indicated, incremental progress has been made, but 
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to deal with the human element, which is the main cause of most ADEs (Westbrook et 
al., 2011), a new system must be developed, one that incorporates the main benefits of 
existing systems while adding new measures to reduce error rates even more 
(Samaranayake et al., 2014). A system of this nature cannot be developed unless the issue 
is thoroughly evaluated with various assessments simultaneously. Evaluating the issue of 
ADEs with various techniques was the purpose of the mixed methods approach employed 
in my research. 
Research Questions and Hypothesis 
Qualitative Portion of the Research 
Research question 1. How are drugs administered in the participating facility?  
The notion that adverse drug events are prevalent in nursing homes (Horowitz, 2014) 
may indicate that NHs vary greatly in how they administer drugs. Such drug 
administration processes and procedures vary for many reasons, but since ADEs are 
affecting the quality of life for so many seniors dependent on NH care, it was necessary 
to evaluate these processes and procedures to determine if they contributed to ADE 
occurrences, either directly or indirectly. Familiarity with the processes and procedures at 
the participating NHs was acquired through the focus group discussions. Consideration of 
how NH processes dictate how nurses administer medications was also necessary to 
determine if a robotic system could potentially be instrumental to overcoming situations 
where a human-initiated ADE may otherwise have occurred.  
To answer this RQ, administrator personnel (including nurse supervisors) in each 
NH were asked to participate in a focus group discussion. Since administrators are the 
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governing body within these NHs, their perspective on how drug administration errors 
occurred was important to assess whether processes and procedures are contributing 
factors in addition to the mistakes nurses make. The focus group discussion took place 
within each NH after the survey period for both groups had concluded. As anticipated, 
this timing generated heightened excitement among administrators and stimulated 
enhanced conversation. As an expression of gratitude, a catered lunch accompanied this 
discussion, which was structured using the six focus group questions listed in Appendix 
D.  
The questions posed during the focus group were intended to gain insight into 
whether drug administration policies were designed as a result of funding, management’s 
opinion as to the cause of ADEs, management’s knowledge of existing prevention 
measures, and whether internal training is available to refresh and extend the skills nurses 
have related to drug administration. As the discussion unfolded, additional questions 
emerged from the responses received from participants. In addition to focus group data, 
the scores obtained from the ADE survey (Appendix A) were also used to answer this 
RQ.  
Research question 2. How do ADE errors in the form of pills, tablets, or capsules 
occur in nursing homes?  According to the reviewed literature, the causes of ADEs are 
vast (Wittich et al., 2014). Some of the reasons for ADE occurrences more than 10 years 
ago may still be prevalent today. However, processes, procedures, and technologies used 
within NHs are most likely not the same as they were 10 years ago, due to a variety of 
factors aimed to improve care. For these reasons, any attempt to address ADEs must 
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continue with discovery of the current causes. As Horowitz (2014) indicated ADEs are 
still high, which justifies the need to re-evaluate the causes since they may or may not be 
the same as they were during previous research.  
To answer this question, I identified the causes of ADEs through an evaluation of 
historical evidence (errors reported by the NH to the National Institute of Health) to 
determine which errors occurred and how they occurred between residents and nurses, 
and results from the ADE survey (Appendix A). This segment of data collection did not 
involve direct observation of any drug administration activities. Instead, I used the 
historical ADE data collected from each participating NH to help answer my first 
purpose, which was to evaluate the causes of ADEs. 
Research question 3. What knowledge do managers have of existing practices to 
reduce ADEs?  The focus group discussion at each NH and data from the ADE survey 
(Appendix A) provided a forum to answer this question. Since the issue of ADEs is quite 
prevalent (Handler, 2012) any new attempts to reduce incident rates should evaluate 
recent improvements, especially in the area of technology. Improvements in the domain 
of ADEs have had a positive effect, but not to the degree to reduce the thousands of 
deaths and countless medical complications of unfortunate patients Handler mentioned. 
Evidence lies in the literature where it was reported that ADE occurrences are steadily 
increasing (Horowitz, 2014). 
Diaz Pavon and de la Portilla (2011) observed that technology, specifically RT, 
has brought some magnificent benefits to the medical industry. Perhaps the usage of RT 
can assist in the administration of medications and produce similar ground-breaking 
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benefits, such as a significant reduction in ADE error rates in NHs where Van den Bemt 
et al. (2011) stated that RT does not exist.  
To answer this question, I used the same administrative population selected for 
RQ1 at each NH. I assessed their knowledge and perceptions of existing measures to 
reduce ADEs via a focus group discussion. It was important to discover if their lack of 
knowledge or their perceptions are contributing factors to ADEs. This potential 
deficiency aligns with the contention of Westbrook et al. (2011) and Kiekkas et al. (2011) 
that human error is the primary reason for ADEs. Although, the idea expressed here was 
that management’s lack of, or limited knowledge of, existing measures that could be 
deployed to reduce ADEs in their NHs is also a kind of human error. If management is 
not up to par on current knowledge of existing measures, then errors can result as a 
consequence of simply not knowing. Also, critical for this question was an assessment of 
management’s enthusiasm and support for new measures that may contribute to reducing 
ADE error rates. 
Quantitative Portion of the Research 
The quantitative portion of my research involved one dependent variable, 
individual participant survey response (r); two independent variables:  whether or not the 
participant witnessed the robotic simulation and which survey (the first or second RT 
survey) (Figure B1). The population property that I measured was the individual’s 
(nurses and administrators) response to each question on the RT survey (r). Since there 
were two independent variables with two categorical values each, there were four 
populations (2 x 2 = 4) associated with my research from an experimental design 
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perspective. To answer the RQs, and test the research hypotheses, I made the following 
statistical comparisons between those populations:  
 Control group at the time of the first survey (before the treatment group 
sees the robotic demo). 
 Control group at the time of the second survey (after the treatment group 
sees the robotic demo). 
 Treatment group prior to seeing the demo (first survey). 
 Treatment group after seeing the demo (second survey). 
Using the numerical index of the individual responses (r) from all participants, I 
calculated several mean responses (R) calculated from samples of the four populations. I 
used the sample means to perform three categories of hypothesis tests: (a) comparing a 
sample mean (the mean response regarding robotics) relative to a fixed number (a neutral 
response = 3); (b) comparing the sample means of two separate, independent populations 
(a control group and a treatment group); or (c) comparing sample means between two 
related populations (e.g., the treatment group before and after the robotic demonstration 
or the control group between the first and second survey). Details related to the actual 
hypothesis tests that I performed are described in the next section. Specifically, I 
executed six hypothesis tests to analyze the participants’ views regarding robotics and 
their comparative reactions to the robotic demonstration. 
Variables and comparisons. To answer the hypotheses described in RQs 4 and 
5, I calculated several sample means (R) based on the individual responses (r) from the 
RT survey (Figure B1) to perform several comparisons (hypothesis tests). Figure 1 
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depicts the various sample means and comparisons (hypotheses). Table 1 depicts the 
comparisons in this research. 
  All participants, before demonstration
(R1A) 
Control group before demo 
and first survey
R1C 
Treatment group before 
demo and first survey
R1T 
Demonstration
Control group after demo 
and second survey
R2C 
Treatment group after 
demo and second survey
R2T 
Six comparisons of sample data as follows:
1. All participants prior to the demo (R1A) against neutral response (3)
2. Treatment group (R2T) versus control group ((R2C) after demo
3. Treatment group after demo (R2T) against neutral response (3)
4. Paired comparison of treatment group after demo (R2T) to treatment 
group before demo (R1T) 
5. Paired comparison of control group after demo (R2C) to control group 
before demo (R1C) 
6. Comparison of treatment group before and after demo (R1T - R2T) to 
control group before and after demo (R1C - R2C)
 
Figure 1. Relational diagram of RT survey posttest and pretest comparisons. 
Table 1 
Relationship of the Population Parameters and Sample Means 
 Population 
parameter 
Response 
sample means 
All participants of the sample population (first 
survey) 
µ1A 
 
R1A 
 
Control group before demo (first survey) to 
treatment group 
µ1C 
 
R1C 
 
Control group after demo (second survey) to 
treatment group 
µ2C 
 
R2C 
 
Treatment group (first survey) before demo µ1T R1T 
Treatment group (second survey) after demon µ2T R2T 
Paired difference of control group (first and 
second survey) 
µDC =µ1C - µ2C RDC = R1C - R2C 
Paired difference of treatment group (first and 
second survey) 
µDT =µ1T - µ2T RDT = R1T - R2T 
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In the quantitative portion of this research (addressing RQs 4 and 5), there were 
six comparisons (and hypothesis tests) involving survey sample means (R):  
 Response of all participants before the demonstration (R1A) compared to a 
neutral response (3). 
 Response of the treatment group (R2T) compared to the control group (R2C), 
after the demonstration. 
 Response from the treatment group (R2T) after the demonstration compared to 
a neutral response (3). 
 Response from treatment group after the demonstration compared to the 
response from the same group before the demonstration (RDT). 
 Response from the control group during a second survey (after the treatment 
group sees the demonstration) compared to the same group the first time they 
took the survey (RDC). 
 Change in response for the treatment group (before and after viewing the 
demonstration) compared to the change in response for the control group 
(before and after the treatment group views the demonstration) (RDT versus 
RDC). 
The fifth of these comparisons addressed the issue of determining whether or not 
any differences in the treatment group response after viewing the demonstration was due 
to taking the survey a second time. To eliminate this potential influence, I performed the 
same hypothesis test for the control group during a second round of the survey, which 
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was after the treatment group viewed the demonstration. With this direction, if the control 
group showed no difference in their response during the second survey, then there would 
be significant evidence to support the claim that taking the survey a second time would 
not influence the results. If there was a difference, I would not be able to determine with 
certainty that for the treatment group, the demo made a difference or that taking the 
survey a second time made a difference.  
Research question 4. How do nursing home professionals feel about the potential 
for RT to reduce ADEs?  According to the reviewed literature, it is unknown if RT can be 
effective in reducing the rate of ADEs due to its sparse use in assisting with the 
administration of medications in NHs. Van den Bemt et al. (2011) acknowledged this 
sparse use. On the contrary, the success of robotic systems in hospital pharmacies to 
dispense medications opens the door to question if it can be successful in the NH setting 
as well. 
I answered RQ4 based on the responses to the 5-point Likert scale RT survey 
(Figure B1) from both groups collectively and prior to the treatment group viewing the 
model, meaning none of the participants had seen the model. In this quantitative portion 
of my research, I understood how NH professionals felt in general about RT to assist with 
solid drug administrations in NHs without the influence of a model of the RT. Their 
perception may have indicated that an advanced technology that was currently not being 
used in NHs was necessary to reduce ADEs or their perception may indicate that a 
technology that has no history of being used to assist with solid drug administrations in 
NHs was impractical. It was also possible that their overall perception would be neutral 
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(a Likert scale ranking of 3), which could have meant that nurses and administrators felt 
RT may or may not change the rate of ADEs in NHs.  
Hypothesis 1 (H1): Pertained to the favorability of all participants (prior to the 
demonstration) from all three NHs collectively. For H1, I used the mean response to all 
10 questions for all participants to determine if their perception of RT was greater than 
the neutral response. The null hypothesis was that the mean response from all participants 
is less than or equal to a neutral response. This would indicate that the participants overall 
felt RT would increase the rate of ADEs or keep the rate of ADEs the same in NHs. The 
alternative hypothesis was that the mean response from all participants is greater than the 
neutral response. This would indicate that overall the participants felt RT may reduce 
ADEs, despite not having seen how the technology might work. The higher the mean 
response (for all of the survey questions collectively), the more favorably the participants 
perceived the technology. The computed mean provided data to test the hypothesis with 
the t test of the mean of a single population. The hypothesis was expressed 
mathematically as follows: 
H10: µ1A ≤ 3 
H1a: µ1A > 3 
Research question 5. Do nursing home professionals have a more favorable 
perception about RT to reduce ADEs after viewing a demonstration of that technology?  
Some nurses and administrators may find it difficult to visualize RT working in a NH 
environment to assist with solid drug administrations to reduce ADEs. Van den Bemt 
(2011) stated that RT does not exist in NHs for this purpose. Therefore, an historical 
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basis for nurses and administrators to base their opinion on did not exist, which could 
possibly lead them to believe that RT for the purpose of reducing ADEs in NHs is not 
possible.  
During the course of my research, I built a physical model similar in nature to 
existing robotic systems that are used to dispense medications in some U.S. hospitals. 
Using the model, I demonstrated the technology only to nurses and administrators 
assigned to the treatment group to acquire data that represented how they viewed RT after 
seeing how it would work. I did not demonstrate the model to the control group, which 
gave me the opportunity to compare how the treatment group thought about the 
technology as opposed to the control group.  
Hypothesis 2 (H2): Pertains to comparing the treatment group with the control 
group from all three NHs collectively, after the treatment group viewed the model. For 
hypothesis 2, I compared the mean response from the treatment group (after viewing the 
model) to the control group (their second survey, administered after the treatment group 
has viewed the model). The mean response was the average score from all 10 survey 
questions for all participants of each group (the treatment group and the control group). 
The null hypothesis was that the mean response from the treatment group is less than or 
equal to the mean response from the control group. This would indicate that the treatment 
group felt RT (based on a demonstration of the model) may increase or not change the 
rate of ADEs in NHs compared to the control group. The alternative hypothesis was that 
the mean response from the treatment group is greater than the mean response from the 
control group. This would indicate that the treatment group felt RT could reduce ADEs in 
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NHs as compared to the control group. The computed mean provided data to test the 
hypothesis with the t test of the means of independent populations. The hypothesis was 
expressed mathematically as follows: 
H20: µ2T ≤ µ2C   
H2a: µ2T  µ2C 
Hypothesis 3 (H3): Pertains to all treatment group participants (after viewing the 
model) from all three NHs collectively. For hypothesis 3, I compared the mean response 
from the treatment group (after viewing the model) to a neutral response. The null 
hypothesis was that the mean response of the treatment group is less than or equal to a 
neutral response. This would indicate that the treatment group felt RT may increase or 
not change the rate of ADEs in NHs. The alternative hypothesis was that the mean 
response from the treatment group is greater than a neutral response. This would indicate 
that the treatment group had a favorable view of RT to reduce the rate of ADEs in NHs. 
The computed mean provided data to test the hypothesis with the t test of a single 
population. The hypothesis was expressed mathematically as follows: 
H30: µ2T ≤ 3 
H3a: µ2T > 3 
Hypothesis 4 (H4): Pertains to the perception of the treatment group (after and 
before viewing the model) from all three NHs collectively. For hypothesis 4, I assessed 
the paired differences for the treatment group, before and after viewing the model. I first 
calculated the mean response of each participant to all 10 questions before viewing the 
model, and then calculated the mean response for each participant to all 10 questions 
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after viewing the model. Then for each participant, I subtracted their mean response 
before from their mean response after to come up with their difference scores. Then I 
calculated the mean difference scores for the treatment group participants.  
The null hypothesis was that the mean difference for the treatment group is less 
than or equal to zero. This would indicate that the demonstration did not influence 
positively the perception of participants within the treatment group (or negatively 
influenced them). The alternative hypothesis was that the change in mean response for 
the treatment group is greater than zero. This would indicate that the demonstration did 
influence positively the perception of the treatment group. I tested the hypothesis with the 
paired t test of the means of two related populations. The hypothesis was expressed 
mathematically as follows: 
H40: µDT ≤ 0 
H4a: µDT > 0 
Hypothesis 5 (H5): Pertains to the perception of the control group (after and 
before the treatment group view the model) from all three NHs collectively. For 
hypothesis 5, I assessed the paired differences for the control group, before and after the 
treatment group sees the demonstration of the model. I first calculated the mean response 
of each participant to all 10 questions on the first survey, and then calculated the mean 
response for each participant to all 10 questions on the second survey. Then for each 
participant, I subtracted their mean response before from their mean response after to 
come up with their difference scores. Then I calculated the mean difference scores for the 
control group participants.  
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The null hypothesis was that the mean difference for the control group is less than 
or equal to zero. This would indicate that the control group provided a similar response, 
after taking the RT survey a second time. The alternative hypothesis was that the 
difference in mean response from the control group is not equal to zero. This would 
indicate that the control group provided a different response the second time, possibly as 
a result of taking a second survey. I tested the hypothesis with the paired t test of the 
means of two related populations. The hypothesis was expressed mathematically as 
follows: 
H50: µDC = 0 
H5a: µDC ≠ 0 
Hypothesis 6 (H6): Pertains to the perception of the treatment group (before and 
after viewing the model) as compared to the control group (before and after the treatment 
group views the model) from all three NHs collectively. For hypothesis 6, I compared the 
average paired difference from the treatment group (obtained from Hypothesis 4) to the 
average paired difference from the control group (from Hypothesis 5). The null 
hypothesis was that average paired difference from the treatment group is less than or 
equal to the average paired difference from the control group. This would indicate that 
the treatment group had a less favorable view of RT (after seeing a demonstration of the 
model) than the control group which took a second survey but never saw the 
demonstration. The alternative hypothesis was that the average paired difference from the 
treatment group is greater than the average paired difference from the control group. This 
would indicate that the treatment group had a more favorable view of RT (after seeing the 
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model) than the control group which did not see the model. I tested the hypothesis with 
the t test of the means of two independent populations. The hypothesis was expressed 
mathematically as follows: 
H60: µDT < µDC 
H6a: µDT > µDC 
Role of the Researcher 
As the researcher, I handled all activities related to the ADE survey (Appendix A) 
and the RT survey (Figure B1) as these activities did not require specialized skills to 
oversee. I handled the focus group discussion by beginning each of three discussions (one 
per NH) with the focus group questions listed in Appendix D. During the course of the 
discussion, I intentionally evolved the conversation with additional questions based on 
responses from the participants while limiting the discussion to an hour or less. I also 
handled all activities related to demonstrating the model, which included setting it up, 
describing it, and acquiring the minimum calculated sample size for each of the two 
groups within each participating NH. 
Prior to the demonstration of the model, I explained to all nurses and 
administrators within the treatment group the context of my research, the overall intent of 
the model, and what was expected of them. I provided the same explanation to the control 
group, but without mentioning the model. I hoped that this brief conversation would 
generate enthusiasm among all participants and inspire them to respond with genuine 
feedback during the demonstration and/or on the survey. I also explained to nurses and 
administrators that their contribution to provide any feedback was not mandatory. Rather, 
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it was requested to support my research and the potential future benefits that RT may 
bring. Naturally, I acquired informed consent from the NH and from each nurse and 
administrator prior to their inclusion in my research. 
Sampling and Survey Plan 
To ensure that each of the two samples (participants who viewed the model and 
participants who did not view the model) contained an equal number of participants, I 
assigned every other participant, based on the order in which they consented to 
participate, to one of the two groups based on simple random sampling. The participants 
were mainly from the day shift since the majority of medications are administered during 
day shift hours when residents are typically awake. This timeframe lowered the number 
of available participants; however, the number of available participants was still slightly 
greater than the number of willing participants.  
I asked any participant with a heavy or busy workload to refrain from 
participating along with informing the administrator that enough participants had already 
consented to take part in the research. This strategy resulted in the sample size being 
slightly above the minimum sample size needed, which saved a considerable amout of 
time and effort during the data collection period.  
Along with randomly assigning the participants to the control group or treatment 
group, I assigned the participants of each group to a numerical code beginning with 1. 
For example, I assigned one person in both groups to number 1, one person in both 
groups to number 2, and so on. As I made these numerical assignments, I kept a manual 
record (first name, last initial, last 4 of phone number, group, and numerical assignment) 
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for each participant to ensure that I would administer the appropriately marked RT survey 
(Figure B1) to the correct particpant at the right interval of this research. The RT survey 
instrument was subtly different (only indicated by an identification code) to ensure that I 
would able to match the before and after results from each participant, but coded in a way 
that would make it difficult to trace the results to a specific participant. The ADE survey 
(Appendix A) was not marked with an identification code, because all participants took 
this survey once, and the results were aggregated for all NHs taking part in my research.  
I coded the before and after RT survey (Figure B1) with a three part numerical 
identification code separated by a single dash. The first number (first part) identified the 
group the participant was assigned to where a 1 indicated the control group and a 2 
indicated the treatment group. The second number (second part) identified which 
occasion of the survey the results were from. For the control group, a 1 indicated their 
first occasion of taking the survey and a 2 indicated their second occasion. For the 
treatment group, a 1 indicated their survey results before viewing the demonstration and a 
2 indicated their survey results after viewing the demonstration. The last number (third 
part) anonymously identified an individual participant. For example, participant 5 of the 
control could be John and participant 5 of the treatment group could be Bill. Only I, as 
the researcher, knew the numerical assignment (last part) associated with each 
participant.  
 As an example of the identification code, the RT survey (Figure B1) for 
participant 5 of the control group was coded with 1-1-5 in the upper left hand corner, 
meaning the results were from the control group (1), the first survey (1), and participant 5 
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of the control group. For participant 5’s second survey, the survey had identification code 
1-2-5 in the upper left hand corner, meaning the results were from the control group (1), 
the second survey (2), and participant 5 of the control group.  
The before and after RT survey (Figure B1) for the treatment group was coded in 
a similar pattern. For example, the before survey was coded with identification code 2-1-
5, meaning the results were from treatment group (2), before the demonstration (1), and 
participant 5 of the treatment group. For the same participant, the after survey was coded 
with identification code 2-2-5, meaning the results were from the treatment group (2), 
after the demonstration (2), and from participant 5 of the treatment group.  
Each individual NH was not represented in the schema of the identification code, 
because I did not intend to assess each NH independently. My assessment was collective. 
So, there was not a need to identify a participant in either group to a specific NH.  
Survey Sample Size 
The ultimate goal in computing an adequate sample size is to reduce the 
probability of making a false positive (Type I error) outcome or a false negative (Type II 
error) outcome. Using the values Cohen recommended, the chances that a researcher 
might make a false negative claim (failure to find an actual difference in means) is 
greater than the chances of a making a false positive claim (detecting a difference in 
means that does not exist). While neither a false positive or false negative claim is the 
goal of scientific research, the claim of a false negative is more tolerable, because 
inaccurate results are not distributed throughout scholarly literature.  
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 Using the G*Power software designed by Faul, Erdfelder, Lang, and Buchner 
(2009), I calculated a minimum sample size for each hypothesis. For a conventional a 
priori power analysis, I used Cohen’s (1992) recommendation of a medium effect size of 
50% with a statistical power of 80% (where β = 0.20) and a confidence level of 95% 
(where α = 0.05) to compute a minimum sample size for a normally distributed 
population.  
For H1 and H3, I intended to determine if there was a difference between a mean 
index and a constant value of three (neutral response). For H2 and H6, I intended to 
determine if there was a difference between the means of two independent populations. 
For H4 and H5, I intended to determine the difference in means between two related 
populations (paired).  
I evaluated H1 and H3 with a single-group, one-tailed t test; H2 with a two-group, 
one-tailed t test; H4 with a paired, one-tailed t test; H5 with a paired, two-tailed t test; 
and, H6 with a two-group, one-tailed t test. The t test was appropriate in each case 
because the population standard deviation of the survey responses was unknown. For H1, 
H3, and H4 (single-group, one-tailed test), I computed a minimum sample size of 45. For 
H5 (two-tailed test), the minimum sample size was 54. For H2 and H6 (two groups), the 
minimum sample size was 51 per group or 102 total.  
Mowery (2011) stated that collecting data beyond the calculated sample size 
increases the accuracy and validity (power and confidence) of any statistical test. 
Therefore, I used the larger sample size of 102 or 51 per group (where critical t =1.660) 
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as the minimum required sample size for each hypothesis test, which exceeded the 
minimum computed sample size of H1, H3, H4, and H5.  
I estimated that among the small, medium, and large NHs that I would select for 
my research, each NH would have, respectively, a minimum of 45, 55, and 65 nurses and 
administrators on staff to cover all shifts over the course of a week. Thus, the available 
population would be more than sufficient to acquire the calculated sample size to 
effectively test each hypothesis. 
Regarding the calculated sample size of 102 and three NHs, each of the six groups 
(three control groups and three treatment groups) would require a minimum of 17 surveys 
(102/6 = 17) to obtain adequate sampling. This yielded a minimum required sample size 
of 34 in each NH, 51 responses from the control group and 51 responses from the 
treatment group. 
There was no guarantee that all participants in each group would take part in my 
research. Since both groups (control and treatment groups) took the RT survey (Figure 
B1) initially and at the same time, the number of participants in the treatment group prior 
to viewing the model (17 at a minimum) dictated the final number of participants for the 
treatment group after viewing the model and for the control group. For example, if 17 of 
30 available participants from the treatment group (prior to viewing the model) took the 
survey, the participants in both the control group and the treatment group would be 
limited to 17 to preserve equal sampling between the two groups. Ensuring equal sample 
sizes between the two groups may have required a random discard of surveys 
(participants) from each group.  
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If the required sample size for the treatment group (at the stage when they view 
the model) was not acquired in one day, the group session to show the model would 
extend to a second or third day with the purpose of demonstrating it to other available 
participants. If the required sample size was still not acquired, I planned to reduce the 
number of surveys acquired from the control group to equal those acquired from the 
treatment group to no less than the minimum required sample size of 17. As a last option, 
I planned to choose a different NH with adequate available staffing to obtain the 
minimum required sample size of 17. 
Focus Group Sample Size 
The focus group provided a means of gathering candid feedback in a single 
setting from individuals who have extensive knowledge on issues related to ADEs. The 
three individual sessions (one session in each of three participating NHs) provided an 
environment where administrators (including nurse supervisors) felt comfortable sharing 
openly their experiences, opinions, and perspectives. The promise of confidentiality 
added to their comfort level and allow healthy, open conversations.  
A mathematical formula was not used to calculate the minimum sample size for 
each focus group. According to the literature, an adequate sample size for a focus group 
can range from 4 to 12 people. For example, Krueger and Casey (2008) recommended 4 
to 12 and Doody, Slevin, and Taggart (2013) recommended 6 to 10 as an adequate 
number of participants for a focus group. Gibbs (1997) pointed out that small sample 
sizes for focus groups are acceptable if the participants have similar backgrounds and are 
comfortable discussing the topic of interest in a group setting. More importantly, the 
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researcher should be able to obtain relevant, diverse, and similar information to assess the 
topic of interest from multiple perspectives with the small sample size (Gibbs, 1997).  
Carlsen and Glenton (2011) pointed out that for a focus group a suitable sample 
size should be based on the number of groups rather than the number of participants 
within each group. This implies that the researcher must be careful to establish enough 
groups so that similar and diverse themes can be heard among them (DePaulo, 2000). To 
this end, the researcher must be careful to set an appropriate sample size in each group, 
comprised of individuals with specific characteristics (for example, gender, experience, 
and race), to obtain comprehensive data from the perspective of the participants (Gibbs, 
1997). Gibbs (1997) further contended that the researcher must also establish enough 
groups based on similar research, availability of research participants, or the discretion of 
the researcher as to how many groups are applicable.  
Based on the recommendations from Krueger and Casey (2008) and the general 
guidelines from Gibbs (1997), my sample size was set to a minimum of four 
administrators (and nurse supervisors) for each focus group session (one in each of three 
participating NHs). I chose this sample size because I anticipated that at least four 
administrators (including nurse supervisors) would be present in the NH on the day that I 
would conduct the focus group session.  
In the event that additional administrators were available to participate, I purposely set 
the maximum sample size to six so that their responses could be included. Overall, the 
minimum size for each of three focus group sessions was four and the maximum was six, 
for an overall maximum of 18 participants.  
  
 
88 
Instrumentation 
ADE Scorecard 
All ADEs analyzed from the historical ADE data acquired from each participating 
NH was recorded on the ADE Scorecard (Appendix C) that I designed for this purpose. 
The data recorded on the ADE Scorecard was categorized from several perspectives. For 
example, type of medication, category of medication, frequency, and reason for the ADE. 
This data was qualitatively analyzed and triangulated with the survey results to provide 
critical information to answer the RQs.  
Prior to my analysis of the historical ADE data, I printed hardcopies of the ADE 
Scorecard so that I could manually write on it during the inquiry. I chose that route to 
clearly delineate what information from the raw historical data I included in my research 
and how it was assessed. Each manually written upon sheet was scanned into a computer 
and stored in a password-protected directory onto an external hard drive. At the 
conclusion of my research, I stored the hard drive in a safety deposit box for a minimum 
of 5 years.  
Survey Design 
For my research, I designed two separate 5-point Likert scale surveys. The first 
survey, entitled Adverse Drug Event Survey (Appendix A), was based on the literature 
that I reviewed in Chapter 2 in which many authors concluded that most ADEs fall into 
one of three categories: training, experience, and guidelines & procedures. I used that 
survey in the qualitative portion of the research.  
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The second survey, the Robotic Technology Survey (Figure B1), addressed an 
additional topic, robotic technology, because the use of RT to assist with administering 
solid medications in NHs was not evident in the literature. Regarding this last topic, I 
sought the opinions of nurses and administrators about their outlook on RT to reduce 
ADEs. I used that survey in the quantitative portion of the research.  
Each statement in both surveys could have been answered with one of five 
possible responses: strongly disagree, disagree, neutral, agree, and strongly agree, where 
the number assignment ranged from +1 to +5 respectively. The 5-point Likert scale 
enabled me to quantify the responses based on a middle point of three (neutral). A 
response to the left of the middle point on the scale represents a pessimistic (negative) 
response. A response to the right of the middle point on the scale represents an optimistic 
(positive) response. Thus, pessimistic responses are (R ≤ 2); neutral responses are (R = 3); 
optimistic responses are (R ≥ 4). 
Each survey was designed to include both negatively and positively worded 
statements. Negatively phrased statements elicit a low level of agreement for the attribute 
being measured and positively phrased statements elicit a high level of agreement for the 
attribute being measured (Van Sonderen, Sanderman, & Coyne, 2013). According to Van 
Sonderen, Sanderman, and Coyne (2013), the inclusion of both types of statements on the 
same survey reduces the possibility of response bias, which occurs when participants 
respond with answers that do not reflect their true belief, answer all items in an auto-pilot 
fashion (acquiescent bias) with either high or low scores, or answer the items without 
paying much attention to the context of each individual item. 
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The ADE survey (Appendix A) was designed to collect a variety of qualitative 
data related to three dimensions: training, experience, and guidelines & procedures. Since 
I did not compare the means of each dimension and did not use the results for quantitative 
analysis, it was not necessary for me to ensure that the directionality of the items were 
consistent. Therefore, I did not reverse score any of the negatively phrased items 
associated with this survey.  
The RT survey (Figure B1) was designed to collect quantitative data to assess the 
participants’ perceptions of using RT at the administration stage. Currently, RT designed 
to assist with drug administrations at the administration stage in NHs does not exist (Van 
den Bemt et al., 2011). As a consequence, nurses and administrators do not have any real-
world experience with an RT system of this nature. Therefore, it is reasonable to assume 
that the general consensus among nurses and administrators would be that even with an 
RT system human involvement would still be the determining factor. This means that any 
negatively phrased item would most likely receive a low score. To ensure that a low score 
would represent agreement, reverse scoring must be considered for any type of statistical 
analysis so that all of the items would have the same meaning in terms of high agreement 
or low agreement—that is, the same directionality in response.  
In an effort to prevent any manner of response bias as described by Van 
Sonderen, Sanderman, and Coyne (2013), I phrased 3 out of 10 items on the RT survey 
(Figure B1) negatively. I used the survey responses to conduct six different hypothesis 
tests; therefore, it was necessary for me to reverse score the negatively phrased items 
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prior to calculating the mean responses of the four samples. By reverse scoring these 
three items, all items were consistent in terms of the directionality of the responses.  
Specifically, survey items 3 (“A comprehensive interactive computer system will 
cause nurses to be less aware when administering medications.”), 5 (“A robotic system 
would not be useful to assist in administering solid medications.”), and 8 (“A robotic 
system would decrease the success rate of administering medications on time.”) from the 
RT survey (Figure B1) elicited a response for which a higher score would indicate that 
the respondents perceived RT as not being a good option to reduce ADEs at the 
administration stage in NHs (in contrast to the other questions). The expressions of “will 
cause nurses to be less aware” in item 3, “would not be useful to assist” in item 5, and 
“would decrease the success rate” in item 8 define these items as negative.  
To compute the mean responses to test the hypotheses, I first averaged the 
response for each participant to all 10 questions of the RT survey (Figure B1) to calculate 
an individual mean response. Using the individual mean responses, I calculated a mean 
response for all participants from the participating NHs collectively. I then separated the 
individual means for the control group (before and after) and the treatment group (before 
and after) based on the first two parts of the identification code. Based on this separation, 
I calculated the following means: 
 Mean response for all participants before the treatment group views the 
model in all participating NHs collectively (R1A). 
 Mean response for all control group participants before the treatment 
group views the model in all participating NHs collectively (R1C). 
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 Mean response for all control group participants after the treatment group 
has viewed the model in all participating NHs collectively (R2C). 
 Mean response for all treatment group participants before viewing the 
model in all participating NHs collectively (R1T). 
 Mean response for all treatment group participants after viewing the model 
in all participating NHs collectively (R2T). 
The identification code was not be used to identify a particular NH. Since the 
survey results were aggregated to represent all three NHs, knowing exactly which NH the 
results came from was not important in my research. Therefore, the ADE survey 
(Appendix A) was not marked an identification code, because I only administered it once 
to all participants. Pertaining to the RT survey (Figure B1), the identification code was 
used to match the before and after results from each participant from each group. The 
identification code also provided a means of eliminating results from the same participant 
from the control group or the treatment group to maintain equal sampling within each 
participating NH. The identification code was not used to individually assess the results 
obtained from each NH or from an individual participant. Rather, assessment of the data 
was collective. 
Pilot Study 
To assess reliability and validity of the surveys, I conducted a pilot study with a 
small group of nurses and administrators who were not associated with the three NHs that 
participated in this research. By conducting this pilot study, I acquired the perspective of 
nurses and administrators working in the healthcare industry to gain a better 
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understanding of what questions would work best to determine how they felt about the 
potential use of RT to reduce ADEs. The pilot study also helped me acquire their 
perspective of ADEs in the general areas of experience, training, and guidelines & 
procedures. I carried out this pilot study after IRB approval to conduct this research. The 
details related to the pilot study are disclosed in Chapter 4.  
Survey Administration 
Participants completed both the ADE survey (Appendix A) and the RT survey 
(Figure B1) anonymously. Upon completion, they placed their surveys in a box, which 
remained sealed and secured throughout the duration of the survey period at each 
participating NH. The same box was used by all participants in each participating NH. As 
the survey period concluded in one NH, I physically transported the box to the next NH. 
By using a single box, I was able to protect the integrity of the data as well as the privacy 
rights of the individuals involved. 
I received participation from the majority of those who received a copy of the 
surveys. There were a few cases where a participant did not take the surveys, because he 
or she was on temporary assignment or was no longer servicing the NH, the participant 
was no longer employed with the NH, or the participant was too busy attending to his or 
her assigned duties.  
Focus Group 
To protect the confidentiality of the participants, I assigned each participant to a 
unique number. At the beginning of each session, I asked each participant to introduce 
themselves with their numeric assignment. Correlation of the numeric assignment and the 
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actual administrator (or nurse supervisor) was only known to the researcher, but not 
revealed in any manner to anyone else.  
I recorded the conversations from the focus group discussions using a digital 
voice recorder. At the conclusion of those conversations, I transcribed each recording on 
paper, using Microsoft Word, to create an electronic and backup source. To further 
organize the data acquired from the focus group sessions, I uploaded the Microsoft Word 
version of the transcribed conversations into the NVivo software application for a 
detailed and thorough analysis. After completion, I correlated the results with my 
qualitative assessments from the ADE survey (Appendix A), the historical errors 
recorded on the ADE Scorecard, and the outcomes of the quantitative assessment of nurse 
and administrator perceptions on using RT to reduce ADEs.  
Robotic Model 
Since an application of RT to assist in patient-specific drug administrations does 
not exist in NHs (Van den Bemt et al., 2011), the use of a model was ideal to evaluate 
personal perspectives on the prospect of using RT to reduce ADEs in a NH environment. 
My model was sufficient for this evaluation and eliminated the complexity, time, and cost 
it would have taken to build an actual robotic system.  
Physical Mechanization of the Model 
The model that I built was similar in concept to the stationary robotic dispensing 
cabinets used in centralized and decentralized distribution systems within various 
hospitals. Tsao, Lo, Babich, Shah, and Bansback (2014) mentioned that a majority of 
these stationary cabinets interface directly with pharmacy information systems to deliver 
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medications, but the effectiveness of this technology to reduce ADEs varies depending on 
how it is implemented in each hospital. This may explain why Wakefield, Ward, Loes, 
and O’Brien (2010) found that these kinds of systems have had varying degrees of 
success in a limited number of critical care hospitals that have implemented this 
technology.  
Interestingly, these dispensing cabinets were not patient-specific. Rather, these 
cabinets held a specific assortment of drugs that could be delivered based on the 
prescribed orders of many patients or commonly used drugs within specific locations of 
the hospital. To receive a medication contained within the system, the nurse had to scan a 
barcode, but it was the exclusive responsibility of the nurse to extract the correct 
medicine and quantity for a particular patient.  
  Pedersen, Schneider, and Scheckelhoff (2012) noted that robotic dispensing 
systems are present in 63% of hospitals in the U.S. (p. 780). However, many of these 
hospitals have implemented dispensing systems that contain automated dispensing 
cabinets that stock drugs in bulk based on patient-specific profiles (p. 771). Although, 
these systems still required the nurse to the extract the right quantity or dosage once they 
have acquired access to the drugs in the system. The model that I designed for my 
research mimicked these patient-specific cabinets in their ability to connect a patient to a 
specific drug regimen via a scanned barcode. In contrast to existing non-mobile patient-
specific cabinets, my design contained the added features of self-guided mobility, and 
automation directly linked to prescribed orders. Specifically, the components of my 
model are listed in Table 2.  
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Table 2  
Components of the Robotic Model 
 Component Name 
A 
B 
C 
D 
E 
F 
G 
Multidrawer cabinet 
Prelabeled numbered drawer 
Cardboard poster 
Microsoft access application 
Laptop 
Index cards representing fictitious resident 
Wired scanner 
H Mobile cart 
I Printout of drug regimen preassignments 
 
Deployment of the Robotic System Replicated by the Model 
 The model that I built was based on the idea of a mobile, patient-specific, semi-
intelligent robotic system that would assist nurses in administering medications. A real-
world application of my model would work from these two high level perspectives: load 
component and delivery component.  
 The load component would require someone at the NH to place solid drugs 
received from an external pharmacy into a stationary multidrawer cabinet that was not 
permanently connected to the mobile robotic unit. Each of these drawers in the cabinet 
would contain a specific type of solid drug of which these assignments would be known, 
through software, by the robotic system. At various intervals throughout the day, the 
mobile robotic unit would automatically navigate to the stationary multidrawer cabinet 
and connect to it in order to fill or refill drugs prescribed for administration into its 
inventory or to remove drugs from its inventory that were not administered during a 
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particular shift. This connection between the mobile robotic unit and the stationary 
multidrawer cabinet would also serve to recharge the batteries that power the unit.  
As each resident’s electronic record of their prescribed medications was read from 
the host system by the robotic system, the two systems would work in tandem to transfer 
drugs from the stationary multidrawer cabinets to the mobile, patient-specific robotic 
unit. Only drugs, based on prescribed drug orders, which were not loaded on a previous 
load would be loaded during the process. The robotic unit would then remain dormant at 
the docking cabinet until it was summoned by a nurse who is ready to administer a 
medication.  
 The delivery component would involve the independent movement of the robotic 
unit to a specific location, via GPS positioning boundaries, within the NH when 
dispatched by the nurse. Each nurse assigned to administer drugs would wear a watch-
like device that pairs that nurse, via wireless technology, to the mobile robotic unit. This 
means that no other nurse or individual would have the ability to dispatch the mobile unit 
or be able to extract drugs from it.  
To dispatch the mobile robotic unit to a specific location, the nurse would press a 
button on the watch-like device, which would send the GPS coordinates of the nurse’s 
location at the time of the initial dispatch summon. With the GPS coordinates and other 
parameters that manage the mobility of the system, the robotic unit would automatically 
navigate its way to that location.  
Upon arrival of the robotic unit to the dispatched location, the nurse would use a 
scanner that is physically attached to the robotic unit to scan a unique barcode that is 
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assigned to one specific resident. Via a computer screen affixed to the robotic unit, the 
software system will respond to the scanned barcode by displaying the prescribed drug 
order associated with the resident assigned to the scanned barcode or, if necessary, by 
notifying the nurse that the barcode is invalid.  
Simultaneously, the system software will compare which drugs were loaded and 
recorded to the drawer against what was actually prescribed to the resident according to 
the host system at the time of the administration. If differences are noted, the system 
software will alert the nurse with a low intermittent beeping tone, emitted from the 
watch-like device. The nurse must then make an exception entry on the computer screen 
and confirm before the system will continue with any further actions. If no differences 
are noted or after an exception entry is made, the correct drawer corresponding to the 
scanned barcode will open to give the nurse access to the medications.  
Once the administration is complete, the nurse will be required to confirm the 
completion on the computer screen. Otherwise, the robotic unit will not allow him or her 
to go forward with another administration. If another administration does not take place 
within a configurable amount of time, the robotic system will automatically return to the 
docking cabinet or the nurse can dispatch the unit to return to the docking cabinet 
immediately via a return home option on the computer screen.  
Another aspect of this system is the software application. In addition to 
controlling mobility of the system, the software will maintain detailed records of all 
activities for auditing purposes. It will keep an accurate account of which medications 
went into the system, who extracted the medication from the system, which resident it 
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was extracted for, the medication quantities administered, and the time at which the 
medication was removed from the drawer. In addition to these basic features, the 
software system will be semi-intelligent and sophisticated enough to handle all the 
intended functions under various conditions.  
The basic idea that I have described here will start with a small number of drugs 
and a small number of mobile units. Once a working system is up and running, 
refinements to the system, including hardware and software, can take place to perfect 
how it operates from all perspectives.  
Verification and Validation of the Model 
To determine if the model that I built would be fit to carry out this research, I 
adopted the approaches described in Chapter 2 to assess verification and validation. 
Specific to verification, I subjected the model to several scenarios to ensure that it 
functioned as expected. Specific to validation, I subjected the model to a series of 
predefined tests in additional to exposing it to a group of IT professionals for additional 
scrutiny. The details of how I tested, verified, and validated the model are forthcoming in 
Chapter 4.  
Simulation Demonstration 
For my research, I employed the model in a demonstration, which simulated how 
a robotics system might be employed in a NH setting. Here are the specifics of that 
demonstration. 
A unique barcode that corresponded to a specific fictitious resident and a 
prelabeled numbered drawer in the cabinet was assigned in advance of the simulation. 
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Each of 10 physical barcode labels was affixed to a cardboard poster (see item C in 
Figure 2) where each label represented one fictitious resident as identified on individual 
index cards (see item F in Figure 2). The simulated representations did not mimic actual 
drug regimens for seniors living in NHs, which rendered the limitation of 10 solid drugs 
tolerable for the demonstration. This consideration made the simulation appear more 
practical and realistic, because the number of possibilities evaluated was relatively small 
and tailored to solid drugs. 
 
 
Figure 2. Model configuration. 
 
For each real drug, I assigned a specific colored jellybean to represent that drug in 
the simulation. For example, an orange jellybean represented Warfarin, a blood thinning 
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medication and a purple jellybean represented Oxycodone, an opioid pain medication. 
See Table 3 for the full list of selected drugs for the simulation and the correlating 
jellybean color. 
Table 3 
Correlation Table of Actual Drug to Jellybean 
 Drug name Jellybean color           
1 Aspirin White 
2 Warfarin Orange 
3 Oxycodone Purple 
4 Lorazepam Pink 
5 Fentanyl Black 
6 Furosemide Yellow 
7 Alprazolam Blue 
8 Metoprolol Lime 
9 Omeprazole Red 
10 Clonazepam Green 
     
Prior to the simulation, I loaded each prelabeled numbered drawer (see item B in 
Figure 2) with the specific color and quantity of jellybean, which represented the 
simulated drug(s) that a fictitious resident was currently taking. For example, fictitious 
resident number one was taking two units of Warfarin and one unit of Fentanyl. In this 
case, I preloaded drawer number one with two orange jellybeans and one black jellybean. 
See Appendix E for a storyboard arrangement of the model.  
To begin the group session to demonstrate the simulation, I gave a brief 
description of the setup and design of the model to those in attendance. To engage the 
participants, I asked for a volunteer for the purpose of randomly choosing one of 10 index 
cards representing a fictitious resident and their fictitious drug regimen (see item F in 
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Figure 2). Each participant also received a printout of the preassignments (see item I in 
Figure 2) so that they could easily follow and validate the outcome of each simulated 
administration that corresponded directly with the index cards.  
As the barcode corresponding to the number on the chosen index card was 
scanned, the Microsoft Access application showed the drugs and corresponding 
jellybeans on the laptop screen. Immediately following, I instructed the volunteer to open 
the associated drug cabinet drawer, which contained the appropriate colors and quantities 
of jellybeans prescribed for the chosen fictitious resident, thus demonstrating that the 
model had the capacity to assist nurses in accurately administering the correct solid drugs 
to residents. By involving the participants in conversation and engagement in the 
demonstration, I expected the survey results to be rich and reflective on this approach to 
reduce ADEs.  
Data Analysis Plan 
Quantitative Analysis of Survey Data 
  I acquired the data necessary to test each hypothesis only from the RT survey 
(Figure B1). To carry out these tests, I averaged the responses (reverse scored where 
appropriate, as explained earlier) from each survey from all three participating NHs 
collectively to compute several means based on a Likert scale ranking value of +1 to +5: 
(a) a single mean for all participants prior to the treatment group viewing the model, (b) a 
single mean for the control group prior to the treatment group viewing the model, (c) a 
single mean for the control group after the treatment group view the model, (d) a single 
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mean for the treatment group before viewing the model, and (e) a single mean for the 
treatment group after viewing the model.  
For a one-tailed test, when the null hypothesis includes a less than or equal 
expression, the null hypothesis is rejected when the t statistic is greater than the critical 
value of t. However, the statistical power, confidence, and effect size chosen by the 
researcher factor into the probability of correctly rejecting the null hypothesis. If the 
researcher intends to prove that the treatment group surpasses the control group or from a 
specified constant (rejection of the null hypothesis), high statistical power is imperative 
for the significance test (Liu, 2012).  
According to Mowery (2011), it is common among health care researchers to use 
the paired t test to determine if there is a significant difference between two normally 
distributed and related groups. The paired t test was applicable to my research because of 
the natural pairing of the before and after survey results associated with H4 and H5. As a 
result, I acquired another view of how NH professionals felt about RT, since the 
participants assigned to the treatment group took the RT survey (Figure B1) before and 
after viewing the model. The participants in the control group also took the survey twice, 
but without viewing the model on either occasion.  
Disposition of Survey Data 
To protect and save the survey results from both surveys, I scanned each physical 
survey into a computer and stored the electronic copies in a password-protected directory 
on an external hard drive. Upon completion of my research, I stored the external hard 
drive in a safety deposit box for a minimum of 5 years. 
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Qualitative Data Analysis 
In addition to the hypothesis tests for the quantitative assessment, I conducted a 
qualitative assessment with the historical ADE data in conjunction with the focus group 
data and the ADE survey (Appendix A) data from all participating NHs collectively. In 
particular, I entered the unstructured survey data, which pertained to training, experience, 
and guidelines & procedures and the focus group data into the NVivo software 
application so that I could utilize the software’s query, summarization, and visualization 
tools to analyze the data from different angles.  
I analyzed the data to determine if any additional themes or patterns exist that 
have not otherwise been stated in the scholarly literature. I extended my analysis further 
by looking for any other subtle trends or connections within the data. Overall, I analyzed 
the data from these various perspectives to better understand the reasons for ADEs and 
the potential impact for RT to reduce their numbers. The continued persistence of ADEs 
(Handler, 2012) warrants exploration into every possible avenue for decreasing their 
prevalence. 
I used triangulation to synthesize and correlate the data acquired from the ADE 
survey (Appendix A) with the reasons associated with the reported ADEs received from 
each NH and with the data acquired from the three planned focus group sessions. The 
results from the survey from all three NHs, collectively, were categorically tabulated to 
view the data in terms of frequency (high, medium, low, average). The results were 
further reduced to numerically summarize each scale of the response categories. From 
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these tabulated results, I applied inductive reasoning to draw broad generalizations for 
each category, which I analyzed in conjunction with the other sources of data.  
I expected that the data collection design employed in this mixed methods 
approach would offset the limitations inherit within each individual data collection 
method being used. Together these data collection methods provided a view of ADE 
causes from three perspectives: actual ADEs reported by the facility, the personal 
perspective of the nurse, and the personal perspective of the administrator. As a result, 
the data was fertile with common information which supported the outcome of the 
simulation to combat ADE occurrences. With this design, I delivered a high degree of 
reliability and validity relative to the outcome of my research. 
Threats to Validity 
The design framework presented in this chapter called for the utilization of two 
survey instruments to acquire a qualitative and quantitative perspective from nurses and 
administrators involved with the drug administration task. Using these instruments, I 
gained their personal accounts, perspectives, and beliefs as to why ADEs occur at this 
stage of the medication-use process. Since all the participants that took the surveys work 
in similar environments (NHs) with similar care seekers (residents), the answers I 
acquired from both surveys was consistent among the three participating NHs.  
The ADE survey instrument (Appendix A) was a custom-designed survey that 
provided a means for me to gain some insight into three areas:  training, experience, and 
guidelines & procedures. These areas of focus was based on the literature that I reviewed 
in Chapter 2.  
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Van den Bemt et al. (2011) emphasized training as an opportunity to prevent 
errors when transferring medications while Wittich et al. (2014) expressed training as 
continued education to stay abreast of new medications introduced within the NH. 
Aljadhey et al. (2013) saw experience as a significant factor in improving care related to 
administering medications while Wittich et al. mentioned experience in reference to the 
excessive workloads and stressful situations nurses, doctors, and pharmacists must endure 
when executing any stage of the medication-use process. USDHHS (2014b) noted that 
some problems related to ADEs can be minimized if existing guidelines are followed 
while Sawarkar et al. (2012) recognized that busy workflows could sometimes lead to 
ADEs.  
Thus, I intended to gain insight into the causes of ADEs directly from nurses and 
administrators relative to these areas of focus. The RT survey (Figure B1) was also a 
custom-designed survey. It provided a means for me to gauge how nurses and 
administrators view RT to assist in drug administrations from several viewpoints. 
However, to avoid overlooking potential issues of internal validity, I administered the 
survey to both the control group and the treatment group on two occasions: once before 
the treatment group viewed the model and again after the treatment group viewed the 
model.  
Nachmias and Nachmias (1992) noted that it is necessary for the researcher to 
ensure that any change affecting the dependent variable is influenced only by the 
independent variable. To account for the possibility of different responses to the RT 
survey (Figure B1), I calculated the associated means (before and after) of the control 
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group in case these participants provided different answers on each occasion of taking the 
survey. The questions on the RT survey were derived directly from the researcher, 
because scholarly literature related to the use of RT for the purposes of reducing ADEs in 
NHs is scarce (Van den Bemt et al., 2011).  
The importance of both Likert scale surveys was the design of the questions 
where the choice and assembly of words for each question conveyed the same meaning 
and intent to each participant. As a result, each question was interpreted consistently 
among the participants. Each question was short and direct, which allowed the survey 
participant to provide direct responses to all questions, except for the last one question. 
With these questions, I intended to place nurses in the same frame of thinking by 
isolating groups of questions within the same area of the survey. The surveys also took 
into account the possibility of self-incrimination that nurses or administrators may have 
felt. To minimize this emotion, all questions referred to current or past colleagues, which 
may have encouraged participants to answer all questions associated with both surveys. 
The results were consistent and abundant with information pertaining to the ADE issue 
from the personal perspective of the nurse and the administrator.  
Issues of Trustworthiness 
My study design incorporated two data collection methods. In addition, I used the 
technique of triangulation to strengthen the evidence rendered by the data collected. As 
expected, some of the data from the ADE survey (Appendix A) and the focus group 
correlated, which enhanced the validity of the overall findings. Through triangulation, I 
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also found that the errors associated with the reported causes from each NH and the 
outcome of the hypotheses further supported the validity of the overall findings.  
To minimize issues related to external validity, I purposely pursued NHs of 
various dimensions in order to generalize the results to all NHs in the Memphis 
Metropolitan area. Beyond choosing NHs with a quality rating of 3 (medium as 
determined by the CMMS) or less my design included several additional aspects to 
minimize external validity. For example, small, medium, and large NHs based on the 
number of beds were randomly selected, and bias towards well performing NHs or 
extremely poor NHs was avoided.  
Beyond the selection criteria, the data collection design solicited a high rate of 
participation and acquired similar data from several sources where clear triangulation was 
possible to support the results. It was well established in the literature that all U.S. NHs 
suffer from occurences of ADEs. Given this assertion, the results obtained in my research 
can be generalized beyond just NHs in the Memphis Metropolitan area.  
I captured all of the data collected in the natural environment of the NH, where 
the course of how nurses and residents interact was not manipulated or altered in any 
manner. Preconceptions or biases of the researcher was not be an issue because the data 
collected was reflective of the participants and their thoughts. By maintaining objectivity 
in this manner, the data represented the complex interactions that take place within these 
NHs.  
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Ethical Procedures 
Preceding the collection of any data, I acquired a signed consent document from 
the administrator of each of the three participating NHs, in which I summarized the 
interaction with nurses and the abstention of any interaction with residents. I obtained 
permission from the Institutional Review Board (IRB; Approval No. 11-09-15-0123805) 
to conduct the presentation to demonstrate the robotic simulation, administer the surveys, 
and conduct a focus group discussion at these NHs. At no time during the course of data 
collection, none of the NHs that I recruited expressed the desire to withdraw from the 
study. Therefore, recruitment of replacement NHs was not necessary.  
Comparably, I did not require nurses or administrators to take either of the two 
surveys or participate in this research. Likewise, I did not require administrators to 
participate in the focus group discussion, but I did strongly encouraged both groups to 
participate for the benefit of this research. At the conclusion of my research, I presented 
each NH with a full copy of my research for their reference. 
Measures Taken for Protection of Participants 
Nursing homes that participated in my research remain anonymous. Similarly, 
nurses and administrators within these NHs also remain anonymous. However, for the 
purpose of matching the before and after RT survey (Figure B1) results, I assigned each 
participant to a unique number within their assigned group. This numeric assignment did 
not apply to the ADE survey (Appendix A), because it was not necessary for me to know 
from which participant those results came from. 
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Since residents are not direct participants in my research, I did not make any 
identifiable references to individuals in this population. Rather, I created fictitious 
residents that had no reference to any actual residents to use within the simulation, where 
a barcode that corresponds to a fictitious resident was necessary. These barcodes were not 
affixed to any actual residents, property of the NH, or personal property of the resident. 
Instead, I affixed each barcode, uniquely assigned to a particular fictitious resident, to a 
single cardboard poster board (see item C on Figure 2).  
Summary 
In this research, I investigated the reasons for ADEs caused at the drug 
administration stage in conjunction with a personal assessment on the effect RT might 
have on reducing the high incident rate of ADEs. My research was based on a mixed 
methods approach, where I collected and analyzed both quantitative and qualitative data 
to view the issue from a broader perspective. This broader perspective included an 
evaluation of historical ADEs recorded by each NH along with the perceptions and 
beliefs of both nurses and administrators related to why drug administration errors occur.  
To acquire the qualitative data, I used the survey method and the focus group 
method to collect two distinct classes of data from three different NHs. I began data 
collection in each NH by acquiring historical data directly from each NH and progressed 
into administering the ADE survey (Appendix A) to all participants taking part in my 
research. In addition, I asked administrators and nurse supervisors in each participating 
NH to give feedback during the focus group discussions, which provided me with data to 
take into account a view from management to establish a comprehensive result.  
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To acquire a portion of the quantitative data, I used a model to demonstrate how 
RT might work to assist with solid drug administrations in NHs, and used the RT survey 
(Figure B1) to assess overall how nurses and administrators feel about the technology. I 
administered this survey on two occasions to determine if the perception of the control 
group remained the same or changed between the first and second survey, and if the 
perception of the treatment group changed after viewing the model as compared to before 
viewing the model. Using the results obtained from both occasions of the survey, I 
computed five separate means to answer RQ4 and RQ5.  
It was unknown how NH caregivers might view a robotic system capable of 
assisting with the drug administration task, namely due to the fact that scholarly research 
into whether or not RT can reduce ADE error rates is lacking (Van den Bemt et al., 
2011). Therefore, this investigation into whether this kind of technology could be 
instrumental at all was necessary, before time and money is spent building an impractical 
and unacceptable system. To assess the perception of how nurses and administrators 
perceived the use of RT to reduce ADEs, specifically at the administration stage, I relied 
on the t test to analyze four hypotheses and the paired t test to analyze the other two 
hypotheses.  
Collectively, the mixed methods data that I collected allowed me to fully answer 
the RQs. These questions addressed five pertinent inquiries related to the premise of my 
research: how are drugs administered, how do ADEs occur, what options are available to 
prevent errors, how do NH professionals feel about RT in general, and how do nursing 
professionals feel about RT after seeing how it would work. Together, these questions 
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formed a strong basis to begin discovery related to the possibilities of RT to assist with 
the administration of solid medications in NHs. Details related to the data collected for 
this research are forthcoming in Chapter 4.  
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Chapter 4: Discussion 
The purpose of this mixed methods research was twofold. The first purpose was 
to evaluate the causes of ADEs specific to solid drugs (tablets, pills, and capsules only) 
using several sources of data. The second purpose was to acquire the perspective of 
nurses and administrators in the NH environment on the use of RT to assist in the drug 
administration task to decrease ADEs.  
To address the first purpose, I triangulated the causes of ADEs specific to solid 
drugs in NHs from three perspectives. These perspectives included actual errors that 
occurred at the participating NHs (reported ADEs), the nurse perspective on the causes of 
ADEs via the ADE survey (Appendix A), and the administrator (including nurse 
supervisors) perspective on the causes of ADEs via the focus group session. This data 
was used to answer the three qualitative questions, which addressed how drugs are 
administered, how ADEs of solid form occur, and how familiar NH managers are on 
current technologies.  
To address the second purpose, I addressed two quantitative questions which 
comprehensively assessed the participant’s perception of RT to assist with the drug 
administration task. I answered these questions with the RT survey (Figure B1) data 
where I performed six hypothesis tests relative to two experimental groups (control and 
treatment). 
Chapter 4 includes the results of the pilot study, which was conducted to validate 
the survey instruments, and the validation and verification process that was used to assess 
the robotic model. This chapter includes a detailed presentation of the data and the 
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themes/patterns that I found. I describe how the data were used to address the qualitative 
and quantitative RQs. A discussion of data analysis and results, evidence of 
trustworthiness, and data collection and recording are also included in this chapter.  
Pilot Study Results 
 To assess reliability and validity of the ADE Survey (Appendix A) and the RT 
survey (Figure B1), I recruited eight nurses (including two administrators) who worked in 
the NH environment, and lived in Chesapeake, VA to evaluate the intended purpose of 
each survey. I designed the ADE Survey to acquire firsthand data on how nurses and 
administrators believe ADEs occur in the general areas of experience, training, and 
guidelines and procedures. I designed the RT survey to acquire nurse and administrator 
perceptions on the use of RT to reduce ADEs at the administration stage in the NH 
environment.  
Reliability of the Survey Instruments 
 I began the pilot study by explaining to the pilot study participants that the 
objective of their participation was to assess each survey for reliability and validity. I 
explained to them that these survey instruments were researcher-created and had never 
been used in prior research. Thus, the surveys required a rigorous assessment by an 
appropriate sample to determine if they would be reliable and valid for this research 
project. According to Sullivan (2011), reliability means acquiring consistent responses 
among the same participants. I designed the surveys to acquire information related to 
ADEs in the general areas of experience, training, and guidelines & procedures; and the 
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perception of nurses and administrators (including nurse supervisors) on the use of RT to 
assist with the administration of solid medications.  
After explaining the purpose of the pilot study, I encouraged the participants to 
provide honest feedback at any juncture of the pilot study that they believed would 
improve the quality of the survey instruments. The participants were separated into two 
groups of four in hopes that the separation would discourage them from influencing each 
other on their answers to the survey questions. Both groups took both surveys twice on 
different days.  
To properly manage the results from the surveys, I modified the definition of the 
identification code to be slightly different for the pilot study as opposed to the actual 
research. Instead of the first number of the three digit code representing the group 
(control or experimental), it simply represented whether the participant was in the first 
group or the second group. For example, survey results marked 1-2-3 indicated first 
group (1), second occasion of taking the survey (2), and participant number three (3). I 
did this so that I could easily match the before and after results from each participant. 
I compared the results of the first and second ADE survey to determine the extent 
of correlation. Using the mean score of each question and Pearson’s correlation 
coefficient equation, I calculated a correlation coefficient of 1, which indicated strong 
positive correlation. I also compared the results of the first and second RT survey in the 
same manner using the mean score for each question. This calculation also resulted in a 
correlation coefficient of 1, which again indicated strong positive correlation. As a result, 
I did not add any new questions or remove any existing questions from either survey.  
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Validity of the Survey Instruments 
To assess validity, I used the same pilot study participants (nurses and 
administrators) that I had recruited to assess reliability. I asked these nurses and 
administrators to share their opinions and thoughts to the questions on both surveys to 
assess whether they thought the questions were applicable to acquiring diverse 
information on the causes of ADEs and the use of RT to assist with the drug 
administration task. The majority (6 out of 8) of the participants believed that the 
questions were adequate for the purpose of the research, but suggested rewording several 
questions to avoid misinterpretation. Based on their expertise in the healthcare industry, I 
modified the wording of several questions for better clarity. One nurse questioned the 
small number of questions, but after explaining to her that the research participants would 
be taking the surveys in their natural environment (NH) keeping the survey short was 
critical for completion.  
As a result of this pilot study, I improved face validity of the survey instruments 
by modifying the structure of the questions into a consistently phrased statement to 
encourage better responses. I also rearranged the categories (experience, training, and 
guidelines & procedures) so that an entire section of questions would be present on a 
single page to avoid disruption of thought. After I made these changes, the participants 
raised no additional questions or concerns.  
Robotic Model 
According to Van den Bemt (2011), a mobile, self-directing robotic system does 
not exist in NHs for the purpose of assisting nurses with the drug administration task. To 
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acquire some understanding of how NH professionals feel about RT for this purpose, it 
was necessary to build a visual model that would give them a practical representation of 
how the technology would work. An actual robotic system was not practical because of 
the complex operations it would take to make RT function safely in a NH environment. 
To determine if the model that I built was adequate to acquire data on how NH 
professionals felt about RT, I subjected the model to the constructs of fidelity, 
verification, and validity to justify its reasonableness and acceptable range of accuracy.  
Fidelity of the Model 
It was important to establish fidelity of the model in terms of how it related to 
existing systems to diminish concerns about its ability to produce similar behavior. Real-
world systems, comparable to the concept of my model currently exist and mainly deal 
with delivery, distribution, and dispensing of medications primarily in hospitals. For 
example, Summerfield et al. (2011) evaluated an RT application associated with delivery. 
Chen et al. (2013) evaluated an RT application associated with distribution and 
Samaranayake et al. (2014) examined an RT application that focused on dispensing. The 
common factor among these systems was their usage of computer technology coupled 
with some form of barcode technology, which was the underlying foundation of my 
model. 
To conduct this research, I built a simple model consisting of a movable cart, a 
numbered (ranging from 1 to 10) multidrawer cabinet, a scanner, code 39 type barcodes, 
a laptop computer, and a simple Microsoft Access application (software) where together 
these components mimicked the most basic features of similar real-world systems. These 
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basic features included assigning a barcode to a specific entity (person or specific 
medication) where access to the entity was only granted through the act of scanning a 
barcode. While my model lacked the detailed functionality of a real-world system, an 
approximation of the real thing was acceptable as long as the model accomplished its 
intended purpose (Sokolowski & Banks, 2009).  
I custom-built the software components that worked in conjunction with the 
physical components of the model explicitly for this research. Since the software was 
specific for the model, extensive error checking or extreme functionality was not coded 
into the software. The basic error-handling that was included was sufficient to adequately 
demonstrate the successful operation of the software. The software was composed of two 
user interfaces and a database consisting of three tables. Each table was manually loaded 
to contain 10 fictitious residents that were assigned to a unique barcode (ranging from 1 
to 10) and 10 solid medications represented with uniquely colored jellybeans. The 
assignment of a fictitious resident with a fictitious medication regimen containing 
multiple medications (jellybeans) was defined prior to inserting into the database. 
Since the model was an approximation of the real thing, it was necessary to 
conduct a series of test on it to assure that it functioned within an acceptable range of 
accuracy. Feinstein and Cannon (2001) declared that the researcher cannot omit detail 
testing if the intent is to abolish concerns about the effectiveness of a model. After 
extensive testing, the model performed as I expected where the software displayed the 
scanned barcode and the correlating medications (jellybeans) on the laptop screen. Upon 
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opening the drawer matching the scanned barcode, the drawer contained the same colors 
and quantities of jellybeans as displayed on the screen.  
Verification of the Model 
  The most common approach for verifying a model makes provisions for the 
researcher to subjectively determine if it encapsulates all possibilities related to its 
intended purpose (Sokolowski & Banks, 2009). A secondary approach seeks to determine 
if the model can produce the desired results given all possibilities related to its intended 
purpose (Feinstein & Cannon, 2001). Stated another way, these approaches direct the 
model designer to confirm that the model was implemented correctly according to its 
conceptual design. 
In consideration of these approaches, the intended purpose of my model was to 
direct the user to a specific medication drawer (fictitious) that was associated with a 
specific resident (fictitious) based on a scanned barcode. As a first of two steps to address 
verification of my model, I rigorously tested it multiple times and verified that it 
accurately and consistently produced the correct result. Sargent (2013) cautioned though 
that while researcher-testing is appropriate when verifying a model, it is also imperative 
for the researcher to determine if the model satisfies its predefined experimental 
conditions before rendering it acceptable to partially impersonate a real-world system. 
My test results showed that the model successfully met the predefined test cases that I 
created while building the model.  
As a second of two steps to address verification of the model, I summoned the 
assistance of four IT experts to assess the model in terms of face validity. Feinstein and 
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Cannon (2001) noted that this is a critical part of effectively verifying a model. When a 
model can be evaluated and assessed from a different perspective, it is likely that genuine 
reasonableness can be determined and any deficiencies missed by the model builder can 
be found. Accomplishing both will increase confidence in the model’s credibility.  
After explaining to the experts the purpose of the model, I separated them into 
two equal groups. I gave each group five unique test cases (and the expected outcome) 
that I defined during the build stage of the model and asked them to execute each test 
case in succession. They concluded that the model did not contain any errors and was 
reasonable for its intended purpose. 
As a final assessment of face validity, I compared the barcode aspect of my model 
to Pyxis, a real-world drug dispensing cabinet. The Pyxis system essentially directs the 
user, based on a scanned barcode, to a specific stationary cabinet containing one specific 
medication for patients in general (Weekes, 2014). Thus, the similarity of scanning a 
barcode to direct the user to a specific medication cabinet was basically the same as in 
my model. My model differed slightly, because it was built on the premise of assembling 
different medications for the same patient in one location versus the Pyxis system 
assembling medications of the same kind in one location.  
Validation of the Model 
Validation is concerned with the degree to which a model will meet the 
functionality expectations set by the model builder (Feinstein & Cannon, 2001; Sargent, 
2013). To this end, I expected the test results from the IT experts to be consistent with the 
results I achieved during my own testing. The first four out of five test cases required the 
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experts to scan the barcode for five different fictitious residents, and then compare the 
fictitious medications (jellybeans) shown on the laptop screen to those present in the 
corresponding numbered cabinet. For example, if the user scanned barcode number two, 
the user interface would show the fictitious medication regimen for resident two on the 
screen. Upon the user opening drawer number two, it contained the exact fictitious 
medications and quantities as shown on the laptop screen.  
The fifth test case required the experts to scan an unassigned barcode or any 
random barcode of their choice to confirm that the software did not direct them to an 
incorrect drawer. It was important to establish, through testing, that the system would not 
direct the user to an incorrect drawer, which would result in an inaccurate assisted 
administration. Beyond these five test cases, I encouraged each group to test other 
scenarios of their choice to validate the functionality of the model. Based on their 
objective testing, one additional test case emerged and was added to the standard test set. 
The experts requested confirmation that a barcode could be manually entered if the 
scanner failed. This test case was tested several times by each group (and myself) and 
passed without having to make modifications to the software. Overall, the model 
generated an outcome that was consistent with my initial expectations.  
Research Setting 
To conduct this research, I initially set out to recruit three NHs that had a 
Medicare/Medicaid quality rating of 3 (medium). According to the CMMS (2015), a 
quality rating of 3, on a scale of 1 to 5, is medium. NHs rated as a 1 were found to have a 
significant number of care issues and NHs rated as a 5 had the least number of care 
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issues. By choosing NHs with a medium quality rating, I intended to eliminate choosing 
all poorly or highly scored NHs to dismiss any potential influence on the data. 
Ultimately, I settled on three NHs who had quality ratings of 1, 1, and 2 due to their 
willingness to take part in this research (Table 4) within the permitted timeframe. Each 
NH assured me that since their last inspection, respectively June 19, 2015, October 24, 
2014, and January 15, 2015 (NH 1, Director of Nursing, personal communication, 2015; 
NH 2, Director of Nursing, personal communication, 2016; NH 3, Director of Nursing, 
personal communication, 2016), they had taken the necessary steps to improve upon the 
violations (mostly unrelated to drug administrations) that dictated their rating.  
Table 4  
Nursing Home Characteristics in the Research Sample 
 NH1 
(small) 
NH2 
(medium) 
NH3 
(large) 
Number of available beds 88 130 211 
Number of occupied beds 69 120 180 
Medicare/Medicaid quality rating 1 1 2 
   
Two of the three nursing homes were located within the Memphis metropolitan 
area and one was located 10 miles outside of the Memphis metropolitan area in 
Mississippi. Extension outside of the Memphis area became necessary after other NHs 
with the desired quality rating declined to take part in this research. The participating 
NHs collectively had 429 beds and an 86% (369/429 * 100 = 86%) occupancy rate at the 
time of this research (Table 4). To care for 369 current residents, these NHs collectively 
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employed 215 nurses and administrators to handle the daily activities of its residents as 
required by regulating agencies and their residential care plans.  
At the time of this research, none of the NHs was using an automated medication 
system to assist nurses at the drug administration stage. Even though an automated 
system was not used at the administration stage, these NHs employed technology, like the 
Medication Administration Record (MAR) system, the Electronic Medication 
Administration Record (EMAR), and the Automated Dispensing Unit (ADU), along with 
other checks and balances to assist with other stages of the medication-use process 
mainly to keep an electronic record of medication movement and administration within 
the NH. The non-usage of technology at the administration stage required the nurse to 
heavily rely on their personal skills, knowledge, and experience to extract and administer 
the correct quantities of medications for the correct residents under their care.  
I collected the data in the natural environment of each NH. Therefore, data 
collection was intermittent because all participating nurses were not able to assemble at 
one time due to their responsibilities of resident care. Nonetheless, nurses were 
comfortable taking the surveys and expressed interest in this research with questions and 
comments.  
Demographics 
 The total number of participants to the ADE and RT surveys was N = 105; 
however, three were excluded because (a) the majority of their responses were neutral (3) 
or (b) they did not have nursing qualifications (2). Table 5 outlines the characteristics of 
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N = 102 valid participants to the ADE and RT surveys that were included in the statistical 
analysis.  
Table 5 
 
Characteristics of Participants in ADE Survey (N = 102) 
 
Characteristic Group  n % 
Nursing Home  1  34 33.3 
  2  34 33.3 
  3  34 33.3 
Number of Beds  1 
 2 
 3 
 88 
 130 
 211 
   20.5 
   30.3 
   49.2 
Title LPN 41  40.2 
 CNA 39  38.2 
 RN 14  13.7 
 RN (Supervisor) 2    2.0 
 Director of Social Services 1    1.0 
 RN -Director of Clinical Education 1    1.0 
 RN/Assistant Director of Nursing  1    1.0 
 RN/Director of Nursing 1    1.0 
 Nurse Practitioner 1    1.0 
Certified to Administer No 34  33.3 
 Yes 68  66.7 
Years of Experience 1-5  21 20.6 
 6-10  35 34.3 
 11-15  26 25.5 
 16-20    9 8.8 
 21-25    8 7.8 
 >25    3 2.9 
  
The participants were distributed equally among the three NHs. The most frequent 
job titles were LPN (n = 43, 43/102 = 42.2%) and CNA (n = 39, 39/102 = 38.2%) with 
the remainder including RNs, a Director of Social Services, and a Nurse Practitioner. 
Over two thirds (n = 68, 68/102 = 66.7%) of the participants were certified to administer 
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drugs. The experience of the participants ranged widely from 1 to 34 years (M = 11.05, 
SD = 7.01). The most frequent group classified by years of experience (n = 35, 35/102 = 
34.3%) was 6-10 years, while participants with greater than 25 years of experience were 
the most infrequent (n = 3, 3/102 = 2.9%). Other characteristics, like sex, race, or age was 
not captured as it was not important for my research.  
The number of beds at each participating NH exceeded my original classification 
of small (less than 50 beds), medium (50 to 105 beds), and large (greater than 105 beds). 
My original classification was based on the number of beds at NHs in the Memphis 
metropolitan area that had a quality rating of 3. These NHs varied in their number of beds 
at approximately 50, which dictated the preset bed range at an increment of 50. However, 
the number of beds in the participating NHs did not fit this definition, which rendered a 
change in my definition of size. The participating NHs had 88, 130, and 211 beds 
respectively. Thus, based on the actual participating NHs, I reset the bed range at an 
increment of 90. As a result, small NHs were redefined as less than 90 beds, medium as 
90 to 180 beds, and large as more than 180 beds (see Table 5).  
Data Collection 
I asked each of the three participating NHs to provide a list of ADEs (qualitative 
data) that occurred within a 3-month period of time at the onset of my research. 
Collectively, these NHs only had two reported ADEs that occurred over that period of 
time. While there was no expectation of a small or large number of ADE’s over a 3-
month period, the actual number of two ADEs was too small to make a realistic 
assessment related to the causes of ADEs in general. As a result, I expanded the range to 
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6 months, June 2015 through December 2015, which revealed seven solid ADEs among 
the NHs. ADEs in other forms (a total of four), like liquids and ointments, were 
eliminated from consideration, since my research focused specifically on solid 
medications that came in the form of pills, tablets, and capsules.  
Prior to conducting this study, I did not have an expectation of the type, 
classification, or quantity of ADEs in any of the participating NHs. Thus, the ADE 
scorecard was designed from a general perspective to categorize ADEs in seven general 
areas that were prevalent in the literature that I reviewed in Chapter 2. Stated, these 
general areas were (a) wrong medication (b) improper quantity (c) late administration (d) 
early administration (e) no administration (f) improper technique, and (g) other errors 
beyond those that were mentioned. See Figure 3 for a graphical view of the reported 
medications errors, which developed into an ADE that I gathered from the NHs 
collectively.  
 
 
Figure 3. Distribution of reported ADEs.
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In addition to the accumulation of reported ADEs, I acquired another portion of 
qualitative data through the ADE survey (Appendix A) and from the focus group 
sessions. I recorded and later transcribed to paper the data gathered from the three 
separate focus group sessions (one in each NH). The length of each focus group session 
was less than an hour and was conducted using the predefined focus group questions 
listed in Appendix D. As the conversations unfolded within each session, I asked 
secondary questions either to gain clarity of their answers or to encourage further 
discussion to acquire additional information. Each session collectively contained four 
participants, composed of nurse supervisors and administrators that were already a part of 
the overall participant pool.  
Data Analysis  
Qualitative Analysis 
This section presents a collective content analysis of the transcripts of the 
discussions between the researcher and the participants of the focus groups. A total of 73 
significant statements were extracted from the transcripts (see Appendix F). Each 
statement was a sentence or phrase which was considered relevant to answer the RQs. In 
the first stage of the content analysis, I coded each significant statement with a number 
and a name which served to identify the statement as constituent of a primary theme. I 
identified six primary themes, as listed in Table 6. The largest theme was Reasons for 
ADEs based on 24 statements. The smallest theme was Cost Savings based on five 
statements. 
  
 
128 
Table 6 
 
Primary Themes Extracted from Transcripts of Focus Groups 
 
Number Primary Theme  Statements 
1 Reasons for ADEs  24 
2 Process of drug administration  6 
3 Use of technology 15 
4 Training  14 
5 Financial incentives 9 
6 Cost savings 5 
 
 In the second stage of the content analysis, I recoded each significant statement 
within the six primary themes with a number and a name, which served to identify the 
statement as constituent of a secondary theme. I identified a total of 29 subthemes, as 
listed in Table 7.  
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Table 7 
 
Subthemes Extracted from Transcripts of Focus Groups 
 
Number   Primary Theme Number    Sub-theme  Statements 
1 Reasons for ADEs 1.01 Not paying attention 5 
1.02 Too busy 6 
1.03 Limited time 2 
1.04 Stress and fatigue 2 
1.05 Transcription errors 3 
1.06 Medicine not up from the pharmacy 1 
1.07 Unknown medical history of patients 1 
1.08 Wrong patient, wrong drug 1 
1.09 Drug received at wrong time 1 
1.10 Updating MAR 1 
1.11 Lack of community of care 1 
2 Process of drug administration 2.01 Time and effort 6 
3 Use of technology 
  
3.01 MAR and EMR 5 
3.02 ADU 1 
3.03  Best practice alerts 3 
3.04 PCAS 1 
3.04 Robotic Technology 5 
4 Training 4.01 No training 2 
4.02 Training is inadequate 1 
4.03 Training is adequate 2 
4.04 Connect Care class 1 
4.05 Health Stream 1 
4.06 Medication tests 1 
4.07 Orientation 1 
4.08 Training for EMR 1 
4.09 More training is needed 4 
5 Financial incentives 5.01 Agree  6 
5.02 Other incentives 3 
6 Cost savings 6.01 Reducing ADEs results in cost savings 5 
Note. ADU = automatic dispensing unit; EMAR = electronic medical administration 
records; MAR = medical administration records; PCAS = patient controlled analgesia 
system.  
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Theme 1: Reason for ADEs. The focus group participants suggested many 
reasons for ADEs of which the most frequent were “not paying attention” as exemplified 
by Participant 9, who stated the following: 
I [a nurse] worked with a nurse who had medicine ready to go in one patient’s 
room and was then called into another patient’s room, but she could not leave that 
medicine there. But in her haste, she went into the wrong room with this medicine 
and administered this medicine to this patient, because she was not paying 
attention at the time at what she was doing.  
“Too busy” was also frequently mentioned, as suggested by Participant 9: 
“because of patient load they [the nurses] want you to go here, here, here and here. Now 
you have everybody [the residents] calling at one time wanting their medicine and 
everyone [the nurses] talking about everybody [the residents] ready to go to sleep.” 
“Limited time” was illustrated by the following comment from Participant 5: 
“The problem is that you [the nurses] have one hour before and one hour after and that’s 
what your JCHAO [Joint Commission on Accreditation of Healthcare Organizations] 
standards are, but it’s absolutely impossible to pass those meds during that time.” Not 
paying attention, too busy, and limited time were linked to comments from Participant 5 
that included “A lot of times of stress and fatigue” and Participant 6 that included “You 
may have someone [a nurse] that may take an additional shift, because someone didn’t 
come to work. That would cause the fatigue that she’s speaking of.”   
Three statements were concerned with “Transcription errors”. Participant 3 stated, 
“Sometimes a doctor’s handwriting can come to you [the nurse] and you can’t quite read 
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what he has written out or either you read it and it is typed in wrong.” Single statements 
indicated further reasons for ADEs where Participant 2 stated, “The medicine not being 
up from the pharmacy usually is an issue;” Participant 3 stated, “I think the biggest 
reason we see adverse drug events with patients are their unknown medical history that 
contradict the use of certain medications;” Participant 8 stated, “Wrong patient, wrong 
drug” and “Some of your adverse med errors are strictly based on the fact that the patient 
didn’t receive the medication at the right time;” Participant 5 stated, “The problem with 
the MAR is that if a physician comes in and updates a medication it may not be changed 
over into the MAR;” and Participant 7 stated,  
I believe one of the largest indicators is the lack of continuity of care from 
caregivers in the nursing home. We have a high turnover rate and that . . . the 
orientation rate for the new nurses can be really stressful on them and I believe a 
lot of our errors are from that. 
Theme 2: Process of drug administration. The participants highlighted the 
considerable amount of “time and effort” involved in the process of drug administration. 
For example, Participant 4 stated, “We have to come all the way down from B wing hall 
to all the way to A wing hall, because A wing is the only one with the unit [medication 
cart];” Participant 1 stated, “So, I [nurse supervisor] get my report on my patients. I make 
a list of all the medications that are to be administered throughout my shift and then I 
prioritize, you know the patients I need to see first.” Participant 8 stated,  
Well normally you [the nurse] have patients in your undesignated space, which is 
normally one or two halls and those medications are on your med trays. On those 
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med trays though each patient is different and individualized . . . and this is where 
a lot of nurses loose time and where some errors may come in. 
Theme 3: Use of technology. Most of the statements about the use of technology 
referred to the use of MAR, EMAR, and ADU, e.g., Participant 2 stated, “We have a 
scanning system. It’s all computerized. So, it comes up on the MAR what the patient is 
supposed to take and we scan each medication;” Participant 3 stated, “Our EMAR is fully 
equipped with a scanning system.” Participant 3 also stated, “As far as what we [the 
nurses] have, we have our MAR. That will tell us when we’re giving a medication, if 
we’re giving a medication too soon or if it’s not scheduled or the wrong patient, wrong 
medication;” and “They [the administrators] moved everything to the electronic MAR or 
EMAR, and the ADU [automated dispensing unit].” Participant 9 stated,  
It [ADU] will stream out 24 hours’ worth of medications and the 11 to 7 shift puts 
those medications in each individual patient’s slot. So for that 24-hour period, 
every medication that the patient will take is put into that slot.  
The use of “Best practice alerts” was referred to, indicated by the following statement 
from Participant 9:  
It [ADU] alerts you that it’s not time. It would have a time on there when the 
medication was given. It would have the date and the time it was last given. So 
you know, you can see in red the date and the time that it was given so you don’t 
give it too early, because it would have on their give every six hours or, you 
know, so you don’t give it too early. 
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Participant 3 stated, “However, the good thing is that the scanning system does 
stop us from overriding the best practice alerts where there is something wrong with the 
administration.” Participant 3 suggested that “I do kind of have a feeling that this might 
be taking away the nurses responsibility of doing their checks, the patient identified and 
the five rights of drug administration.” Participant 3 also mentioned PCAS, stating “Our 
PCAS [Patient Controlled Analgesia System] will tell us if we were not administering a 
specific narcotic correctly with heparin, for example.” 
 The other statements concerned the use of RT for which the nurses all provided 
positive views, highlighted where Participant 2 stated, “If your robotic can effectively 
handle patient and med safety it would be an awesome addition to what we already 
have;” and Participant 4 stated, “Yes, it would be an improvement. If your robot can 
follow and go patient to patient I mean that works.” 
Theme 4: Training. The statements about training were contradictory. 
Participants 7 and 9 said they had “no” training, but four considered that training was 
inadequate, exemplified where Participant 2 stated, “I think there’s other education that is 
need to be incorporated in our surrounding, not just surrounding the drug administration 
itself, but the rights of the patient when administering the medication;” Participant 3 
stated, “I don’t think we actually have training for events for that;” and Participant 2 
stated, “I also think there’s a lot of pharmacology re-education that needs to be done 
when people get out of school that we don’t focus as much on because we rely too 
heavily on micro medics.” 
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 Other participants provided details of their training, including (a) Connect Care:  
Participant 1 stated, “When you get accepted to being a new nurse you learn how to, you 
know, how to administer meds, you go to a Connect Care class on the computer to learn 
how to scan the medication;” (b) Health Stream: Participant 1 also stated, “We have our 
annual medication requirements that we do on Health Stream;” (c) Medication tests: 
Participant 3 stated, “Every nurse in here takes a medication test;” (d) Orientation: 
Participant 5 stated, “Well, all staff have to go through an orientation and they have to go 
for training.;” and (e) Training for EMAR: Participant 1 stated, “There have been some 
trials though with new employees coming on to our electronic medical records system 
and having to correlate the training with the EMAR and the drug administration.” 
Theme 5: Financial incentives. All the participants agreed with the idea that 
financial incentives should be offered to reduce ADEs, highlighted by six statements, 
including. Participant 1 stated, “I [nurse supervisor] would love to give financial 
incentives to my nurses;” “Yes, money is a huge incentive to us I think;” Participant 2 
stated, “If we had a financial incentive I think we would do better;” Participant 10 stated, 
“I think it would motivate a person to do what they are supposed to do or actually focus 
more, let me say that” and Participant 5 stated 
That would raise the stakes. Well, I [administrator] think it would actually lead to 
a lot of good things. If you had less adverse reactions, one you would retain your 
nurses because they would be working in an environment in which they will be 
happy. And that’s your goal. And once you can achieve that environment you’re 
going to retain that staff. 
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 Three statements referred to incentives that were other than financial, such as 
acknowledgement, recognition, and appreciation, indicated where Participant 1 stated, “I 
am the type of manager that will acknowledge not only the mistakes at work but over 
acknowledge the accomplishments and the recognition that need to be had on the floor;” 
and Participant 7 stated, “Or even give them at the end of every quarter some kind of 
recognition, like a banquet or you know like a special dinner for them” and Participant 8 
stated,  
I don’t know if that . . . will it necessarily have to monetary. It can be like a day 
off or maybe an extra hour for lunch. I think any type of incentive would 
encourage or may make that employee feel more valued and more appreciated. 
Theme 6: Cost savings. All of the focus group participants agreed that reducing 
ADEs would result in cost savings, exemplified where Participant 1 stated,  
I do believe that any decrease in any adverse event is going to save the facility 
money. I think that because with medication. I think seeing the cost saving on the 
treatment that are provided to reverse effects, would be less costly if we prevented 
ADEs. 
Participant 3 stated, “When people make med errors people die and get sicker and we 
have to fix that” and “Yes, it would save everybody a lot of money.” 
Triangulation of qualitative data. The responses to the ADE survey indicated 
that the perceptions of the participants toward training were the most positive. In contrast, 
the focus group responses provided contradictory evidence concerning training. Some 
nurses complained of no or inadequate training, while others reported adequate training.  
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 The significant statements extracted from the focus groups provided rich details 
concerning the many reasons why the participants thought ADEs occurred, and also 
explained the difficulties that the nurses experienced in the use of technology, including 
MAR, EMR, and ADU. These statements reflected the relatively negative perceptions of 
the participants to the questions in the ADE survey, based on their experiences, training, 
and guidelines & procedures.  
 All of the participants in the focus groups welcomed the potential usage of RT, 
which they believed could reduce ADEs. This positive viewpoint was also reflected by 
the responses to the RT survey (Figure B1), which showed that, after viewing the 
demonstration, the treatment group perceived that RT could reduce ADEs.  
Descriptive Statistics 
 I evaluated the survey response data using descriptive statistics to (a) analyze the 
responses to the ADE survey (Appendix A), and (b) compare the responses from the RT 
Survey (Figure B1) of the treatment group (who viewed the demonstration) and the 
control group (who did not view the demonstration) using inferential statistics before and 
after viewing the demonstration. The results of the hypothesis tests are described for RQs 
4 and 5 (later in this chapter) while the scores related to the ADE survey are further 
discussed in this chapter specific to qualitative RQs 1, 2, and 3. 
Descriptive statistics of the ADE survey. Tables 8, 9, and 10 summarize the 
responses to the 26 items in the ADE Survey, classified by three dimensions (a) 
experience; (b) training, and (c) guidelines & procedures. I computed the mean (M) and 
standard deviation (SD) of the responses to each item using the designated 5-point scale, 
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where 1 = strongly disagree, 2 = disagree, 3 =neutral; 4 = agree, 5 = strongly agree. I 
listed the items based on the numerical sequence on the survey so that the results could be 
easily matched to the item. 
For the experience dimension of the ADE survey (Table 8), there were no mean 
scores greater than 4.0. The highest level of agreement, was for “Administration mistakes 
are commonly caused by a lack of attention” (M = 3.82). The lowest scores (< 3) 
corresponding to the lowest level of agreement, were for “A nurse with more than 3 years 
of experience is likely to make a drug administration mistake” (M = 2.75); 
“Administration errors are common because of the number of drugs prescribed to nursing 
home residents” (M = 2.90); “Nurses administer prescription medications to residents that 
were not prescribed by a doctor” (M = 2.90); and “Nursing home residents cause 
incorrect drug administrations” (M = 2.15). 
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Table 8  
 
Summary of Responses to Experience Dimension of ADE Survey (N = 102) 
 
Item 
Nbr 
 
Item 
 
 M 
 
SD 
  1 A nurse with less than 1 year of experience is likely to make a 
drug administration mistake 
3.45 
 
1.12 
 
  2 A nurse with more than 3 years of experience is likely to make a 
drug administration mistake 
2.75 
 
1.08 
 
  3 Administrative errors are common because of the number of drugs 
prescribed to nursing home residents 
2.90 
 
1.23 
 
  4 Administration mistakes are commonly caused by a lack of 
attention 
3.82 
 
0.89 
 
  5 When administration errors occur they are reported 3.48 1.05 
  6 Solid medications, like pills, tablets, and capsules, are more prone 
to administration errors  
3.04 
 
1.13 
 
  7 When a drug appears inappropriate, nurses question transcription 
orders made by doctors 
3.41 
 
0.98 
 
  8 Nurses administer prescription medications to residents that were 
not prescribed by a doctor 
2.21 
 
1.10 
 
  9 Nursing home residents cause incorrect drug administrations 2.15 0.94 
 10 Nurses vary administration techniques based on the resident 3.35 1.17 
 
For the training dimension of the ADE survey (Table 9), the highest scores (> 4.0) 
corresponding to the highest level of agreement (reflecting a favorable perception) were 
for “Nurses are encouraged to ask questions about prescribed orders that appear 
inappropriate” (M = 4.02) and “Nurses are encouraged to report adverse drug events that 
they are aware of” (M = 4.20). The lowest scores (< 3.6) corresponding to the lowest 
level of agreement, were for “Nurses with less than 1 year of experience are adequately 
trained to administer drugs” (M = 3.58); “Educational seminar's related to new drugs are 
available in nursing homes” (M = 3.59); “Nurses are required to attend educational 
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seminars on new drugs” (M = 3.58); and “Adequate information about drugs readily exist 
on NH wards” (M = 3.56). 
Table 9  
Summary of Responses to Training Dimension of ADE Survey (N = 102) 
Item 
 Nbr 
 
Item  
 
M 
 
 SD 
  11 Agency nurses are adequately trained to administer medications 
common in nursing homes 
 3.67 
 
0.88 
 
  12 Nurses with less than 1 year of experience are adequately trained to 
administer drugs 
 3.58 
 
0.83 
 
  13 Nurses with more than 3 years of experience are adequately trained 
to administer drugs 
3.90 
 
0.64 
 
  14 Educational seminar's related to new drugs are available in nursing 
homes 
3.59 
 
0.75 
 
  15 Nurses are required to attend educational seminars on new drugs 3.58 0.90 
  16 Adequate information about drugs readily exist on nursing home 
wards 
3.56 
 
0.82 
 
  17 Nurses are encouraged to ask questions about prescribed orders that 
appear inappropriate  
4.02 
 
0.61 
 
  18 Nurses are encouraged to report adverse drug events that they are 
aware of 
4.20 
 
0.60 
 
 
 For the guidelines & procedures dimension of the ADE survey (Table 10), there 
were no mean scores greater than 4.0. The highest level of agreement, was for “Nurses 
generally follow the drug administration guidelines and procedures set by the facility they 
work in” (M = 3.80) and “Instruments, such as a computer, are used as an aide to 
administer drugs” (M = 3.69). The lowest scores (< 2) corresponding to the lowest level 
of agreement were for “Nursing homes allow visitors to bring in over the counter 
medications for residents” (M = 1.89) and “Nursing homes allow doctors to bring in 
medications for residents” (M = 1.94).  
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Table 10  
 
Summary of Responses to Guidelines and Procedures Dimension of ADE Survey (N = 
102) 
 
Item 
Nbr Item M SD 
 19 Nurses generally follow the drug administration 
guidelines and procedures set by the facility  
3.80 
 
0.68 
 
 20 Instruments, such as a computer, are used as an aide to 
administer drugs 
3.69 
 
0.87 
 
 21 Various policies and procedures contribute to drug 
administration errors 
2.80 
 
0.98 
 
 22 Decisions made by administrators contribute to drug 
administration errors 
3.03 
 
1.19 
 
 23 Nursing homes allow visitors to bring in prescription 
medications for residents 
4.12 
 
1.21 
 
 24 Nursing homes allow visitors to bring in over the counter 
medications for residents 
1.89 
 
1.23 
 
 25 Nursing homes allow doctors to bring in medications for 
residents 
1.94 
 
1.14 
 
 26 Nursing homes allow medication substitutes when the 
prescribed medication is unavailable 
3.34 
 
1.29 
 
 
Descriptive statistics of the RT survey. The descriptive statistics for the baseline 
or pretest scores for the 10 items in the RT Survey (Figure B1), classified by the control 
group who did not view the demonstration (n = 51) and the treatment group who did view 
the demonstration (n = 51) are presented in Table 11. The differences between the mean 
scores for each item were due to random variation and sampling bias.   
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Table 11  
 
Response of the Control Group and the Treatment Group to the RT Survey at the Pretest 
 
Item  
Nbr 
 
Item 
    Control  
     Group 
 
Treatment 
    Group 
 Mean 
Difference 
  
  M           SD   M       SD 
1 Nurses would use a robotic system to 
assist them with administering pills, 
tablets, and capsules, to prevent 
possible mistakes 
3.53 
 
 
 
1.05 
 
 
 
3.29 
 
 
 
1.28 
 
 
 
     0.24 
 
 
 
2 Keeping medicines isolated in 
patient-specific containers could 
decrease the administration  errors of 
solid drugs 
4.04 
 
 
 
0.72 
 
 
 
4.08 
 
 
 
0.84 
 
 
 
    -0.04 
 
 
 
3 A comprehensive interactive 
computer system will cause nurses 
to be less aware when 
administering medications 
3.59 
 
 
 
0.96 
 
 
 
3.08 
 
 
 
1.37 
 
 
 
     0.51 
 
 
 
4 Some new form of advanced 
technology is needed to reduce 
administration errors 
3.94 
 
 
0.93 
 
 
3.88 
 
 
1.05 
 
 
     0.06 
 
 
5 A robotic system would not be 
useful to assist in administering 
solid medications 
3.00 
 
 
1.18 
 
 
3.02 
 
 
1.22 
 
 
    -0.02 
 
 
6 A robotic system would be useful if it 
provided the right medication for 
each resident 
3.75 
 
 
1.06 
 
 
3.27 
 
 
1.17 
 
 
     0.48 
 
 
7 A robotic system would be useful if it 
did not slow down the task of 
administering solid medicines 
3.67 
 
 
0.95 
 
 
3.51 
 
 
1.03 
 
 
     0.16 
 
 
8 A robotic system would decrease 
the success rate of administering 
medicines on time  
2.86 
 
 
0.96 
 
 
2.88 
 
 
1.19 
 
 
    -0.02 
 
 
9 A robotic system would help 
decrease administration of errors of 
solid medications  
3.00 
 
 
1.00 
 
 
2.35 
 
 
1.13 
 
 
     0.65 
 
 
10 A robotic system would make my job 
of tracking what medicines I have 
administered easier 
3.35 
 
 
1.13 
 
 
2.96 
 
 
1.41 
 
 
     0.39 
 
 
Note. Bold items 3, 5, and 8 were reversed-scored in the positive direction. 
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 The descriptive statistics for the posttest scores for the 10 items in the RT Survey 
(Figure B1), classified by the control group who did not view the demonstration (n = 51) 
and the treatment group who did view the demonstration (n = 51), are presented in Table 
12. On only two items were the mean responses for the treatment group lower than the 
control group. Specifically, “A comprehensive interactive computer system will cause 
nurses to be less aware when administering medications” and “A robotic system would 
not be useful to assist in administering solid medications.” For the other eight items, the 
mean differences were negative, because the treatment group scored higher than the 
control group. 
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Table 12  
 
Responses of the Control Group and the Treatment Group to the RT Survey at the 
Posttest 
 
Item 
Nbr 
 
Item 
Control  
Group 
Treatment  
Group 
 Mean 
Difference 
     M       SD      M     SD 
1 Nurses would use a robotic system 
to assist them with administering 
pills, tablets, and capsules, to 
prevent possible mistakes 
 3.49 
 
 
 
0.88 
 
 
 
   4.37 
 
 
 
0.72 
 
 
 
      -0.88 
 
 
 
2 Keeping medicines isolated in 
patient-specific containers could 
decrease the administration of errors 
of solid drugs 
 3.98 
 
 
 
0.55 
 
 
 
   4.49 
 
 
 
0.50 
 
 
 
      -0.51 
 
 
 
3 A comprehensive interactive 
computer system will cause nurses 
to be less aware when 
administering medications 
 3.27 
 
 
 
0.94 
 
 
 
   3.00 
 
 
 
1.20 
 
 
 
       0.27 
 
 
 
4 Some new form of advanced 
technology is needed to reduce 
administration errors 
 3.10 
 
 
1.47 
 
 
   4.49 
 
 
0.58 
 
 
      -1.39 
 
 
5 A robotic system would not be 
useful to assist in administering 
solid medications 
 2.69 
 
 
1.16 
 
 
   2.61 
 
 
1.34 
 
 
       0.08 
 
 
6 A robotic system would be useful if 
it provided the right medication for 
each resident 
 4.18 
 
 
0.91 
 
 
   4.41 
 
 
0.64 
 
 
      -0.23 
 
 
7 A robotic system would be useful if 
it did not slow down the task of 
administering solid medicines 
 3.51 
 
 
1.12 
 
 
   4.45 
 
 
0.54 
 
 
      -0.94 
 
 
8 A robotic system would decrease 
the success rate of administering 
medicines on time  
 3.00 
 
 
1.15 
 
 
   3.45 
 
 
1.08 
 
 
      -0.45 
 
 
9 A robotic system would help 
decrease administration of errors of 
solid medications  
 3.24 
 
 
1.09 
 
 
   4.53 
 
 
0.50 
 
 
      -1.29 
 
 
10 A robotic system would make my 
job of tracking what medicines I 
have administered easier 
 3.45 
 
 
0.94 
 
 
   4.20 
 
 
0.69 
 
 
      -0.75 
 
 
Note. Bold items 3, 5, and 8 were reversed-scored in the positive direction. 
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Once reverse scoring of items 3, 5, and 8 was completed, the responses to the 10 
items in the RT survey were averaged for each participant. Table B2 in Appendix B lists 
the original score (pretest) and final score (posttest) for the control group and Table B3 in 
Appendix B lists the original score (pretest) and final score (posttest) for the treatment 
group. The frequency distributions of the composited scores awarded by N = 102 
participants in the RT survey at the pretest and posttest are illustrated in Figures 4 and 5, 
respectively. The majority of the participants (n = 84, 40.2%+31.4%+5.9%+4.9% = 
82.4%) had an overall mean score above 3.0 to 5.0, trending above neutral toward the 
agreement end of the scale at the pretest. An even higher proportion (n = 97, 
25.5%+40.2%+25.5%+3.9% = 95.1%) endorsed the agreement categories between 3.0 to 
5.0 at the posttest. 
 
Figure 4. Frequency distribution of the mean pretest scores for the RT survey. 
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Figure 5. Frequency distribution to the mean posttest scores for the RT survey. 
 
Research Results 
Research Question 1 
How are drugs administered in the participating facility?  The data acquired from 
the focus group sessions exposed the fact that the administration of medications is mostly 
a non-technology assisted task. Primarily, nurses were required to go to a single location, 
interfacing with a medication dispensing system, to acquire medications for their resident 
assignments as a first step. Secondary steps involved sorting the medications per resident 
to assure accuracy and prioritizing administrations based on administration orders and 
situational circumstances within the NH. In other words, distractions and too busy were 
noted as significant events that contributed to ADEs.  
Distractions and too busy correlate with lack of attention. When distractions are 
present or nurses engage in too many overlapping tasks, the potential possibility for an 
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ADE increases, especially when they are required to care for a high number of residents 
on a given shift or pressured to meet time constraints to administer medications according 
to doctor orders to multiple residents simultaneously. The participants acknowledged this 
possibility with the strong score they gave to item 4 of the ADE survey (“Administration 
mistakes are commonly caused by a lack of attention.” M = 3.82). In fact, item 4 received 
the highest score among the items in the experience dimension, which suggests that even 
with experience, losing focus during drug administrations can still lead to ADEs. 
Nurses realize the complexity of managing medications in the systems they have. 
Many medications look alike. Medication orders change frequently. New medications can 
be present on any given day for any resident. If nurses are not familiar with these aspects 
of medication administration, an ADE could occur because they are not keenly in tune to 
their dynamic environment as it relates to medications. According to item 7 of the ADE 
survey (“When a drug appears inappropriate for a resident, nurses question transcription 
orders made by doctors.” M = 3.41), nurses understand the importance of asking 
questions related to unfamiliar medications, and rarely administer medications that were 
not ordered by a doctor as indicated by the low score for item 8 (“Nurses administer 
prescription medications to residents that were not prescribed by a doctor.” M = 2.21). In 
contrast, administrators do encourage their nurses to ask questions about prescribed 
orders as indicated by the high score for item 17 (“Nurses are encouraged to ask 
questions about prescribed orders that appear inappropriate for a resident.” M = 4.02). 
Administrators also realize the complexity of managing medications in the 
systems they have. Evidence lies in the positive scores for items 14 (“Educational 
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seminar’s related to new drugs are available in nursing homes.” M = 3.59), items 15 
(“Nurses are required to attend educational seminars on new drugs.” M = 3.58), and item 
16 (“Adequate information about drugs readily exist on nursing home wards.” M = 3.56). 
Ongoing education related to medications and how they are administered is an essential 
part of medication safety.  
 Information accumulated during the focus group sessions revealed that once 
medications were dispensed from the centralized system, such as the MAR, EMAR, or 
ADU, the administration task was solely dependent on the nurse. This task was 
complicated by the fact that (a) the medication dispensing system was not mobile, (b) the 
medication dispensing system was not centrally located to make acquisition of the 
medication easier, and (c) the medication dispensing system allowed acquisition of 
multiple medications for multiple residents simultaneously. Further complications 
involved (a) delayed updates of medication orders in the system, (b) the medication order 
was not in the system, or (c) the medication order was updated in the system after 
dispensing of the medications was completed. At the end-point of administering the 
medication to the resident, the nurse could possibly unknowingly commit an ADE due to 
non-notification or late notification of medication changes in the system.  
 Perhaps this is why item 5 of the ADE survey (“When administration errors occur 
they are reported.” M = 3.48) scored toward the agreement end of the scale. This could 
mean that nurses and administrators are aware of the possibility that an ADE can occur 
due to other factors beyond their control moments before actually administrating the 
medication. In such a case, the mistake was due to an issue with the system, not the 
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person. It could also mean that nurses may fear dire consequences related to their career, 
which may encourage them to report ADEs especially if witnesses or evidence are 
present. In my research, half the participants in my study stated that errors are reported. 
But, that means that half the participants stated that errors are not reported. That, plus the 
slightly above median score obtained for item 5, aligns with the claim made by Sawarkar 
et al. (2012) that many ADEs are not reported. If many ADEs are not reported then the 
problem of ADEs is more severe than what is currently being reported. It is impossible to 
say how much more severe, because it is unknown how many ADEs go unreported. 
 A contributing factor to this situation lies in the administration techniques nurses 
use for some residents. This is indicated by the median score obtained for item 10 of the 
ADE survey (“Nurses vary administration techniques based on the resident.” M = 3.35). 
If a resident is uncooperative when it comes to taking solid medications, the nurse may 
mix the medication with food versus just administering with water. If a resident is 
mentally challenged (for example, dementia) the urge to resist taking medications is 
common. In such cases, the nurse may administer multiple medications one pill or tablet 
at a time over an extended period of time to minimize the residents’ anxiety. If a resident 
is physically challenged (for example, difficulty swallowing large pills) the nurse may 
crush the medication into smaller pieces so that it is easier to swallow. While the action 
to ensure uncooperative, mentally, or physically challenged residents take their 
medication is admirable, a nurse could unknowingly cause an ADE when the medication 
is administered contrary to manufacturer instructions. Since it is unknown that an ADE 
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could have occurred, it is difficult to track and report the occurrence of an ADE from the 
perspective of varying administration techniques.  
 Nurses and administrators agree that policies and procedures are not leading 
contributors to ADEs as indicated by the low score obtained for item 21 of the ADE 
survey (“Various policies and procedures contribute to drug administration errors.” M = 
2.80) and the stronger score obtained for item 19 (“Nurses generally follow the drug 
administration guidelines and procedures set by the facility they work in.” M = 3.80). In 
contrast, nurses and administrators felt that while policies and procedures are satisfactory, 
administration errors can occur due to direct decisions made by administrators. The 
responses were virtually neutral for item 22 (“Decisions made by administrators 
contribute to drug administration errors.” M = 3.03), which may indicate a deeper issue to 
investigate or that sometimes administrators simply make inadvertent mistakes that are 
not challenged by a nurse.  
 While the centralized system contained safeguards against ADEs at the dispensing 
stage, such as notifying the nurse if the medication had already been given or if it was too 
early/late to carry out the administration, the only safeguard at the administration stage 
was the selection of the correct medications for the correct resident by the nurse. The 
participants mentioned, however, that dispensing systems could cause some nurses to 
lessen their checks when administering medications, losing reference to the universally 
adopted concept of the 5 rights of medication administration (right patient, right drug, 
right dose, right route, and right time).  
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In contrast to the use of technology at the dispensing stage, technology at the 
administration stage in the participating NHs was not used. Nurses may inappropriately 
associate technology at the dispensing stage with technology at the administration stage, 
but no evidence of this was present in the data. Similarly, nurses may use some other 
form of technology, such as barcode technology, to assist at the administration stage, but 
again no evidence was present in the data. Despite these possibilities, many nurses (and 
administrators) believe that they are already assisted by computer technology at the 
administration stage as indicated by the above average score obtained for item 20 
(“Instruments, such as a computer, are used as an aide to administer drugs.” M = 3.69). 
Therefore, an enhanced technology, such as RT, designed specifically for the 
administration stage would readily be accepted by nurses. 
Research Question 2 
How do ADE errors in the form of pills, tablets, or capsules occur in nursing 
homes?  From the data gathered to answer this RQ, I did not discover any new causes to 
ADEs. The reasons noted were consistent with existing literature where the most frequent 
reasons mentioned were related to the administration stage of the medication-use process. 
Participants overwhelmingly mentioned that the NH environment often requires nurses to 
have responsibility for a large patient load. This caused stress and fatigue, and when 
medications have to be delivered to all assigned residents within a certain time limit 
(usually one hour before or one hour after the scheduled administration time) nurses often 
rush in order to meet this standard timeframe. This was further complicated by high 
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turnover rates, where when new nurses began working they were required to begin 
administering medications during their first week to residents they were unfamiliar with.  
Measures to prevent ADEs at the dispensing stage were present in the 
participating NHs, however, potential issues at other stages of the medication-use process 
were also mentioned. For example, at the prescription stage the participants mentioned 
that it was common for pharmacy personnel to misinterpret, due to the doctor’s 
handwriting, the type of medication or the quantity of medication ordered. This leads to a 
transcription error from the pharmacy that could lead to an ADE at the administration 
stage. Errors at the beginning of the medication-use process can be amplified in later 
stages especially if personnel at earlier stages are unaware of the resident’s medical 
history. The potential for contradicting medications becomes possible.  
Education did not appear to be a significant contributing factor to ADEs. The 
responses from the training dimension of the ADE survey indicated that a majority of 
currently employed nurses believed first-time nurses (less than 1 year) receive adequate 
training in schools, but with experience (greater than 3 years) they become more adept at 
administering all classes of medications in a NH setting. This perspective was supported 
by four items from the training dimension which had the lowest level of agreement, but 
still trended toward the agreement end of the scale. Specifically stated, “Nurses with less 
than 1 year of experience are adequately trained to administer drugs” (M = 3.58), “Nurses 
are required to attend educational seminars on new drugs” (M = 3.58), “Educational 
seminars’ related to new drugs are available in nursing homes” (M = 3.59), and 
“Adequate information about drugs readily exist on nursing home wards” (M = 3.56). 
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Therefore, it can be said that new nurses are better with drug administrations after 3 years 
of on-the-job experience.  
Experience also did not appear to be a significant contributing factor to ADEs. 
When the participants were asked about administering multiple solid medications to the 
same resident, the number of different medications NH residents typically take was not a 
leading factor. Item 3 (“Administration errors are common because of the number of 
drugs prescribed to nursing home residents.” M = 2.90) scored below neutral which 
suggests nurses and administrators become somewhat accustomed to administering 
multiple medications. Support for this claim lies in item 1 (“A nurse with less than 1 year 
of experience is likely to make a drug administration mistake.” M = 3.45) as compared to 
item 2 (“A nurse with more than 3 years of experience is likely to make a drug 
administration mistake.” M = 2.90) where nurses and administrators may believe more 
years of experience could lower the likelihood of an ADE related to multiple 
medications. Regardless, the neutral score expressed by the participants in item 6 (“Solid 
medications, like pills, tablets, and capsules, are more prone to administration errors than 
other forms.” M = 3.04) clearly indicates that ADEs are equally possible with all forms of 
drugs, not just pills, tablets, and capsules.  
Research Question 3  
What knowledge do managers have of existing practices to reduce ADEs?  The 
technologies expressed in the focus group sessions indicated that NH managers were 
familiar with some of the most widely used technologies (MAR, EMAR, and ADU) in 
the NH industry. Although, at the administration stage the participants did not mention 
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the usage of any technologies, such as barcodes. The participants from one NH described 
a two-step process at the administration stage.  
A night nurse would fill the medication trays, containing medications for a group 
of residents (those assigned to a nurse) for the upcoming day, and the day nurse 
would verify the medications on the tray based a report generated by the system 
[MAR].  
The participants from another NH encouraged their nurses to practice the five rights of 
drug administration, which is a universally adopted practice to help decrease ADEs in all 
healthcare settings (Otto, 2015).  
Closely associated with the familiarity of widely used technologies is training. 
There is no guarantee that training will reduce ADEs, but it is essential for nurses to 
receive some kind of training related to new technologies, techniques, medications, and 
policies. Items 11 (“Agency nurses are adequately trained to administer medications 
common in nursing homes.” M = 3.67), 12 (“Nurses with less than 1 year of experience 
are adequately trained to administer drugs.” M = 3.58), and 13 (“Nurses with more than 3 
years of experience are adequately trained to administer drugs.” M = 3.90) indicate that 
nurses agree that they receive sufficient training to perform their duties, regardless of 
title, experience, or employment status. While more stringent training may be applied to 
nurses with one year of experience due to advancements in medications, techniques, and 
education, the participants indicated that training coupled with experience better prepares 
nurses for the rigors of drug administrations as indicated by the mean score of 3.58 for 
item 12 and the higher mean score of 3.90 for item 13.  
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Item 23 (“Nursing homes allow visitors to bring in prescription medications for 
residents.” M = 4.12) draws particular interest because it was the highest scored item in 
the guidelines & policies dimension. It is common for family members, and sometimes 
friends, to pick up prescribed medications for family members living in NH quarters. 
While the gesture is genuine, it does not come without risk. Since the medication does 
not come from the pharmacy, the history and handling of the medication is unknown to 
the NH. If managers realize this risk and insist that medications come via the pharmacy, 
this practice could possibly prevent an ADE. Perhaps it is guidelines and policies that 
discourages doctors from bringing in prescription medications for residents as indicated 
by the low score obtained for item 25 (“Nursing homes allow doctors to bring in 
medications for residents.” M = 1.94) or which disallows family and friends from 
bringing in over the counter medications that may conflict with prescribed medications as 
indicated by the lower score obtained for item 24 (“Nursing homes allow visitors to bring 
in over the counter medications for residents.” M = 1.89). 
A key defense against ADEs for administrators lies in the cooperation of nurses. 
If administrators demonstrate to nurses that they realize the reality of ADEs and are 
willing to combat them with positive actions, nurses may be more willing to report ADEs 
that they commit without fear of negative repercussions. Sawarkar et al. (2012) claimed 
that many ADEs are not reported, but administrators realize that encouraging nurses to 
report ADEs is a best practice. This may explain why nurses and administrators scored 
item 18 (“Nurses are encouraged to report adverse drug events that they are aware of.” M 
= 4.20) with strong agreement. However, the fear nurses may realize associated with an 
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ADE can be tremendous, which could very easily over rule any positive measures that 
administrators may have in place. 
Based on the feedback from the ADE survey and the focus group discussions, 
nurses and administrators alike understand the severity and danger of ADEs. What the 
participants realized, after the demonstration of the model, was the potential benefit of a 
patient-specific technology-assisted approach at the administration stage. The participants 
acknowledged that this kind of technology could possibly enhance medication safety at 
the administration stage in addition to streamlining the drug administration process to 
make it more efficient. These efficiencies may increase the focus factor from nurses, 
because for each administration, interaction with the RT system would be necessary. The 
participants believed that such a system could possibly have the capacity to reduce 
turnover, where frustration and stress due to having responsibility to administer 
medications to residents they were not acquainted with, is greatly reduced.  
Research Question 4 
Do nursing home professionals have a favorable perception about the potential for 
RT to reduce ADEs?   
Hypothesis 1 (H1): Pertained to the favorability of all participants (prior to the 
demonstration) from all three NHs collectively. 
H10: µ1A ≤ 3 
H1a: µ1A > 3 
This RQ was answered quantitatively using the survey results from the RT Survey 
(Figure B1). Associated with this RQ was one hypothesis (H1), which I evaluated with 
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the t test. Table 13 presents the results of the one-tailed, one-sample t test that compared 
the pretest RT survey scores (M = 3.36, SD = 0.52) against a neutral response (M = 3.0) 
for all participants (N = 102). The mean pretest RT survey score was greater than 3.0. 
The tstatistic = 6.972 > tcritical = 1.66, and the p-value < .001. Therefore, I reject the null 
hypothesis and conclude that there is sufficient evidence that nursing home professionals 
have a favorable perception about RT. 
Table 13  
 
Comparison of Mean Pretest RT Index vs. Neutral Response 
 
t df  p Mean 
Difference 
95% Confidence Interval of 
the Difference 
Lower Upper 
6.972 101  <.001 0.36 0.31 0.41 
 
Research Question 5 
Do nursing home professionals have a more favorable perception about RT to 
reduce ADEs after viewing a demonstration of that technology?   
This RQ was answered quantitatively using the survey results from the RT Survey 
(Figure B1). Associated with this RQ were five hypothesis tests (H2, H3, H4, H5, and 
H6), which I tested individually with the t test.  
Hypothesis 2 (H2): Pertains to comparing the treatment group with the control 
group from all three NHs collectively, after the treatment group has viewed the model.  
H20: µ2T ≤ µ2C   
H2a: µ2T  µ2C 
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Table 14 presents the results of a one-tailed independent sample t test that 
compared the posttest RT survey scores (M = 3.984, SD = 0.27) of the treatment group (n 
= 51) vs. the posttest RT scores (M = 3.398, SD = 0.39) of the control group (n = 51), 
assuming equal variances. The mean posttest RT survey score of the treatment group was 
greater than the mean posttest RT survey score of the control group. The tstatistic = 8.612 > 
tcritical = 1.66, and the p-value < .001. Therefore, I reject the null hypothesis and conclude 
that there is sufficient evidence that the treatment group had a more favorable perception 
about RT at the posttest than the control group.  
Table 14  
 
Comparison of Mean Posttest Scores of Treatment Group vs. Control Group 
 
t df  p Mean 
Difference 
95% Confidence Interval of 
the Difference 
Lower Upper 
8.612 100  <.001 0.58 0.56 0.60 
 
Hypothesis 3 (H3): Pertains to all treatment group participants (after viewing the 
model) from all three NHs collectively.  
H30: µ2T ≤ 3 
H3a: µ2T > 3 
Table 15 presents the results of a one-tailed one-sample t test that compared the 
mean posttest RT survey score (M = 3.984, SD = 0.27) of the treatment group (n = 51) vs. 
a neutral response (M = 3.0). The mean pretest RT survey score was significantly greater 
than 3.0. The tstatistic = 25.815 > tcritical = 1.66, and the p-value < .001. Therefore, I reject 
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the null hypothesis and conclude that there is sufficient evidence that the treatment group 
had a favorable perception about RT at the posttest.  
Table 15  
 
Comparison of Mean Posttest RT Survey Score vs. Neutral Response 
 
t df  p Mean 
Difference 
95% Confidence Interval of 
the Difference 
Lower Upper 
25.815 50  <.001 0.98 0.95 1.02 
 
Hypothesis 4 (H4): Pertains to the perception of the treatment group (after and 
before viewing the model) from all three NHs collectively.  
H40: µDT ≤ 0 
H4a: µDT > 0 
Table 16 presents the results of a paired t test that compared the RT survey scores 
of the treatment group at the pretest vs. the posttest (n = 51). The average paired 
difference in responses from the treatment group before and after viewing the demo (M = 
0.73) was significantly greater than zero. The tstatistic = 8.280 > tcritical = 1.66, and the p-
value < .001. Therefore, I reject the null hypothesis and conclude that there is sufficient 
evidence that the treatment group had a more favorable perception about RT at the 
posttest compared to the pretest.  
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Table 16  
 
Comparison of Mean Pretest vs. Posttest RT Survey Scores of Treatment Group 
 
Paired Differences t df p 
Mean SD SE 95% Confidence 
Interval of the 
Difference 
Lower Upper 
0.73 0.22 0.03 0.69 0.76 8.280 50 <.001 
 
Hypothesis 5 (H5): Pertains to the perception of the control group (after and 
before the treatment group viewed the model) from all three NHs collectively.  
H50: µDC = 0 
H5a: µDC ≠ 0 
Table 17 presents the results of the paired t test that compared the RT survey 
scores of the control group at the pretest and posttest (n = 51). The average paired 
difference in responses from the control group before and after viewing the demo (M = -
0.07) was greater than zero. The tstatistic = -1.137 > tcritical = -1.98, and the p-value = .130 > 
.05. Therefore, I fail to reject the null hypothesis and conclude that there is not sufficient 
evidence that the control group experienced any change in their perception about RT 
from the first survey to the second.   
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Table 17  
 
Comparison of Mean Pretest vs. Posttest RT Survey Scores of Control Group 
 
Paired Differences t df p 
Mean SD SE 95% Confidence 
Interval of the 
Difference 
Lower Upper 
-0.07 0.14 0.02 0.05 0.07 -1.137 50 .130 
 
Hypothesis 6 (H6): Pertains to the perception of the treatment group (before and 
after viewing the model) as compared to the control group (before and after the treatment 
group views the model) from all three NHs collectively.  
H60: µDT < µDC 
H6a: µDT > µDC 
Table 18 presents the results of a one-tailed independent sample t test that 
compared the mean paired difference (M = 0.73, posttest minus pretest) of the treatment 
group (n = 51) vs. the mean paired difference (M = -0.07, posttest minus pretest) of the 
control group (n = 51), assuming equal variances. The average paired difference from the 
treatment group was significantly greater than the average paired difference from the 
control group. The tstatistic = 7.86 > tcritical = 1.66, and the p-value < .001. Therefore, I 
reject the null hypothesis and conclude that there is sufficient evidence that the treatment 
group had a greater change in perception about RT as compared to the control group, 
from the first survey to the second.   
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Table 18  
 
Comparison of Mean Paired Differences of Treatment Group vs. Control Group 
 
t df  p Mean 
Difference 
95% Confidence Interval of 
the Difference 
Lower Upper 
7.86 100  <.001 0.79 0.77 0.73 
 
Evidence of Trustworthiness 
To confirm that the research design employed in this research encompassed a high 
degree of trustworthiness, I considered value, credibility, transferability, dependability, 
and confirmability. Shenton (2004) mentioned that qualitative studies must address the 
validity and reliability concerns of positivists since qualitative outcomes are not 
definitive in nature, unlike quantitative outcomes. Common strategies, such as the usage 
of multiple methods, triangulation of multiple data sources, and the random selection of 
participants were utilized to ensure credibility, transferability, dependability, and 
confirmability.  
A random selection of participants (nurses involved with direct resident care and 
administrators) at the participating NHs were summoned to participate in this research. I 
asked all participants, via the ADE survey (Appendix A), to share their honest thoughts 
and opinions on why ADEs occurred. Likewise, I asked three groups of four 
administrators (and nurse supervisors) to share their opinion on the open-ended questions 
listed in Appendix D, along with secondary questions that arose during a focus group 
session. In addition to the qualitative data, the RT survey (Figure B1) provided a means 
to statistically test the participant’s perception of RT for the purpose of assisting with 
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patient-specific drug administrations. Out of 102 participants, there were no results from 
either survey that were exactly the same. Thus, there was no reason to believe the 
information the participants provided did not adequately reflect their honest opinion 
about RT and how ADEs occurred in NHs. Consequently, the data were exposed in the 
findings, which lessens concerns of credibility, especially since the datum was taken at 
face value.  
I confirmed the reported findings directly with the physical surveys and the focus 
group recordings, and found similar and some repeating content in both sources. 
Therefore, the themes extracted from the data can be generalized to a larger population of 
NHs, thus supporting transferability to other NH settings. This assumes, however, that the 
research participants (nurses and administrators) would be of the same profession, and of 
the same size of NHs (small, medium, and large based on number of beds) to acquire 
similar results to maintain external validity. If the type of participants change, for 
example the inclusion of social workers, dieticians, or physical therapist, the results may 
change as their outlook upon ADEs would most likely be different than nurses. 
Obviously, they have no direct or indirect relationship with medications in the NH. The 
same can be said of administrators, although, administrators do carry responsibility of 
ADEs which makes their perspective relevant.  
I excluded the data acquired from one participant, because the individual was not 
a nurse or an administrator. Perhaps this individual was eager to take part in this research, 
but to avoid possible distortion of the results from the intended participants (nurses and 
administrators only), I eliminated the results from that individual. I eliminated two other 
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participants because, in both cases, all of their answers to every survey (both RT and 
ADE) question were the same in contrast to the diverse answers among 102 other 
participants. Again, I eliminated the results from those two participants to avoid possible 
distortion of the overall results. To further aid in dependability, I checked the survey 
results entered into the SPSS application three times to ensure accuracy. As a result of 
these actions, the data collection and analysis process were consistent and accurate. 
Since literature related to the use of RT in a NH environment to assist with drug 
administrations did not exist (Van den Bemt, 2011), it was not possible to collaborate the 
findings from the RT aspect of this research with other researchers to support 
confirmability. Although, all of the findings, except the perceptions of RT, were common 
and published throughout existing literature. For example, the reasons for ADEs captured 
in this research were also present in other works. 
I conducted this research exclusively. Since an assistant was not involved to 
validate the quality of the results, the research design included measures to support 
confirmability further in terms of data validity. For example, the physical surveys were 
scanned onto a hard drive while the focus group recordings were saved. Therefore, 
evidence is available to confirm that the findings were reflective of the data and were 
void of any bias from the researcher. 
Summary 
The mixed methods approach for this research required an assessment of the 
researcher-created survey instruments through the use of a Pilot Study. I assessed 
reliability and validity of the surveys to justify their usage using a group of eight nurses 
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in Chesapeake, VA. Also, I carried out an evaluation of the robotic model to assess its 
fidelity, verification, and validation for usage in this research. In addition to researcher 
testing, I summoned a group of IT professionals to evaluate the model independently.  
The mixed methods results collected for this research were extensive. I collected 
qualitative data via the survey method (ADE survey) and the focus group method, and 
quantitative data via the survey method (RT survey). Overall, 105 participants took part 
in this research; however, I eliminated three participants due to questionable survey 
answers or due to job title. I gathered and presented information related to the sample 
population (NHs) and the participants in Table 5. 
To carry out the qualitative analysis, I used the NVivo software where six primary 
themes (and 29 subthemes) emerged from the data: reasons for ADEs, process of drug 
administration, use of technology, training, financial incentives, and cost savings. I 
presented details related to each theme with direct quotations from the participants. I 
triangulated this data (themes), the reported ADEs acquired from each NH, and the ADE 
survey results to confirm validity and understanding of the reasons behind ADEs. I used 
this collection of data to answer RQs 1, 2, and 3.  
To carry out the quantitative analysis, I used the SPSS software explicitly with the 
data acquired from the RT survey (Figure B1). I evaluated a total of six hypotheses using 
the t test and the paired t test. In addition, I composed descriptive statistics of both the 
ADE and RT survey responses to better understand the overall perspective of the 
participants. I answered RQ4 using the results from H1 and RQ5 using the results from 
H2, H3, H4, H5, and H6. Overall, I rejected each of the null hypotheses, except for H5, 
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which tested the average paired difference in responses from the control group before and 
after viewing the demo. 
In this research, I intended to understand the cause of ADEs more deeply and to 
assess perceptions of using RT to reduce ADE numbers in a NH environment. In Chapter 
5, I will interpret the findings on both points. Specifically, an in-depth discussion 
covering my interpretation of the findings, limitations of the research, implications, and 
recommendations for further research and professional practice will be presented.  
  
 
166 
Chapter 5: Conclusion 
The intent of this mixed methods research was to assess the causes of ADEs from 
a diverse perspective (qualitatively) in addition to exploring how NH professionals 
(nurses and administrators) felt about using RT to assist at the drug administration stage 
(quantitatively). This investigation was important because the reasons behind ADEs are 
still elusive (Aljadhey, 2013; Weiss and Elixhauser, 2013; Sawarkar, 2012), illustrated by 
the high numbers that continue rising throughout the healthcare industry. This implies 
that our knowledge related to the causes of ADEs is lacking and that our current 
technologies are not capable of reducing these high numbers down on a broad scale.  
Regardless of either implication, ADEs are a significant problem that will 
continue to grow until more advanced technological solutions are created to begin 
trending ADEs down. Tremendous challenges exist in every stage of the medication-use 
process to safeguard against ADEs, but the latter stage of the process (administration) is 
perhaps the most vulnerable, where medications are passed from the care-giver directly to 
the care-receiver. In many cases, it is nearly impossible to extract a drug from within the 
human body once the drug has been taken, especially if harm or death has already taken 
place. Thus, errors at the other stages have a greater opportunity to be caught prior to 
harm or death.  
Chapter 5 contains a thorough interpretation of the findings and the limitations 
that potentially had an effect on this research. Also included in Chapter 5 are 
recommendations for extending this research and the implications of this research in the 
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NH environment. This chapter ends with a succinct summary of the research and its 
results. 
Interpretation of Findings 
Provisions and systems are in place to mitigate ADEs at all stages of the 
medication-use process, yet it is still common for NH residents to be unwilling victims of 
ADEs (Harris-Kojetin et al., 2013). Nurses are the last line of defense for preventing 
ADEs at the administration stage (Kruer, 2014), which is a heavy burden to carry. As 
other research has pointed out, the causes are varying and divergent among and within 
each phase of the medication-use process (AHRQ, 2001) which complicates the creation 
of a universal solution. Although, within this research the causes of ADEs noted from 
three focus group sessions, the ADE surveys, and the historical data from three NHs were 
not new discoveries. This comprehensive view did highlight the main concerns related to 
circumstances that could lead to ADEs at the administration stage, information that will 
be useful in advancing the conceptual utilization of RT at the administration stage in 
NHs.  
Mainly, human environmental factors affect the correct administration of 
medications. Reasons cited such as not paying attention, too busy, numerous distractions, 
limited time, stress, and fatigue were among the leading factors. The data indicated that 
these factors can be somewhat mitigated by offering financial incentives or by deploying 
a newer technology at the administration stage that interacts with existing technologies at 
other stages comparable to what Bates and Slight (2014) suggested. Most NHs are not 
able to offer financial incentives nor is it feasible to do so, because currently a newer 
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technology does not exist to offset these factors. Thus, errors related to these factors will 
remain the same.  
Based on my research results, skills and knowledge factors do not have a 
significant impact on ADEs. Perhaps this is because ADEs at the administration stage are 
associated with human environmental factors, which could leave nurses and 
administrators to believe that skills and knowledge are not significant contributors to 
ADEs. For example, a nurse with one year of experience administered a wrong 
medication because she was not paying attention. RT, as presented in this research, would 
have the functionality to diminish not paying attention which would highlight 
opportunities related to lacking skills and knowledge. Stated another way, human 
environmental factors would be offset by a technological aid that would most likely 
decrease administration errors (Garroustte-Orgeas et al., 2012).  
Dahl and Boulos (2014) acknowledged that any new technology must be vetted 
with its intended end-user, not its designer, to determine acceptability and ultimate 
functionality. This is why I wanted to gauge the perception of nurses and administrators, 
those who are involved or who have responsibility for ADEs, on the possibility of 
tailoring a noninvasive, self-guided, resident-specific RT system to assist at the 
administration stage. The perception of NH professionals about this RT concept was 
more important, because there is an insufficient understanding about whether innovations 
in RT can improve upon human-initiated ADEs of solid medications in NHs (Van den 
Bemt et al., 2011; Wild, 2011).  
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Before any of the participants viewed the model, they were intrigued from the 
introduction of the research about the potential contributions of RT at the administration 
stage as indicated by the rejection of the null hypothesis for H1. Alone, this hypothesis 
test was quite profound, because it implies that, overall, nurses and administrators would 
embrace a new technology (RT) that would potentially help them reduce ADEs. This 
means that they realize the benefits of an enhanced technological aid at the administration 
stage.  
The isolation of participants into the two groups (control and treatment) supports 
this claim further. When I assessed the treatment group at the posttest as compared to the 
control group at the posttest (H2), the treatment group’s view of RT was more favorable. 
A more favorable outcome also resulted when I assessed the treatment group 
independently at the posttest (H3), and at the posttest as compared to the pretest (H4). 
Further statistical testing revealed that when I compared the change in response for the 
treatment group from the first to the second survey with the change in response for the 
control group from the first to the second survey, the treatment group had a greater 
change and a more favorable perception of RT as compared to the control group.  
Based on the results from these hypothesis tests, I conclude that the demonstration 
of the model influenced the treatment group’s view of RT, since the null hypotheses for 
H2, H3, and H4 were rejected. The lack of influence from the model explains why the 
null hypothesis for H5 was not rejected, where the control group showed no significant 
change in their perception from the first survey to the second. Since the control group did 
not see the model in action, it was not possible for them to be influenced by it.  
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Prior to conducting this research, I did not know if the pretest and posttest results 
from the control group would vary due to an unexpected phenomenon regarding taking 
the survey twice. Therefore, H5 was conducted specifically to make this determination. 
Since the treatment group changed from the pretest to posttest and the control group did 
not (H5), I can rule out that taking the survey twice as influential and that an unexpected 
phenomenon was not present.  
Overall, indications from the data revealed that nurses have an optimistic view of 
the RT concept presented in this research. Complexities associated with other phases of 
the medication-use process dictate that it must be coupled with existing technologies to 
cover a greater range of causes. Ranji, Rennke, and Wachter (2014) found that combining 
systems designed to reduce ADEs is no easy task, but they recognized that assembling a 
single comprehensive system connecting all phases of the medication-use process would 
most likely yield the greatest results. My RT concept could potentially be the final 
component of this comprehensive system.  
By isolating solid medications for one resident into a single cabinet only 
accessible via individualized barcodes, the chances of a nurse giving the wrong 
medication or wrong quantity to a resident greatly diminishes the potential for an ADE. 
This view aligns with Wittich, Burkle, and Lanier’s (2014) assertion that improving the 
selection of the right drug and right quantity for the right patient is paramount in reducing 
ADEs. This view also aligns with research by Samaranayake et al. (2014) where barcode 
technology was instrumental in reducing medication errors in the administration stage. 
Applying the same barcode concept at a resident-specific level versus a medication-
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specific level would most likely yield greater results, since the usage is elevated from 
general to specific. Looking further, if the number of wrong drug errors and wrong 
quantity errors, a total of five out of seven from the collected historical ADE data, were 
eliminated by using barcodes associated with resident-specific drug cabinets, ADEs 
would have been reduced in the participating NHs by 71% (5/7 * 100 = 71%).  
If the assertion by Sawarkar et al. (2012) that ADEs at the administration stage 
rank in the top three categories is indeed true, then it is plausible to generalize one third 
of 71% to the 105,000 deaths reported by Aljadhey et al. (2013). In other words, if the 
RT application presented in this research was fully operational, approximately 24% (71/3 
= 24%) or 25,200 (105,000 x .24 = 25,200) people would not have died at the hands of an 
ADE. 
Even with the proposed RT application presented in this research, medication 
errors would still be possible, because human-interaction would still be necessary. It 
would remain a human task to place medications and the correct quantities into the 
system correctly. It would remain a human task to confirm that what is in the system 
matches current drug orders for individual residents at the time of administration. 
Similarly though, human interaction is also necessary for existing systems to function. 
For example, as noted from the research results the MAR and EMAR systems must be 
manually loaded by a nurse upon receipt of medications from the pharmacy and manually 
confirmed by the nurse during extraction in preparation for administration.  
Regardless, it is evident from existing literature that cost savings from preventing 
ADEs can be substantial. USDHHS (2014a) estimated the cost of ADEs in hospitals and 
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NHs at $5 billion a year. If approximately 24% of $5 billion could be saved, assuming 
errors in other NHs are also mainly related to wrong drug and wrong quantity, an 
additional $2 billion would be available annually to handily support the kind of RT 
system presented in this research.  
As an alternative to various forms of traditional ambulatory error-reporting 
systems, an RT system, which is nothing more than a complex computer system capable 
of movement, would have the capacity to track medications from the time of entry into 
the system to the time of exit out of the system, along with system generated inquiries. 
Stated differently, RT can electronically record all activities associated with error-
reporting and alignment with medication changes, thus eliminating much of the manual 
aspect of medication management at the administration stage, thereby producing an 
intelligent decision support arrangement. If a drug regimen is modified prior to extraction 
of the medications from the system, a system alert would be generated prompting the 
nurse to continue with the appropriate action. Because of the limitations associated with 
the human brain and general human effort, manual processes of incident reporting 
drastically reduce the rate of accuracy. However, with a computerized system, efficiency 
and effectiveness are typically better, assuming there are no significant issues in the 
system, and that the system is utilized properly for its intended purpose.  
This assumption can be made because computerized systems can be fully 
automated. So, the chances that the automatic performance of roles would be disrupted 
can be minimized. Indeed, when an automated system is used to detect errors, the error 
margin of the system is negligible. What this means is that there would virtually be no 
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errors taking place that would be uncounted for by the system. As effective error-
reporting and tracking processes take place, a greater portion of potential medication 
errors leading to ADEs will be detected and prevented. At this point, it must be 
emphasized that the use of RT is one of the most effective computerized error-reporting 
and tracking systems available. Therefore, an optimized RT application should be 
considered at the administration stage to decrease ADEs (Kruer, 2014) in the NH 
environment.  
Limitations of the Study 
 The limitations that could have impacted the outcome of this research were 
thoroughly discussed in Chapter 1. There were no changes in these limitations even 
though the participants were curious as to why the model was limited to only 10 solid 
drugs. Further curiosity from the participants on how the model would work with other 
categories of drugs other than in solid form extended the explanation of the model. The 
participants understood that the model designed for this research was a first of its kind. 
However, the limitations set within the model did not hinder the demonstration to acquire 
data on how NH professionals felt.  
 The most significant limitation of this study was the usage of a model in lieu of a 
real-world robotic system. I specifically designed the model to be simple where it only 
contained a small quantity (10) of one class of fictitious medications (in solid form such 
as tablets, capsules, and pills) for a small number of residents (10). Participants who 
viewed the model could only base their opinion on their understanding of the model 
which could generate a different appeal from a real system. Despite this limitation, the 
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participants were still eager to participate due to their curiosity of an assistive technology 
to assist at the administration stage.  
 At the onset of this research, I predicted that the information from the focus group 
sessions and the surveys may not be 100% accurate. Participants were encouraged to use 
their assigned number to maintain confidentially, but some participants still placed their 
name on the surveys which may have influenced the results they provided. This limitation 
was not expected because the research design had provisions to prevent it.  
Recommendations 
A key component in introducing assistive RT in NHs at the drug administration 
stage is to thoroughly assess how nurses and administrators who would be tasked to use 
the technology feel about it. It is simply not enough to create a technology that 
accomplishes its intended purpose without making sure it would be acceptable by its end-
user. Without this confirmation, the usefulness of the system would not foster maximum 
effectiveness; thus, the problem that it was intended to solve remains the same in addition 
to the possibility of new causes because of a new system.  
I recommend that the research design employed in this research be repeated in 
other settings and with other sample sizes to determine if similar results would be 
obtained. Perhaps there are additional causes of ADEs associated with solid medications 
in the NH environment that did not surface in this research. More importantly, these 
causes may be instrumental in the future development of RT for assisting nurses at the 
administration stage in NHs. Publishing this research would facilitate future development 
of RT for this purpose.  
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I also recommend expanding upon the RT survey with additional questions to 
acquire a greater depth of perceptions related to the use of this proposed RT application. 
Administering the survey was not a simple task as it took multiple trips to the NHs to 
acquire the required number of completed surveys. This was mainly due to the ever-
changing dynamics of the NH on a daily basis, which was dictated mostly by resident 
needs, family needs, and state government needs. To overcome this issue, I recommend 
that an expanded version of the RT survey be conducted through an online survey service 
with no regards to the Medicare/Medicaid quality rating of where the participant works. 
The most frequent causes that could potentially aid in an ADE were relative to person, 
not the NH. For instance, stress and fatigue are common among nurses regardless of the 
quality rating of the NH.  
A repeat of this research or additional investigation into the perceptions of RT at 
the administration stage will require the usage of a model. Since this domain of research 
is relatively new, knowledge related to its efficacy is unknown. So, it would be immature 
at this point to create an actual RT system designed to assist with the drug administration 
task in NHs. To this end, the presentation of the model could be demonstrated more 
extensively if it were done via a video that could be viewed online. Additional aids, such 
as manikins representing NH residents with uniquely assigned wristband barcodes (a 
staged environment) and an attached multidrawer cabinet affixed to the platform of the 
mobile cart can be incorporated to enhance the visual presentation. Another benefit of an 
online video would be that the demonstration of the model would only be done one time, 
which means all the participants would see the exact same thing. Since the video could be 
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accessible within and outside of the NH, the participant would have the opportunity to 
view it at their leisure, which eliminates working around their schedule at work and 
possible influences in the workplace. An enhanced model would enhance the authenticity 
of this RT concept. 
Implications 
This is the first research study to investigate assistive RT to be used at the 
administrative phase of the medication use process in NHs. Technological advances have 
been made in the transcription, prescribing, and monitoring phases, yet ADEs are still a 
significant problem in all healthcare settings. While the RT application presented in this 
research will not eliminate ADEs, it has the potential to greatly add to the progress that 
has already been made in other phases, especially since it has been reported that most 
ADEs occur in the administration phase.  
Since this research took into consideration perceptions of RT only at the 
administration stage, as a first step, a tremendous amount of research lies ahead before 
this kind of RT can become a reality. However, the outcome of this first step showed that 
nurses and administrators have a favorable perception of RT. Perhaps the research 
community will be inspired by this outcome and continue extending this domain of 
research. After all, resident-specific technology isolating multiple medications for one 
resident in an individual cabinet appears to improve safety, assuming medications are 
loaded into the cabinets correctly.  
The healthcare industry is committed to improving the lives of the citizens it 
serves. With this domain of research tied to the healthcare industry, every technological 
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idea should be explored to the point where the idea is no longer feasible for continued 
development or it becomes a practical opportunity for continued development with the 
expectation of advancing new solutions to solve existing problems, especially long-
standing problems. If  thousands of lives can be saved or extended by some technological 
solution, such as RT, then the solution might be worthwhile, assuming its cost to 
purchase and maintain are reasonable. If three lives could be saved from each of 15,600 
NHs in the U.S. (Centers for Disease Control and Prevention, 2016, p. 1) by some 
technological solution, 50% (3*15,600 = 46,800) of the 93,600 ADEs that occur annually 
(Handler, 2012) could be prevented.  
My application of RT could become the technological solution that improves 
medication safety at the administration stage for NH residents. To this end, the positive 
social implications of saving lives by preventing or decreasing the frequency of ADEs via 
RT at the administration stage in NHs could be monumental. Continued research may 
make this a reality. 
Conclusion  
This research will add to the knowledge base on the use of RT at the 
administration stage in NHs. Specifically, this research will promote the feasibility that 
RT can save nurses valuable time and present medications in an untraditional manner that 
increases safety. Additionally, this kind of system will stimulate a behavior change in 
how nurses approach medication administration due to the intrinsic capability of error-
reporting, medication tracking, and real-time updates and notifications that will be part of 
the system.  
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The healthcare industry has recognized and capitalized on the benefits of tailoring 
RT for specific medical issues. Over the last 10 years, numerous RT applications, mainly 
for surgical procedures and dispensing applications, have become practical and beneficial 
in many ways. These successes have spurred development of robotic applications in 
many other healthcare niches, like social robots, service robots, nanobots (related to 
diminishing end of aging), and nanotechnology (related to prevention and treatment of 
diseases). The RT application presented in this research addressed the need for assistive 
automation at the administration stage of the medication-use process in NHs.  
In order for this RT application to become practical and effective, continued 
discovery of the causes of ADEs at the administration stage must occur and the 
acceptance of the technology by those who would be expected to use it must be well 
established. Without knowing the causes, the functionality of the system would likely 
miss the inclusion of critical components that would still allow ADEs. Without 
determining if the technology would be acceptable by nurses and administrators, the 
system may not become practical or it may be incorrectly used, causing a non-reduction 
in ADEs or an increase in ADEs. Ease of use and user acceptance are important factors of 
consideration, especially in a dynamic fast-paced environment such as a NH.  
The results from this research did not reveal any causes of ADEs that have not 
been previously reported. Despite this finding, investigation into the causes should 
continue because the creation or evolution of various systems and processes may generate 
new reasons that were not evident in this research. Until a solution is found to begin 
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trending ADE occurrences down at the administration phase, researchers must continue 
evaluating the causes to assure that they are addressed in any potential solution.  
The RT concept in this research, where solid medications (pills, capsules, and 
tablets) would only be accessible via a mobile RT unit one resident at a time, was rated 
positively by the participants. Perhaps this is because nurses and administrators recognize 
the challenges at the administration stage and the benefits this kind of system would 
bring. A reduction in time to acquire medications, a real-time tracking and update system, 
and the unique feature of keeping medications separate at the resident level could indeed 
increase efficiency at the administration stage. The bottom line is that RT will improve 
the effectiveness of drug safety by nurses and the quality of life for NH residents as it 
relates to solid medications.  
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Appendix A: Adverse Drug Event Survey Instrument 
 
Strongly 
Disagree Disagree Neutral Agree Strongly Agree
Example: Drug administration errors 
occur in the facility that I work at X
Experience
Strongly 
Disagree Disagree Neutral Agree Strongly Agree
1. A nurse with less than 1 year of experience is 
likely to make a drug administration mistake
2. A nurse with more than 3 years of experience is 
likely to make a drug administration mistake
3.
Administrations errors are common because of 
the number of drugs prescribed to nursing home 
residents
4. Administration mistakes are commonly caused 
by a lack of attention
5. When administration errors occur they are 
reported
6. Solid medications, like pills, tablets, and 
capsules, are more prone to administration 
errors than other forms     
7. When a drug appears inappropriate for a 
resident, nurses question transcription orders 
made by doctors
8. Nurses administer prescription medications to 
residents that were not prescribed by a doctor
9. Nursing home residents cause incorrect drug 
administrations
10. Nurses vary administration techniques based on 
the resident
Thank you for taking the time complete this survey.  Your responses are strictly confidential and will not be revealed 
to the administrators of your facility. Your honest feedback, based on your experience, is valuable to this research 
project.  It should only take about 15 minutes of your time to complete.  Please answer all questions. 
For each question, mark one box with an X to represent your answer. 
 Job Title:
 Nbr Years of Experience:
Are you certified to administer drugs? (Y/N) ______
Adverse Drug Event Survey     
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Training
Strongly 
Disagree Disagree Neutral Agree Strongly Agree
11. Agency nurses are adequately trained to 
administer medications common in nursing 
homes
12. Nurses with less than 1 year of experience are 
adequately trained to administer drugs
13. Nurses with more than 3 years of experience 
are adequately trained to administer drugs
14. Educational seminar's related to new drugs are 
available in nursing homes
15. Nurses are required to attend educational 
seminar's on new drugs
16. Adequate information about drugs readily exist 
on nursing home wards
17. Nurses are encouraged to ask questions about 
prescribed orders that appear inappropriate for 
a resident
18. Nurses are encouraged to report adverse drug 
events that they are aware of
Guidelines and Policies
Strongly 
Disagree Disagree Neutral Agree Strongly Agree
19. Nurses generally follow the drug administration 
guidelines and procedures set by the facility 
they work in
20. Instruments, such as a computer, are used as an 
aide to administer drugs
21. Various policies and procedures contribute to 
drug administration errors
22. Decisions made by administrators contribute to 
drug administration errors
23. Nursing homes allow visitors to bring in 
prescription medications for residents
24. Nursing homes allow visitors to bring in over the 
counter medications for residents
25. Nursing homes allow doctors to bring in 
medications for residents
26. Nursing homes allow medication substitutes 
when the prescribed medication is unavailable
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In the space below, please share any way you think drug administration errors occur in nursing homes.
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Appendix B: Robotic Technology Survey Instrument and Scores 
 
Figure B1. Robotic Technology Survey
 
1-1-5
Strongly 
Disagree Disagree Neutral Agree
Strongly 
Agree
Example: Drug administration errors 
occur in the facility that I work at X
Robotic Technology
Strongly 
Disagree Disagree Neutral Agree
Strongly 
Agree
1.
Nurses would use a robotic system to 
assist them with administering pil ls, 
tablets, and capsules, to prevent possible 
mistakes
2.
Keeping medicines isolated in patient-
specific containers could decrease 
administration errors of solid drugs
3.
A comprehensive interactive computer 
system will  cause nurses to be less aware 
when administering medications
4. Some new form of advanced technology is 
needed to reduce administration errors
5. A robotic system would not be useful to 
assist in administering solid medications
6.
A robotic system would be useful if it 
provided the right medication for each 
resident
7.
A robotic system would be useful if it did 
not slow down the task of administering 
solid medications
8.
A robotic system would decrease the 
success rate of administering medications 
on time
9. A robotic system would help decrease 
administration errors of solid medications
10.
A robotic system would make my job of 
tracking what medicines I have 
administered easier
For each question, mark one box with an X to represent your answer. 
Robotic Technology Survey     
Thank you for taking the time complete this survey.  Your responses are strictly 
confidential and will not be revealed to the administrators of your facility. Your honest 
feedback, based on your experience, is valuable to this research project.  It should only 
take less than 5 minutes of your time to complete.  Please answer all questions. 
 Job Title:
 Nbr Years of Experience:
Are you certified to administer drugs? (Y/N) ___
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Table B2  
 
RT Survey Means Before and After Reverse Scoring for the Control Group 
 
  
 
 
Item 
Control Group 
(Pretest) 
   Control Group 
       (Posttest) 
Item  
Nbr 
 Original 
 Score             
Final  
Score 
Original    
Score 
Final 
Score 
1 Nurses would use a robotic system to 
assist them with administering pills, 
tablets, and capsules, to prevent possible 
mistakes 
  3.53 
 
 
 
3.53 
 
 
 
3.49 
 
 
 
3.49 
 
 
 
2 Keeping medicines isolated in patient-
specific containers could decrease the 
administration  errors of solid drugs 
  4.04 
 
 
4.04 
 
 
3.98 
 
 
3.98 
 
 
3 A comprehensive interactive 
computer system will cause nurses to 
be less aware when administering 
medications 
  2.41 
 
 
 
3.59 
 
 
 
2.73 
 
 
 
3.27 
 
 
 
4 Some new form of advanced technology 
is needed to reduce administration errors 
 3.94 
 
3.94 
 
3.10 
 
3.10 
 
5 A robotic system would not be useful 
to assist in administering solid 
medications 
  3.00 
 
 
3.00 
 
 
3.31 
 
 
2.69 
 
 
6 A robotic system would be useful if it 
provided the right medication for each 
resident 
  3.75 
 
 
3.75 
 
 
4.18 
 
 
4.18 
 
 
7 A robotic system would be useful if it 
did not slow down the task of 
administering solid medicines 
  3.67 
 
 
3.67 
 
 
3.51 
 
 
3.51 
 
 
8 A robotic system would decrease the 
success rate of administering 
medicines on time  
  3.14 
 
 
2.86 
 
 
3.00 
 
 
3.00 
 
 
9 A robotic system would help decrease 
administration of errors of solid 
medications  
  3.00 
 
 
3.00 
 
 
3.24 
 
 
3.24 
 
 
10 A robotic system would make my job of 
tracking what medicines I have 
administered easier 
  3.35 
 
 
3.35 
 
 
3.45 
 
 
3.45 
 
 
Note. Bold items 3, 5, and 8 were reversed-scored in the positive direction. Listed is the 
original mean per item prior to reverse scoring and the final mean per item after reverse 
scoring for the control group pretest and posttest. 
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Table B3 
 
RT Survey Means Before and After Reverse Scoring for the Treatment Group 
 
  
 
 
Item 
Treatment Group 
(Pretest) 
Treatment Group 
(Posttest) 
Item  
Nbr 
Original 
Score             
Final 
Score 
Original  
Score 
Final  
Score 
1 Nurses would use a robotic system to 
assist them with administering pills, 
tablets, and capsules to prevent possible 
mistakes 
 3.29 
 
 
 
3.29 
 
 
 
4.37 
 
 
 
4.37 
 
 
 
2 Keeping medicines isolated in patient-
specific containers could decrease the 
administration  errors of solid drugs 
 4.08 
 
 
4.08 
 
 
4.49 
 
 
4.49 
 
 
3 A comprehensive interactive 
computer system will cause nurses to 
be less aware when administering 
medications 
 2.92 
 
 
 
3.08 
 
 
 
3.00 
 
 
 
3.00 
 
 
 
4 Some new form of advanced technology 
is needed to reduce administration errors 
 3.88 
 
3.88 
 
4.49 
 
4.49 
 
5 A robotic system would not be useful 
to assist in administering solid 
medications 
 2.98 
 
 
3.02 
 
 
3.39 
 
 
2.61 
 
 
6 A robotic system would be useful if it 
provided the right medication for each 
resident 
 3.27 
 
 
3.27 
 
 
4.41 
 
 
4.41 
 
 
7 A robotic system would be useful if it 
did not slow down the task of 
administering solid medicines 
 3.51 
 
 
3.51 
 
 
4.45 
 
 
4.45 
 
 
8 A robotic system would decrease the 
success rate of administering 
medicines on time  
 3.12 
 
 
2.88 
 
 
2.55 
 
 
3.45 
 
 
9 A robotic system would help decrease 
administration of errors of solid 
medications  
 2.35 
 
 
2.35 
 
 
4.53 
 
 
4.53 
 
 
10 A robotic system would make my job of 
tracking what medicines I have 
administered easier 
 2.96 
 
 
2.96 
 
 
4.20 
 
 
4.20 
 
 
Note. Bold items 3, 5, and 8 were reversed-scored in the positive direction. Listed is the 
original mean per item prior to reverse scoring and the final mean per item after reverse 
scoring for the treatment group pretest and posttest. 
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Appendix C: ADE Scorecard Instrument 
 
  
 
ADE Scorecard of Historical Data
 Med Category: Pills, Capsules, Tablets
 
Faci l i ty          ________________________________________ Qual i ty Rating _______ Error Type  
Employee    ________________________________________ Gender (M/F)  _______ W - Wrong Medication
Status             ________________________________________ Tenure (yrs )  ________ Q - Improper Quantity
Month           ________________________________________ Tot Beds  ___________ L - Late Administration
E - Early Administration
   N - No Administration
   T - Improper Technique
  O - Other
Time Freq
Med 
Category Notes
Error 
(Y/N)
Error 
Time
Error 
Type
 
 
Total Errors:Total Administrations:
 
Medication
Prescribed Medication Administration Activity
Error Description
  
 
197 
Appendix D: Focus Group Questions 
1. How do ADEs occur in nursing homes? 
2. What do you think is the single most cause for ADEs in nursing homes? 
3. Does your facility offer any ongoing training programs for staff nurses qualified to 
administer drugs? 
 
4. Would you be willing to offer a financial incentive if ADEs were less than 5% of 
all administrations in your facility? 
 
5. Would a substantial decrease in ADEs cause your facility to save money in addition 
to improving care? 
 
6. Does your facility currently use technology to assist in drug administrations? 
 
7. Describe your current processes and procedures for administering drugs? 
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Appendix E: Robotic Simulation Storyboard 
 
 
 
Assign Unique Barcode Number to Each ResidentInitialization Drug Assignment to Fictitious Resident
Drug Name Jellybean Color
1 Aspirin White
2 Celexa Orange
3 Theophylline Purple
4 Diphenhydramine Pink
5 Nitrates Black
6 Pentazocine Yellow
7 Indomethacin Blue
8 Zoloft Lime
9 Digoxin Red
10 Propranolol Green
Researcher
1
Researcher
Fictitious Resident 1
Actual Drug      Jellybean     Qty
Nitrates             Black              1
Zoloft                 Lime              3
Digoxin              Red                2
Fictitious Resident 2
Actual Drug      Jellybean     Qty
Theophylline    Purple           4
Zoloft                 Lime              1
Indomethacin   Blue              3
Fictitious Resident 3
Actual Drug      Jellybean     Qty
Aspirin        White            2
Celexa               Orange           2
Nitrates             Black              1
Zoloft                 Lime              3
Digoxin              Red                2
2
 Fictitious Resident   Barcode Assignment
1
2
3
4
5
6
7
8
9
10  
Multi-drawer Cabinet
Cardboard with 
Barcodes
3
4
1.Researcher correlates a specific jellybean 
color to a specific drug for a maximum of 10 
solid drugs common in nursing homes. 
a. Assignment is random
b. Real medications will not be utilized 
2. Researcher creates 10 fictitious resident/drug assignments 
on index cards.
a. In this example, fictitious resident 2 is taking Theophylline, 
Zoloft, and Indomethacin over the course of an 8 hour shift
b. Multiple assignments and quantities are in accordance to 
Vance’s (2003) assertion that many residents take multiple 
drugs and quantities per day. 
3. Label each drawer in the simulated drug cabinet with a unique 
barcode number.
4. Affix physical barcode numbers 1 through 10 on the cardboard poster.
 
A. The lowercase x on the multi-drawer represents an unused cabinet in 
the simulation. 
Assign a specific 
color jellybean to 
a 1 specific drug
Start
 
Set up 10 fictitious 
residents with a 
fictitious drug regimen
Label each of 10 drawers 
in the cabinet with a 
unique barcode number 
beginning at 1
Affix the fictitious 
resident number to the 
cardboard poster with its 
corresponding barcode 
label
 
x
xx
21 4
5
3
76 8
9 10 x
xx
S
t
o
r
y
b
o
a
r
d
S
t
e
p
s
S
e
t
u
p
 
F
l
o
w
A
Initialization Drug Assignment to Fictitious Resident Assign Unique Barcode Number to Each Resident 
Robotic Simulation Setup
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Assign Unique Barcode Number to Each ResidentInitialization Drug Assignment to Fictitious Resident
S
t
o
r
y
b
o
a
r
d
S
t
e
p
s
S
e
t
u
p
 
F
l
o
w
A
Resident Landscape 
Table 
Resident 
ID Nbr 
Drug 
Regimen Nbr 
1 2 
2 7 
3 9 
4 10 
5 11 
6 12 
8 13 
10 14 
 
5. Each resident is assigned to a “resident ID number” 
that corresponds to a specific “drug regimen nbr”
a. These are fields in a table referred to as Resident 
Landscape
b. Each “drug regimen nbr” equates to various drugs the 
resident is taking
c. Assignments are fictitious and do not represent any 
resident
Set up Resident ID 
numbers 1 through 10 in 
the database with the 
corresponding drug 
regimen number
Drug Regimen Master Table 
Drug Regimen Nbr Drug Nbr Qty Start Time End Time 
6 130 1 7:30:00 AM 8:30:00 AM 
6 192 1 7:30:00 AM 8:30:00 AM 
7 131 4 7:30:00 AM 8:30:00 AM 
7 143 3 7:30:00 AM 8:30:00 AM 
7 145 1 7:30:00 AM 8:30:00 AM 
8 192 2 10:00:00 AM 11:00:00 AM 
8 143 1 10:00:00 AM 11:00:00 AM 
9 143 1 12:00:00 PM 1:00:00 PM 
10 142 1 12:00:00 PM 1:00:00 PM 
11 130 2 12:00:00 PM 1:00:00 PM 
12 130 1 12:00:00 PM 1:00:00 PM 
 
6. For each drug regimen number, enter a pre-defined 
number that represents one particular drug.  
a. In this example, fictitious resident 2 is assigned to drug 
regimen number 7. Drug regimen 7 illustrates that this 
resident is taking drugs 131, 143, and 145.  See Step 7 for 
the actual drug name and the correlating jellybean.
b. This table is referred to as the Drug Regimen Master.
Assign drug, 
quantity, and time to 
the drug regimen 
number
Drug Register Table 
Drug Nbr Drug Name Drug Candy 
129 Aspirin White 
130 Celexa Orange 
131 Theophylline Purple 
132 Diphenhydramine Pink 
141 Nitrates Black 
142 Pentazocine Yellow 
143 Indomethacin Blue 
145 Zoloft Lime 
146 Digoxin Red 
192 Propranolol  Green 
 
7. For each drug number, assign the actual name of the drug and the 
corresponding jellybean color associated with the simulation.
a. For example, fictitious resident 2 is assigned to drug regimen 
number 7 with drug numbers 131, 143, and 145.  Thus, this resident 
is taking 4 Theophylline (purple), 3 Indomethacin (blue), and 1 
Zoloft (lime).
b. Thus, drawer number 2 will contain 4 purple jellybeans, 3 blue 
jellybeans, and 1 lime jellybean.
Assign actual drug 
to a uniquely 
covered jellybean
End
7
6
5
Setup Simulation in MS Access Application – Step 3Setup Simulation in MS Access Application – Step 2Setup Simulation in MS Access Application – Step 1
Robotic Simulation Setup Continued
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Appendix F: Coded Transcript of Focus Group Discussions 
Theme  
Code 
Theme  Subtheme 
Code 
Subtheme Significant Statement 
1 Reasons for ADEs 1.01 Not paying 
attention 
I think the main reason is simply not 
paying attention. 
1 Reasons for ADEs 1.01 Not paying 
attention 
Not paying attention. 
1 Reasons for ADEs 1.01 Not paying 
attention 
Not paying attention. 
1 Reasons for ADEs 1.01 Not paying 
attention 
Not paying attention to what we’re 
actually doing. 
1 Reasons for ADEs 1.01 Not paying 
attention 
There has been errors to occur 
because I have worked with a nurse 
who had medicine ready to go in one 
patient room then was called into 
another patient room, but she could 
not leave that medicine there. But in 
her haste went into this room with 
this medicine and administered this 
medicine to this patient, because she 
was not paying attention at the time at 
what she was doing, you know 
1 Reasons for ADEs 1.02 Too busy I would say being too busy 
1 Reasons for ADEs 1.02 Too busy Being too busy.  
1 Reasons for ADEs 1.02 Too busy I would say being too busy 
1 Reasons for ADEs 1.02 Too busy Just being too busy and rushing 
around the stuff 
1 Reasons for ADEs 1.02 Too busy Then too, because of patient load they 
want you to go here, here, here and 
here. Now you got everybody calling 
at one time wanting their medicine 
and everyone talking about 
everybody ready to go to sleep. 
1 Reasons for ADEs 1.02 Too busy The workload under the nurse. 
1 Reasons for ADEs 1.03 Limited time When you stock your cart to go out 
for that day, you need to have those 
medications on that cart already 
otherwise if your back in the hall 
you’re having to walk all the way 
back up the nurse’s station to supply 
room to get that extra applesauce or 
pudding. What you encounter from 
the end of that hall from the patient 
you’re currently at, it may take you 
20 or 30 minutes to get back 
depending on the circumstances that 
you ran into, which actually may 
become the priority. So, there’s a lot 
of different factors. 
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1 Reasons for ADEs 1.03 Limited time The problem is that you have one 
hour before and one hour after and 
that what your JACO standards are, 
but it’s absolutely impossible to pass 
those meds during that time 
specifically if you have the lead time 
of…. If one of your patients was let’s 
say their a diabetic and you have test 
them and then you have to stay with 
that patient to make sure that blood 
sugar levels are decreasing based on 
the insulin level. You’ve already lost 
your time. Your testing q15, q20…. 
Ummm you can be up to 45 minutes 
with one patient. You’re way pass 
your window of time to pass those 
meds 
1 Reasons for ADEs 1.04 Stress and 
fatigue 
A lot of times stress and fatigue 
1 Reasons for ADEs 1.04 Stress and 
fatigue 
You may have someone that may 
take an additional shift, because 
someone didn’t come to work. That 
would cause the fatigue that she’s 
speaking of. So yes, I think that 
would also have an impact on it as 
well. 
1 Reasons for ADEs 1.05 Transcription 
errors 
I will say a lot of them can occur by 
misreading a transcription wrong.  
1 Reasons for ADEs 1.05 Transcription 
errors 
Sometimes a doctor’s handwriting 
can come to you and you can’t quite 
read what he has written out or either 
you read it and it is typed in wrong. 
1 Reasons for ADEs 1.05 Transcription 
errors 
Transcription has been the majority 
of what I have seen. 
1 Reasons for ADEs 1.06 Medicine not 
up from the 
pharmacy 
The medicine not being up from the 
pharmacy usually is an issue 
1 Reasons for ADEs 1.07 Unknown 
medical 
history of 
patients 
I think the biggest reason is that we 
see adverse drug events with patients 
are their unknown medical history 
that contradict the use of certain 
medications and in turn we end up 
seeing the adverse drug event when 
it’s too late. 
1 Reasons for ADEs 1.08 Wrong 
patient, 
wrong drug 
Wrong patient, wrong drug.  
1 Reasons for ADEs 1.09 Drug 
received at 
wrong time 
In some of your adverse med errors 
are strictly based on that the patient 
didn’t receive the medication at the 
right time.  
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1 Reasons for ADEs 1.10 Updating 
MAR 
(Medical 
Administrati
on Record) 
The problem with the MAR is that if 
a physician comes in and updates a 
medication it may not be changed 
over into the MAR. So, that can lead 
to some adverse effect and disrupt 
medications. It was the correct 
medication at the time, however, 
because of their symptoms this 
medication has been changed…And 
to no fault of her own, she would be 
charged with the error. Yes, yes. She 
would because the information was 
not updated (in the MAR). Right. 
1 Reasons for ADEs 1.11 Lack of 
continuity of 
care 
I believe one of the largest indicators 
is the lack of continuity of care from 
caregivers in the nursing home. We 
have a high turnover rate and that 
umm… the orientation rate for the 
new nurses can be really stressful on 
them and I believe a lot of our errors 
are from that. 
2 Process of drug 
administration 
2.01 Time and 
effort 
Then I would take those medications 
to the patients room, identify the 
patient, make sure they do have the 
order for the medication I have in 
hand, and proceed with the 
administration. 
2 Process of drug 
administration 
2.01 Time and 
effort 
We have to come all the way down 
from B wing hall to all the way to A 
wing hall, cause A wing is the only 
one with the unit (medicine cart). In 
the middle of the med pass cause the 
resident want a pain pill, so I have to 
stop and come all the way down from 
the B wing hall to come all the way 
over to A wing to get a pain pill. 10 
[minutes] is the max. That is a lot of 
time. With enough nurses using the 
machine or like if they are running 
meds a person would have to wait (on 
machine to retrieve meds). 
2 Process of drug 
administration 
2.01 Time and 
effort 
After the prioritization I go to the 
medication room where I withdraw 
the medication by patient and by time 
individually. 
2 Process of drug 
administration 
2.01 Time and 
effort 
That nurse, like I say, again she just 
goes and she pulls it cause it stripped 
by patients. It doesn’t skip. It’s by 
room, so all of section or room 1 
would be here, room 2 would be here, 
room three would be here. So, when 
they pull the strip and it has the 
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names and there’s blocks in between, 
so you know that once you end that 
white section here this is starting a 
new room. So you know that way 
they not getting jumbled or mixed up. 
2 Process of drug 
administration 
2.01 Time and 
effort 
So, I get my report on my patients. I 
make a list of all the medications that 
are to be administered throughout my 
shift and then I prioritize, you know 
the patients I need to see first. 
2 Process of drug 
administration 
2.01 Time and 
effort 
Well normally you have patients in 
your undesignated space, which is 
normally one or two halls and those 
medications are on your med trays. 
On those med trays though each 
patient is different and individualized, 
so you have to ensure that… and this 
is where a lot of nurses loose time 
and where some errors may come in. 
Some of your patients can’t chew 
medicine and so there gonna have to 
be crushed. So, you have to know 
(other participants agreeing) that and 
that has to be reported to you 
otherwise you’re losing time.  
2 Process of drug 
administration 
2.02 Companywid
e process 
I want to say that they started 
companywide. I know we have one. 
I’m not sure about a couple of the 
other areas, but I know we got 
approved for ours. So I’m just taking 
it that everybody else is using it 
3 Use of 
Technology 
3.01 MAR 
(Medication 
Administrati
on Records) 
We have like a scanning system. It’s 
all computerized. So, it comes up on 
the MAR what the patient is 
supposed to take and we scan each 
medication. So, there’s no paper 
charting or things like that. We pull 
all of our med’s and then we scan 
them and administer them. 
3 Use of 
Technology 
3.01 EMR 
(Electronic 
Medical 
Records) 
Our EMR is fully equipped with a 
scanning system as well as best 
practice alerts to let you know when 
there is medications being given to 
soon or the wrong medication that 
there’s no order for.  
3 Use of 
Technology 
3.01 MAR 
(Medication 
Administrati
on Records) 
As far as what we have our MAR. 
That will tell us when we’re giving a 
medication, if we’re giving a 
medication too soon or if it’s not 
scheduled or the wrong patient, 
wrong medication, whatever. It will 
catch us with that.  
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3 Use of 
Technology 
3.01 MAR 
(Medication 
Administrati
on Records) 
Well, we currently use a cart that’s in 
a MAR (Medication Administration 
Record).  
3 Use of 
Technology 
3.01 MAR 
(Medication 
Administrati
on Records) 
EMAR 
(Electronic 
and ADU 
(Automated 
Dispensing 
Unit) 
They moved everything to the 
electronic MAR or EMR, and the 
ADU automated dispensing unit 
3 Use of 
Technology 
3.02 ADU 
(Automated 
Dispensing 
Unit) 
It [ADU] will stream out 24 hours’ 
worth of medications and the 11 to 7 
shift puts those medications in each 
individual patients slot. So for that 24 
hour period, every medication that 
the patient has taken is put in that 
slot. So like 1:00pm today a RN will 
go in and dispense those medicines 
for that 24 hour period. And she will 
put them per unit… bag per unit and 
then the 11 to 7 nurse goes and take 
them to her unit and again put them 
in the slot cause by the time they 
come in for their shift the slots are 
empty, and it will start over like that 
every night. 
3 Use of 
Technology 
3.03 Best Practice 
Alerts  
I do kind of have a feeling that this 
might be taking away the nurses 
responsibility of doing their checks, 
the patient identified and the five 
rights of medication administration.  
3 Use of 
Technology 
3.03 Best Practice 
Alerts  
However, the good thing is that the 
scanning system does stop us from 
overriding the best practice alerts 
where there is something wrong with 
the administration. 
3 Use of 
Technology  
3.03 Best Practice 
Alerts   
It [ADU] alerts you that it’s not time. 
It would have a time on there that the 
last time. It would have the date and 
the time it was last given. So you 
know you can see in red the date and 
the time that it was given so you 
don’t give it too early because it 
would have on their give every six 
hours or you know so you don’t give 
it too early. 
3 Use of 
Technology 
3.04 PCAS 
(Patient 
We also have things like our IV 
pumps or PCAS. Our PCAS will tell 
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Controlled 
Analgesia 
System) 
us if we were not administering a 
specific narcotic correctly with 
heparin for example. That’s weight 
based so it’s very specific. Stuff like 
that. 
3 Use of 
Technology 
3.05 Robotic 
Technology 
If your robotic can effectively handle 
patient and med safety it would be an 
awesome addition to what we already 
have. 
3 Use of 
Technology 
3.05 Robotic 
technology 
It’s kind a cumbersome that you have 
to keep going back and forth to get 
medicine, go get the medicine and go 
back to the resident, get the medicine 
and go back to the resident. Yes it 
would be an improvement. If your 
robot can follow and go patient to 
patient I mean that works 
3 Use of 
Technology 
3.05 Robotic 
technology 
Yes, it would [save a lot of time and 
effort] because right now if they 
don’t have something cause with this 
ADU is setup if they don’t have 
something they got to leave their unit 
and go get it. 
3 Use of 
Technology 
3.05 Robotic 
technology 
Hopefully in the model that you have 
created… that will not stock the pills 
and the medicines it will also put in 
that drawer the applications of the 
pudding of what they supposed to 
take with those pills they giving. So, 
hopefully the model that you have 
those individualized trays would have 
like she said, the applesauce or the 
pudding in there with that already. 
Like in your model somehow you 
would have to work that into your 
robotic model.  
3 Use of 
Technology 
3.05 Robotic 
technology 
I know Baptist pharmacy they have 
the robot that dispenses the 
medications, but it goes to the med 
cart and then after a pharmacist 
actually puts in a med cart. Then we 
take over the med cart. So, nothing 
actually administering it to us so 
there’s still is error with that. But the 
robot in pharmacy at Baptist… that’s 
the only one that I know of. But it is a 
stationary kind of deal. 
4 Training  4.01 No training  No! 
4 Training  4.01 No training  There’s not. There’s not enough time 
to do that.  
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4 Training  4.03 Training is 
adequate 
 I do believe that it’s adequate to get 
the nurse or the certified medication 
administrator the ability to pass 
medications to patients 
4 Training  4.03 Training is 
adequate 
Yeh, I think so. 
4 Training 4.02 Training is 
inadequate 
Well in my experience the facility 
didn’t have continuing education. 
Like if there was new equipment or 
new mediation. Now there would be 
(drug) reps that would come in and 
talk to us about certain medications 
or you know an IV pump…. They 
(drug reps) might come in and do an 
in service but it’s only a short amount 
time and it’s usually during our shift. 
We’re pulling away from our patient 
to talk with them for about 10 to 15 
minutes and then we go back  
4 Training  4.04 Connect Care 
class 
Like learning how, I mean, when you 
get accepted to being a new nurse you 
learn how to, you know, how to 
administer meds, you go to a Connect 
Care class on the computer to learn 
how to scan the medication. 
4 Training    4.05 Health 
Stream 
We have our annual medication 
requirements that we do on Health 
Stream. So yes, there are available for 
that.  
4 Training   4.06 Medication 
tests 
Every nurse in here takes a 
medication test and yeh as a matter of 
fact you got one coming up. Say it 
again. New and old nurses have to 
take a medication math test and I got 
a new one that’s coming out. It’s got 
IV’s stuff on it so I hope you ready. 
4 Training  4.07 Orientation Well, all staff have to go through an 
orientation and they have go for 
training.  
4 Training  4.08 Training for 
EMR 
(Electronic 
Medical 
Records) 
There have been some trials though 
with new employees coming on to 
our electronic medical records system 
and having to correlate the training 
with the EMR and the medication 
administration. 
4 Training  4.09 More 
training is 
needed 
I think there’s other education that is 
needed to be incorporated 
surrounding, not just surrounding the 
medication administration itself, but 
the rights of the patient when 
administering the medication, , right 
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route, right dose, right time, and of 
course the right medication, 
4 Training  4.09 More 
training is 
needed 
I feel that we have things in place to 
help with that, such as if I try to give 
a med too soon and I scan it, the 
computer is actually going to tell me 
I’m giving it too soon or it would tell 
me this drug is not scheduled right 
now, stuff like that. Ummm, I don’t 
think we actually have training for 
events for that. 
4 Training  4.09 More 
training 
needed 
I also think there’s a lot of 
pharmacology re-education that needs 
to be done when people get out of 
school that we don’t focus as much 
on because we rely too heavily on 
micro medics. 
4 Training  4.09 More 
training 
needed 
I think additional training may help 
with that. I think that is a possible 
yes. 
5 Financial 
incentives   
5.01 Agree  So, off the record I would love to 
give financial incentives to my 
nurses. 
5 Financial 
incentives 
5.01 Agree  Yes, money is a huge incentive to us I 
think. 
5 Financial 
incentives 
5.01 Agree  If we had a financial incentive I think 
we would do better. I mean I feel like 
a financial incentive is a big deal for 
us. So yea, I bet it would bring it 
down. 
5 Financial 
incentives   
5.01 Agree  I think it would motivate a person to 
do what they are supposed to do or 
actually focus more, let me say that.  
5 Financial 
incentives 
5.01 Agree  You have to budget it. If the budget 
allows for it, yes.  
5 Financial 
incentives 
5.01 Agree  That would raise the stakes. Well, I 
think it would actually lead to a lot of 
good things. If you had less adverse 
reactions, one you would retain your 
nurses because they would be 
working in an environment in which 
they will be happy. And that’s your 
goal. And once you can achieve that 
environment you’re going to retain 
that staff. Exactly! Totally agree with 
that. Totally agree with that. 
5 Financial 
incentives 
5.02 Other 
incentives  
There is a certain sense of satisfaction 
you get when you make no mistakes 
at work and I am the type of manager 
that will acknowledge not only the 
mistakes at work but over 
acknowledge the accomplishments 
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and the recognition that need to be 
had on the floor. 
5 Financial 
incentives 
5.02 Other 
incentives 
Or even give them at the end of every 
quarter some kind of recognition, like 
a banquet or just know like a special 
dinner for them, a special catered 
lunch for them. So, they don’t have to 
go out for lunch. We can get them a 
lunch. 
5 Financial 
incentives 
5.02 Other 
incentives 
Well, I don’t know if that… will it 
necessarily have to monetary. It can 
be like a day off or maybe an extra 
hour for lunch. I don’t know about an 
extra hour for lunch, but…. You 
know some type of incentive other 
than monetary. I think any type of 
incentive would encourage or may 
make that employee feel more valued 
and more appreciated. So, yes I 
would definitely be willing to look at 
things like that. 
6 Cost savings 6.01 Reduces 
costs 
Yes, I am not 100% sure what the 
financial aspect that would affect, but 
as far as the numbers go I do believe 
that any decrease in any adverse 
event is going to save the facility 
medications. I think that because with 
medication…. I think seeing the cost 
saving on the treatment that are 
provided to reverse effects… Ummm, 
would be less costly if we prevented 
there ADEs. 
6 Cost savings 6.01 Reduces 
costs 
Yea, because when people make med 
errors people die and get sicker and 
we have to fix that. Yea, it would 
save everybody a lot of money. 
6 Cost Savings 6.01 Reduces 
costs 
Oh yeh, because I mean med errors 
can cause readmission and a lot of 
other problems. I think it would. 
6 Cost savings 6.01 Reduces 
costs 
Yeh 
6 Cost savings 6.01 Reduces 
costs 
Yes, most definitely. Money, time. 
 
 
 
